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The pig is an economically important species, with pork being the most 
widely consumed meat in the world. Genomic technologies have the potential 
to improve reproduction, health and efficiency in the pig industry. Additionally, 
pigs are more similar to humans than species commonly used as medical 
models and improved genomic resources for the pig may facilitate its use in 
medical modelling. The cost of DNA sequencing has greatly decreased in 
recent years, allowing more researchers to incorporate next generation 
sequencing into their projects. Many bioinformatic tools are designed to 
accept a reference genome as a truth against which individuals are 
compared, however most of the available reference genome sequences are 
low-quality drafts. It is important to understand the limitations of available 
reference genomes in order to make full use of the sequencing technologies 
available. Chapter 2 assesses the quality of the published pig draft reference 
genome sequence, Sscrofa10.2, using short-read sequencing data from the 
individual from which the genome was assembled. By identifying regions 
where the reads disagree with the assembly, regions of low-confidence are 
identified and a filter is produced to reduce the impact of these regions on 
genomic analyses. Chapter 3 makes use of exome sequencing data to 
identify variants that are predicted to truncate proteins in 96 pigs, through 
application of filters, including the filter designed in Chapter 2. This is 
reduced to a short list of variants that are likely to have an impact on 
phenotype, specifically variants that may be associated with reproductive 
phenotypes and embryonic lethality. Additionally, imputation from the 96 pig 
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exomes to a larger set of 446 pigs each genotyped for ~60,000 single 
nucleotide polymorphisms (SNPs) with the PorcineSNP60 BeadChip 
(Illumina) is carried out, and variants are investigated for association between 
two reproductive phenotypes and the imputed exome variants using a 
genome-wide association study (GWAS) and a number of candidate genes 
are identified. Chapter 4 uses an alternate method of identifying phenotype 
altering variants by using whole genome sequencing of a trio of individuals 
(sire, dam and affected individual) to search for a genetic cause of foetal 
mummification in pigs. Finally, chapter 5 focuses on improving the available 
resources for the pig by reassembling the pig genome using the latest long-
read sequencing technologies, producing a much improved assembly, 
Sscrofa11.1. The assembly is one of the most contiguous reference 
genomes currently available with a contig N50 of 48.2Mb, only 103 gaps 
remaining (less the Y chromosome) and two closed chromosomes. This 
project improves the available genomic resources for the pig, and identifies 
several putative causal variants and candidate genes underlying important 





Pork is the most widely consumed meat in the world, and it is important that 
we are able to produce enough pork to meet demand. In order to improve 
pork production, it would be beneficial to know exactly why one pig performs 
better or worse than others. Every living thing is made up of cells, and in 
those cells are a set of instructions, or “DNA”, that determine the traits of 
individuals along with environmental influences. We call the full set of DNA in 
the cell a “genome”, and the sections that specifically instruct on how to 
make proteins are called the “genes”. Using equipment called DNA 
sequencers, we can read the instructions. The DNA is written in sequences 
of “bases” (A, G, T and C). Most DNA sequencers can only read a few 
hundred bases at a time. A pig’s genome has roughly 2.6 billion bases. If we 
piece together sequences from the genome we can make a “reference 
genome”, a sequence that represents the order in which the bases are found 
in the complete set of DNA in an individual. Using this we can take the short 
sequences that DNA sequencers produce and compare them to the 
reference to start to understand what is different between individuals, and 
how those differences, or “variants”, affect the traits of the individual. For the 
pig, there is already a reference genome, however, in the second chapter I 
describe methods I used to identify parts of this reference that are badly 
assembled. The genome has many mistakes in it and thousands of gaps. If 
we compare sequences to a reference that doesn’t accurately represent any 
pig this can confuse analyses and make data harder to interpret. In chapter 
3, I use sequences from the genes of 96 pigs and by comparing them to the 
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reference I try to identify variants that cause the protein to be cut short, 
truncating the protein potentially makes it unable to function. I use the badly 
assembled regions from the second chapter to exclude some inaccurate 
variants and identify several variants that might truncate proteins that are 
important for pork production. I also try to relate the presence of variants to 
differences in the breeding success of the pigs. In chapter 4, I look at 
sequences from a piglet that died during pregnancy, and both of its parents, 
to see if the piglet inherited any variants from its parents that may have 
caused its death. Each individual has two copies of a gene, one copy 
inherited from each parent, so even if both parents are healthy, they might 
each have one copy of a damaging variant, and both pass down this copy to 
the piglet. In chapter 2 and 3, badly assembled regions of the reference 
genome made accurate analysis difficult. In chapter 5, I assemble a new 
reference genome using a new kind of DNA sequencer that can read tens of 
thousands of bases at a time instead of only a few hundred. These longer 
sequences make it easier to find overlapping sequences and assemble the 
genome with fewer mistakes and fewer gaps. This new reference genome is 
much more accurate than the previous one and is now available for other 
researchers to use, and should make genome analysis in the pig more 
accurate and useful. This work provides other scientists with better resources 
to work with, and also identifies genetic variants that might cause smaller 
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“Lisa, honey, are you saying you're never going to eat any animal again? 





“Dad, those all come from the same animal!” 
“Yeah right, Lisa, a wonderful, magical animal.” 
-Homer and Lisa Simpson, The Simpsons  
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Some sections of this review have been taken, adapted and/or updated from 
the published review paper Exome Sequencing: Current and Future 
Perspectives (Warr et al., 2015a). The unedited version of this publication is 
in the appendix (section 7.1). The review paper was largely written by the 
author of this thesis, with edits made by the other authors of the review paper 
and minor revisions inspired by anonymous reviewers. Some sections, 
particularly those discussing the latest sequencing technologies, contain a 
small number of citations from the non-peer-reviewed, pre-print server 
BioRχiv owing to the fast-moving nature of advances in the field, however, 
this has been avoided where possible. 
1.1 Introduction 
With increasing human population size, there is a need for increased and 
sustainable production of dietary protein. Globally, pork is consumed more 
than any other meat and demand is increasing (Kristensen et al., 2014, Food 
and Agriculture Organization of the United Nations, 2015). Scientific research 
will play a leading role in the future of meat production to improve traits 
relating to growth, reproduction, feed efficiency, meat quality and disease 
resistance. Identification of loss of function (LoF) variants, including protein 
truncating genetic variants relevant to these traits may allow for selective 
breeding against undesirable phenotypes or targeted editing of these alleles 
to significantly reduce losses in the industry. Importantly, identifying the 
causative allele may allow for this to be applied to populations and species 
other than the one it was identified in. 
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In addition to the pig’s importance as a food source, the species is 
increasingly being used in medical modelling of human diseases. Porcine 
models have repeatedly been found to be more similar to humans than 
murine models genetically, immunologically, neurologically, anatomically and 
metabolically (Meurens et al., 2012, Kapetanovic et al., 2012, Dolezalova et 
al., 2014, Swindle et al., 2011, Bassols et al., 2014). The genome of the pig 
has been found to have almost identical gene content to humans (Meurens et 
al., 2012). Transgenic porcine models have been created for a variety of 
human diseases including Alzheimer’s Disease, Diabetes Mellitus, Cystic 
Fibrosis and cardiovascular disease (Fan and Lai, 2013). Identification of null 
mutations may allow for new models based on homozygous natural variants 
which can be used in biomedical research.  
In order to further investigate the genomes of pigs and other livestock 
species, methods involving cheap and accurate high throughput sequencing 
(HTS) may be used. These methods allow for large cohorts of individuals to 
be sequenced at high depth to explore differences in their genomes. Many 
applications of HTS rely on the availability of a high-quality reference 
genome. Currently, the first step of most sequencing projects is to align reads 
to a reference genome of the same species, or sometimes in the case of 
microorganisms or species which lack a reference, a closely related species 
or strain (Noonan, 2010, Marston et al., 2013, Schubert et al., 2012). Errors 
in the reference genome will introduce errors in downstream applications and 
hinder the identification of important variants through an increase in poor 
mapping and subsequent false-positives (Zhang and Backstrom, 2014, 
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Phillippy et al., 2008, Salzberg and Yorke, 2005). The accuracy of a 
reference genome depends on several factors including the sequencing 
technology used for assembly and its associated errors, the depth of 
coverage sequenced, and the tools used to assemble, scaffold, gap-fill and 
annotate the assembly (Jiao and Schneeberger, 2017, Paszkiewicz and 
Studholme, 2010, Schatz et al., 2010, Watson, 2018). Genome assemblies 
are often fragmented drafts with a high likelihood of misassembly and this 
should be considered when using them as frameworks for analyses in re-
sequencing studies (Paszkiewicz and Studholme, 2010, Salzberg and Yorke, 
2005, Baker, 2012). Additionally, despite older assemblies using a highly 
accurate sequencing technology with relatively long read lengths and 
additional information such as physical maps, these were produced using 
older, more expensive and more laborious assembly techniques with low 
coverage, and are likely susceptible to errors, often remaining in a 
fragmented, draft state (Salzberg and Yorke, 2005). Recent advances in 
long-read sequencing technologies have reduced the difficulty associated 
with accurate genome assembly, particularly with their ability to span large 
repeat regions, which cannot be accomplished with short reads. Current 
long-read sequencing technologies from Pacific Biosciences (PacBio) and 
Oxford Nanopore Technologies (ONT) have a much lower accuracy than 
Illumina’s short-read sequencing technology and older Sanger sequencing 
technology.  
This review will discuss sequencing technologies and methods for the 
characterisation of large complex genomes; methods of genome 
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interrogation focusing on the use of whole genome sequencing (WGS) and 
whole exome sequencing (WES) for the identification of variants; examples 
of the uses of WES in a range of species; and the potential to implement 
these techniques in pigs to find variants that impact economically important 
phenotypes.   
1.2 A Brief History of Genome Assembly 
The first sequencing of the human genome took more than 200 scientists 
over a decade in a project that cost almost $3 billion before it was declared 
complete (International Human Genome Sequencing Consortium, 2004), and 
even with additional resources that have been allocated to this effort since 
then and much improved technology, the human assembly is still not truly 
complete (Liu et al., 2014). Over the past decade the price of genome 
sequencing has plummeted through the use of high-throughput sequencing 
(Mardis, 2008) and so-called next generation sequencing (NGS) 
technologies, much of the work has become automated and methods have 
improved.  
Historically, the assembly of genomes has not been a trivial task and has 
proven a challenge both to sequencing technology and to bioinformatics (Bao 
et al., 2011, Ekblom and Wolf, 2014, Horner et al., 2010, Jiao and 
Schneeberger, 2017, Schatz et al., 2010, Treangen and Salzberg, 2012). 
There is currently no sequencing technology that can demonstrably 
sequence whole chromosomes in a single fragment, it is therefore necessary 




Figure 1-2- BAC-by-BAC assembly involves the 
breaking down of genomes into 200kb segments, 
which are further fragmented before sequencing. 
These sequences must be assembled first into the 
BAC they came from and then into the genome. DNA 
fragments are shown in blue, sequence in yellow, red 
and brown. 
Figure 1-1- Sections of DNA are added to a vector and 
grown in E.coli as Bacterial Artificial Chromosomes (BACs) 
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sequencing data by identifying regions of sequences from smaller fragments 
that are highly similar over a length sufficient to suggest they originate from 
overlapping regions of the genome. Early methods of genome assembly 
employed bacterial artificial chromosomes (BAC) where DNA fragments from 
the species of interest a couple of hundred kilobases in length are inserted 
into the F-plasmids of bacteria which are grown to amplify the fragment 
(figure 1-1) before Sanger sequencing. In this hierarchical shotgun 
sequencing approach the sequenced fragments are then assembled 
individually and subsequently assembled together (figure 1-2; International 
Human Genome Sequencing Consortium, 2004, Groenen et al., 2012, 
Osoegawa et al., 2004).  While BAC-by-BAC assembly typically employs 
Sanger sequencing, which is a highly accurate sequencing technology, it is 
expensive, labour-intensive, uses low-coverage sequencing and can be 
difficult to assemble both within individual BACs and between BACs. Whole 
genome assembly was initially confined to large consortia assembling the 
human genome and the genomes of important medical models due to the 
costs and time required for this method.  
Over the last decade there have been major advances in sequencing 
technology, reducing the cost and increasing throughput (Schatz et al., 2010, 
Watson, 2014). These advances have allowed more researchers to 
sequence a wider range of species at higher depth. The advancements have 
also brought new bioinformatic challenges for assembly, with most HTS 
fragments being much smaller than Sanger sequenced fragments of BACs, 
initially just tens of bases in length, but now hundreds of bases in length (Bao 
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et al., 2011). As a result it is much more difficult to have confidence that 
highly similar sequences originated from the same genomic location. This 
problem is made more challenging by HTS having fluctuating coverage from 
sequencing bias causing some regions to be underrepresented, and by the 
presence of repetitive elements and low-complexity regions in genomes (de 
Koning et al., 2011, Haubold and Wiehe, 2006) which can only be assembled 
confidently by sequence fragments that span their length (Baker, 2012, 
Treangen and Salzberg, 2012, Roberts et al., 2013, Berlin et al., 2015). While 
high-throughput, short read sequencing has made genome assembly a much 
cheaper process, this has proven to be a trade-off against the quality of the 
analysis and assembly of genome sequences and has produced genomes 
that are highly fragmented (Baker, 2012, Salzberg and Yorke, 2005, 
Hernandez et al., 2008). In addition to actually generating and assembling 
sequences, the assembled contigs (or contiguous sequence) must be 
scaffolded and assigned to chromosomes. In the past, scaffolding has been 
done using pairs of short sequences representing the ends of fragments of 
known size such as the end sequences from fragments cloned in BAC or 
fosmid libraries but also uncloned fragments from so-called mate pair 
libraries. Assignments to chromosomes have been done using physical 
mapping techniques such as fluorescent in situ hybridization and radiation 
hybrid mapping. Most researchers, however, do not have these resources 
available for their species of interest and sequence is not always reliably 
assigned to chromosomes, if at all. 
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More recently, sequencing methods that produce long reads have been 
developed and are a popular choice for genome assembly as they can be 
assembled into highly contiguous sequences (contigs) and span large 
regions that cannot be assembled by shorter reads (Roberts et al., 2013, Jain 
et al., 2018a, English et al., 2012). The longer contigs produced make 
assigning sequence to chromosomes easier in species where there is some 
knowledge of gene positions, and a small number of scaffolds can often be 
obtained per chromosome. Again, this advance introduced new bioinformatic 
challenges with an even higher error rate than the previous generation of 
sequencers, but with the advantage that relatively few regions cannot be 
incorporated into contiguous sequence (Berlin et al., 2015). 
1.3 Important Developments in Sequencing 
Technologies and Associated Tools for 
Genome Assembly 
1.3.1 Sequencing technologies 
There are a number of platforms used for short read sequencing including a 
range of Illumina (CA, USA; formerly Solexa, Cambridge, UK) platforms, Ion 
Torrent (Life Technologies, CA, USA) and 454 Pyrosequencing (454 Life 
Sciences/Roche, Switzerland; discontinued). Short read technologies are 
based on sequencing by synthesis (SBS) and generally involve fixing DNA 
molecules in place in a nanowell, or on a surface or bead with nucleotides 
and polymerases in solution. The DNA is amplified (usually through PCR) to 
form a cluster of identical strands. By denaturing the DNA and synthesising a 
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complementary strand, the base incorporated can be detected in a way that 
differs by technology: coloured fluorescent tags in Illumina, natural release of 
hydrogen atoms during base incorporation in Ion Torrent, and a flash of light 
from luciferase in 454. These technologies have a number of restrictions and 
flaws, notably most involve a PCR step to amplify each strand so that base 
incorporation is detectable. PCR creates bias as it is less reliable in GC- or 
AT- rich regions (Shin et al., 2013, Aird et al., 2011, Chen et al., 2013) and 
these may be underrepresented in the final product. Illumina now offer 
methods using polymerases with less extreme GC-bias and library preps that 
are PCR free to overcome these problems, and these have been found to 
perform better in these regions (Rhodes et al., 2014, Williams et al., 2012). 
Perhaps the most important limitation of these platforms is the read length. 
The addition of bases in waves is not entirely efficient and strands from the 
same cluster can skip ahead or lag behind which creates noise in the signal, 
the more sequencing cycles pass, the more strands will become out of sync 
until the true signal is completely obscured, this is called phase error (Fuller 
et al., 2009). While 454 sequencing has fallen out of use, Illumina and Ion 
Torrent remain, with Illumina being the most widely used and accurate short 
read HTS technology available. Recently Illumina sequencing has been 
improved in the HiSeq X series through the introduction of ordered flow cells 
in which clusters are formed in nanowells. These clusters are more densely 
packed and lead to more usable data per flow cell than clusters formed on a 




Figure 1-3- In areas with tandem repeats (represented by 
coloured blocks), short reads (top) will often produce 
either a collapsed repeat or an unresolved gap (grey). 
Long reads that are able to span the entire repeat region 




While they have high throughput and are accurate on the sequence level, the 
short length of these reads make them a poor choice for genome assemblies 
as they cannot span low-complexity regions and repeats. Assemblies using 
only short-reads will often fragment in low-complexity or repeat regions 
(figure 1-3; Roberts et al., 2013).  
Recently, new technologies have emerged that overcome many of the 
problems encountered by short read sequencing technologies. Long read 
sequencing technologies from Pacific Biosciences (PacBio) and Oxford 
Nanopore Technologies (ONT) do not need to amplify DNA and do not suffer 
from phase error, they also sequence in real-time, not requiring cycling 
waves of base incorporations. While currently short read sequencing from 
Illumina remains the HTS technology with the highest sequence accuracy, 
long read sequencing can span complexities in genomes and allow for much 
more complete and contiguous assemblies.  
In PacBio sequencing, the polymerase rather than the DNA is held in a fixed 
position in a well called a zero-mode waveguide (ZMW) which holds a small 
enough volume that cleaved fluorescent tags can be detected from base 
incorporation. The double stranded DNA molecule has a hairpin with a 
recognisable sequence ligated to each end and when a nucleotide in the 
hairpin interacts with the fixed polymerase sequencing is initiated. 
Fluorescently tagged nucleotides in solution are incorporated by the 
polymerase into the DNA strand and the tag is cleaved, detected and diffuses 
out of the ZMW. Owing to the hairpins on each end of the strand and 
depending on the length of the strand, each strand can be read multiple 
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times allowing for a consensus sequence with increased accuracy, this is 
limited by the functional life time of the polymerase and for longer fragments 
will include fewer passes (Rhoads and Au, 2015). One of the major 
limitations of PacBio sequencing is its error rate of 11-15% (Rhoads and Au, 
2015, Korlach, 2015). While errors in PacBio data are often stated to be 
randomly distributed, they are more common in homopolymers. Errors are 
likely caused by failure of the fluorescent tags to diffuse quickly enough, tags 
diffusing too quickly to properly detect or dissociation of a nucleotide from the 
active site before phosphodiester bonds have formed, resulting in indel errors 
(Eid et al., 2009). This means that for PacBio reads to be accurate there 
must be redundancy in the sequencing (Chin et al., 2013). However, this 
need for redundancy is common to most sequencing strategies and 
technologies, including the highly accurate Illumina technology and is evident 
in the need for high sequence coverage of the target genome during 
assembly. For example, the DISCOVAR strategy for assembling draft 
genome sequences based solely on Illumina data requires sixty-fold genome 
coverage (Weisenfeld et al., 2014). If fragment lengths are long, as is 
desirable in genome assembly, there may not be a sufficient number of 
passes over the sequence to correct the read before the polymerase fails. 
Consequently, high coverage or the use of more accurate short reads is 
necessary to correct the reads. Additionally, due to the indel errors being 
more common in homopolymers, these regions tend to be inaccurate even 
after error correction. For certain applications, such as Iso-Seq which is a 
PacBio protocol for RNA sequencing, there are usually a sufficient number of 
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passes over a single fragment to attain a high accuracy sequence without the 
use of alternate technologies to correct them (Sharon et al., 2013). 
ONT’s sequencing method differs from those mentioned so far in that it does 
not involve a polymerase incorporating bases and is the only sequencing 
technology to detect the template DNA sequence itself and not base 
incorporation during complement synthesis (Loman and Watson, 2015). In 
ONT sequencing a pore is fixed in a membrane and an ionic current is run 
through the pore, the DNA is guided through the pore by the electrophoretic 
effect of the current. A motor protein restricts the speed that DNA can pass 
through the pore and disruptions in the current are measured as the DNA 
passes through the pore, the bases can be determined by the pattern of 
disruption to the current, or “the squiggle”. ONT has produced the longest 
read length of any of the sequencers, with their “ultra-long” reads recently 
exceeding 2 Mb (Payne et al., 2018). There are several forms of library 
preparation for the platform that have different accuracies, read lengths, 
presence or absence of incorporation of the compliment sequence and 
protocol lengths for different applications. ONT’s MinION sequencer is the 
smallest and cheapest sequencer available and has received much attention 
for its portability, being used during disease outbreaks (Hoenen et al., 2016, 
Quick et al., 2017, Quick et al., 2016), in the Antarctic and down mines for 
environmental samples (Johnson et al., 2017, Edwards et al., 2017) and on 
the International Space Station (Castro-Wallace et al., 2016), to name a few. 
Similarly to PacBio, ONT has a higher error rate than short read 
technologies, at 15%, and these are largely random, but occur non-randomly 
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in homopolymeric regions as these cause the squiggle to remain constant 
and currently the number of bases must be determined by the length of time 
the signal is constant (Lu et al., 2016). The majority of errors can be 
corrected with a consensus from high coverage and ONT predict that those 
remaining in homopolymers will be corrected through improvements in base-
calling and modifications to the pore. Thus far, ONT have not been major 
competitors to PacBio and Illumina owing to lower throughput and higher 
error rates, however with accuracy improving, lower costs and the availability 
of new, larger sequencers GridION (up to 5 flow cells) and the more efficient 
PromethION (up to 48 flow cells), ONT sequencing is becoming increasingly 
popular in the field of genome assembly with a number of  genomes being 
assembled using this technology (Jansen et al., 2017, Loman et al., 2015, 
Jain et al., 2018a, Risse et al., 2015). However, currently PacBio is still the 
more commonly used of the two for large genome assembly. 
1.3.2 Genome assembly tools 
Both ONT and PacBio have presented new challenges for bioinformatics 
tools through the length of their reads and their higher error rates. Most 
bioinformatics tools before these technologies were optimised for short and 
highly accurate Illumina data and tools have had to be modified and designed 
anew for sequence base calling, read correction, assembly, sequence 
alignment and variant calling that account for the differences in the 
technologies.  
There are a large number of genome assembly tools for short read 
sequencing including Velvet (Zerbino and Birney, 2008), SOAPdenovo2 (Luo 
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et al., 2012), ABySS (Simpson et al., 2009), Opera (Gao et al., 2011) and 
Celera (Myers et al., 2000). Tools for long-read assemblies include those 
which assemble using only long reads, and hybrid assemblers that make use 
of both long and short reads. Assembly tools for long read sequencing 
include Canu (Koren et al., 2017), Falcon (Chin et al., 2016), Tulipa-julia 
(Formerly Tulip; Jansen et al., 2017) and Miniasm (Li, 2016).  
Assembly tools fall into four major classes of assembly paradigms: overlap-
layout-consensus (OLC), string graph, greedy assemblers and de Bruijn-
graph (Nagarajan and Pop, 2013). OLC assemblers identify overlapping 
sequence using an all-against-all alignment, create a layout graph based on 
the alignment with a node for every read and an edge between reads that 
overlap, and create a consensus sequence for the contig (Pop, 2009). De 
Bruijn graphs break the reads into k-mers and link the k-mer nodes based on 
the order in the reads, assembling the genome by finding the most likely path 
through the nodes based on the links provided by the reads (Pevzner et al., 
2001). De Bruijn graphs rely on accurate sequence, so long reads must be 
corrected before assembly with this approach (Nagarajan and Pop, 2013). 
String graphs are very similar to OLCs, but they remove redundant 
information from the graph, reducing the computational resources required 
(Nagarajan and Pop, 2013, Myers, 2005). Unlike de Bruijn graphs, string 
graphs do not reduce the assembly to k-mers but can have nodes of any size 
allowing them to retain more information. Greedy assemblers assemble 
based on the alignment that has the greatest immediate benefit beginning 
with the most well aligned sequences and extending from there, if the 
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placement of the read does not contradict already placed sequence, it will be 
placed (Pop, 2009). Greedy assemblers are prone to misassembly and while 
early assemblers used this paradigm, they have largely been replaced by 
more selective methods. OLC can be very computationally intensive, 
particularly with high-depth short-reads, as each read essentially acts as a 
node, whereas with de Bruijn graphs, in theory the number of nodes is equal 
to the genome size regardless of depth of coverage, however sequence 
errors will introduce novel false k-mers and these will increase with coverage. 
De Bruijn graphs also have benefits over OLC by not carrying out a 
computationally intensive alignment step, and from the fact that the k-mers 
already contain consensus information (Li et al., 2012, Nagarajan and Pop, 
2013). Depending on k-mer size and repetitive content of the genome being 
assembled, de Bruijn graphs are more likely to struggle with crossing repeat 
regions as the sequence has been broken down into smaller chunks that will 
not span them. De Bruijn -graphs may also struggle to separate similar 
sequences from multiple loci across the genome (Nagarajan and Pop, 2013). 
String graphs handle repeats better as they do not break the reads down into 
k-mers and in fact the nodes are often longer than the reads having been 
formed from overlaps between reads, better incorporating repeats into the 
assembly (Myers, 2005). The successful assembly of repeat regions in a 
string graph depends on the ability of the sequencing technology to span 
them. On the computational side of things, string graphs have solved the 
problem of genome assembly. The limiting factor for genome assembly now 
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is the length of repeats in the genome being assembled and the ability of the 
sequencing technology to span these. 
Following assembly of contigs, they ideally need to be ordered and oriented 
with respect to the position they fall on the chromosome, this process is 
called scaffolding. In the past, methods such as radiation hybrid mapping, 
linkage mapping, physical mapping and fluorescence in-situ hybridisation 
have been used to order and orient contigs and assign them to 
chromosomes. These methods are labour-intensive and expensive. 
Computational methods are much cheaper and more widely used at present, 
though often do not successfully create chromosome-assigned assemblies 
without additional data. 
Assembly tools often have their own associated scaffolder, though 
standalone scaffolders are also available. A common method of scaffolding is 
to use long reads or paired reads such as BAC end libraries, fosmid libraries, 
mate pair libraries or paired end libraries. Paired reads are reads from the 
ends of a molecule whose length is known approximately and where the 
orientation of the reads relative to each other is known. Where one read 
aligns with one contig (contig A) and its paired read aligns with a different 
contig (contig B) then contig A can be linked and oriented relative to contig B 
(figure 1-4). The data is aligned with the contigs and string graph or greedy 
algorithm is used to find likely joins between contigs. For the graph-based 
scaffolders, the contigs are the nodes and the joining reads provide the edge 




Figure 1-4- Paired reads, when aligned to contigs, may align with one of the pair each 
on separate contigs (red), as the approximate distance and orientation relative to each 
other is known, the two contigs can be placed adjacently in the correct orientation 
with a gap between them of an estimated size. Here approximately 120kb of contigs 
are spanned by a pair that originated from a fragment of approximately 200kb, so the 
gap size can be estimated at 80kb. 
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 the gap sizes between the contigs can be estimated reasonably accurately. 
The use of paired read data can be effective, but in cases where the gap is 
larger than the library’s insert size, the gap cannot be closed. An example of 
a greedy assembler is SSPACE (Boetzer et al., 2011) and examples of graph 
based assemblers are ABySS (Simpson et al., 2009), AHA (Bashir et al., 
2012), BESST (Sahlin et al., 2014), GRASS (Gritsenko et al., 2012), MIP 
(Salmela et al., 2011), Opera (Gao et al., 2011), SCARPA (Donmez and 
Brudno, 2013), SGA (Simpson and Durbin, 2011), SOAPdenovo2 (Luo et al., 
2012) and SOPRA (Dayarian et al., 2010). Scaffolders like these may be 
more effective with end sequences from libraries with very large insert sizes 
such as BAC libraries. The data used for assembly may not be sufficient to 
close the gaps, particularly in regions where the gaps exist due to low 
coverage. Although the price of sequencing is dropping, scientists working on 
species that are not directly related to human health and food security may 
not be able to afford extra sequencing to close these gaps. A universal set of 
BACs for scaffolding, designed based on knowledge of evolutionary break 
points, has been put together for birds (Damas et al., 2017) with plans to do 
the same for mammals, while this does risk introducing false joins, these can 
potentially be identified and corrected later in the process. 
An alternative method of scaffolding is to align the contigs with the genomes 
of one or more closely related species and attempt to order and orient the 
contigs based on these genomes. This can be done with or without additional 
paired end data. As the number of available reference genomes increases, 
this becomes a more attractive option. However, the method relies on the 
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accuracy of the reference genome(s) and the relationship between the 
species used. Even the most closely related species can have evolutionary 
break points that will complicate this process and increase the potential for 
false joins and as such it is fairly error prone. Examples of tools that use this 
method are MeDuSa (Bosi et al., 2015), RACA (Kim et al., 2013), Ragout 
(Kolmogorov et al., 2014), CONTIGuator (Galardini et al., 2011) and 
scaffold_builder (Silva et al., 2013). 
The quantity and context of gaps remaining in the assembly after scaffolding 
will depend on the sequencing technology, depth of sequencing and 
assembly method used (Hunt et al., 2014). Assemblies using only short-
reads will have a large number of gaps, particularly in repetitive regions that 
cannot be spanned by the length of the read. Other gap-causing features of 
short-read data include sequence that appears in multiple loci across the 
genome and fluctuating coverage often caused by GC-bias. The number of 
gaps can be reduced through the use of gap fillers. Scaffolding adds 
information to the process of extending contigs by identifying the sequence 
that sits either side of the gap (figure 1-5), which can help to find the specific 
sequence that fits there using either long reads that span the gap, through 
assembling long reads that reach into the gap, or using paired-end and mate-
pair data in short-reads to assemble the missing sequence. Examples of 
tools for gap filling are PBJelly (English et al., 2012), GapFiller (Nadalin et al., 




With the high error rate of long-reads, additional tools are needed for error-
correction before and after assembly. Some of these tools use only the long 
reads and correct by aligning the reads to themselves or to assembled 
contigs and taking a consensus sequence for example, Quiver (Chin et al., 




Figure 1-6- Long DNA fragments can have specific motifs labelled and 
visualised. The same motif can be identified in the assembled contigs to 
create a kind of bar code that helps determine the correct order of the 
contigs and estimate gap size. This is the process used by Bionano. 
Figure 1-5- During assembly a gap may be caused by there being multiple possibilities 
for which contigs belong together, using alternative methods to scaffold can provide 
enough information to close the gap with a gap filler. In this case, once it is known 




(Loman et al., 2015). Others align highly accurate short reads to the long 
reads or contigs and correct them based on the more accurate reads, for 
example Pilon (Walker et al., 2014). The use of accurate short reads to 
correct the assembly is self-evidently limited by the ability to map the short 
reads to unique locations in the assembly. Thus, it is likely that correction of 
repetitive sequences will be less effective. These tools essentially behave 
like variant callers, altering the reference where there are high-confidence 
homozygous SNPs or indels.  
1.3.3 Additional methods for scaffolding and improving 
contiguity 
The problem of scaffolding has been significantly decreased by long-read 
sequencing as there are far fewer contigs following initial assembly and the 
contigs are longer. Several companies now offer additional specialised 
sequencing with various methods to improve the contiguity of contigs from 
long reads and improve scaffolding, a few of these will be briefly discussed. 
Optical mapping using systems such as Bionano use enzymes to nick DNA 
at specific sequence motifs and hybridise fluorophore-labeled probes at the 
location of the nick, the DNA stand is then imaged in a nano-channel and the 
pattern of flourophores can be recorded along with approximate distances 
(figure 1-6). The “barcode” of the motif from the imaging can then be 
matched up with the locations the motif occurs in sequenced contigs to order 
and orient the contigs (Das et al., 2010). Phase Genomics offers Hi-C 
sequencing (Belton et al., 2012, Lieberman-Aiden et al., 2009), a method that 
can reveal the three dimensional structure of folded DNA in the cell. 
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Formaldehyde is used to create cross links between chromatin while the 
DNA is still in the cell. The DNA is then fragmented with restriction enzymes 
and sticky ends are closed with biotinylated and thiolated probes, the 
crosslinks are reversed, and biotinylated fragments are pulled down. The 
biotinylated probes are then removed, and the fragments are sequenced 
using an Illumina sequencer. When the fragments are sequenced they yield 
paired ends that originate from varying distances apart on the strand, 
however the more frequently two sequences appear linked, the more likely 
they are to have been in close proximity to one another in the cell. This 
allows both for scaffolding and for identification of biologically relevant 
physical proximity of different regions of the genome in the cell. Dovetail use 
a method similar to Hi-C sequencing. In a Dovetail Chicago library, chromatin 
is reconstituted upon naked DNA, instead of using naturally occurring 
chromatin. This provides similar scaffolding information, but removes any 
connections caused by biologically relevant physical proximity of DNA in 
order to reduce the associated noise from such interactions. Dovetail’s 
HiRise pipeline can then scaffold contigs based on the linkage information 
from these reads and the probability that sequences were in close proximity 
(Putnam et al., 2016). 10X offer artificial long reads which can be used for 
assembly, scaffolding and phasing based on methods by Zheng et al. (2016). 
These long reads are created by separating the source DNA into droplets 
containing a relatively small amount of the genome each (figure 1-7), where 
each droplet has a unique sequence tag which is attached to the DNA during 




Figure 1-7- The genome is fragmented into pieces 
>50kb in size and each fragment is placed in an 
individual droplet, fragmented and barcoded. 
Following Illumina sequencing the barcodes allow 




sequence tag allows reads that originated from the same location to be 
identified and used to scaffold contigs (Kitzman, 2016). The 10X Genomics 
approach can also be used for assembly, essentially employing a divide and 
conquer approach that breaks the assembly of a complex genome into a 
series of smaller and more tractable assembly challenges reminiscent of the 
BAC-by-BAC approach but at much greater depth. 
1.4 The Future of Genome Assembly 
A number of projects have been set up to increase the number of species 
with high quality reference genomes, including the Vertebrate Genome 
Project (Vertebrate Genomes Project, 2018), the Bird 10,000 Genomes 
project (Zhang, 2015) and the Oz Mammal Genomes project (Oz Mammal 
Genomes, 2016). These projects provide recommendations of technologies 
and methods that should be used to sequence, assemble and annotate 
genomes to get the best quality reference assemblies. The Vertebrate 
Genome Project, for example, currently recommend PacBio sequencing at 
60X or greater, assembly using Falcon unzip (Chin et al., 2016) and error 
correction with Arrow. For scaffolding they recommend Bionano with at least 
2 enzymes at 80X coverage and/or 10X linked reads. They recommend this 
is followed with further scaffolding using Hi-C at 100X. Gap filling should be 
carried out using PBJelly (English et al., 2012). Finally, the assembly should 
be polished using Illumina with at least 50X coverage. The Vertebrate 
Genome Project aims to sequence ~66,000 genomes based on taxonomic 
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hierarchy, beginning with 266 genomes (one genome from each order) in 
phase 1. 
While reference genomes such as these will likely be invaluable to biological 
research, as the currently available genomes have been, the concept is 
imperfect. It was recognised before the first human genome was sequenced 
that treating a single individual as a reference for a variable population is a 
flawed approach (Walsh and Marks, 1986). For many species, assembling a 
genome from a single individual is standard, even though the assembly does 
not truly represent that individual. Most reference genomes represent haploid 
genomes of diploid or polyploid species, meaning that they often switch back 
and forth between haplotypes and consequently do not truly represent the 
genome of any single individual or haplotype (figure 1-8). Additionally, 
reference genomes such as the human genome (International Human 
Genome Sequencing Consortium, 2004) and genomes of microorganisms do 
not represent a single individual, with reference genomes incorporating all 
sequence across a range of individuals in a single linear reference. 
Incorporating sections of sequence into a linear genome that do not 
consistently occur in all individuals in the species or population, such as race-
specific regions in humans, cause the reference to be fragmented, however, 
leaving this sequence out prevents complete analysis of individuals carrying 





Figure 1-8- Linear reference genomes assembled from diploid species often flip back 
and forth between the haplotypes without accurately representing either individual. 
Graph reference genomes incorporate both haplotypes. 
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In mice, multiple assemblies are being used to represent different lines within 
the species (Keane et al., 2011, Yalcin et al., 2012a, Yalcin et al., 2012b), 
and similarly multiple assemblies are now being produced for cattle. 
Currently, however, there are still many species lacking a single high-quality 
reference and the teams such as Ensembl that make reference genomes 
accessible as annotated sequences in public domain genome browsers are 
reluctant to accept multiple references for a single species. To better 
incorporate alternative sequences into an assembly without causing 
fragmentation or the need for multiple linear assemblies, graph based 
reference genomes (figure 1-8) have been discussed (Myers, 2005, 
Compeau et al., 2011, Church et al., 2015, Church et al., 2011). New 
reference formats present new challenges for methods of genome 
visualisation, annotation and analysis. While these formats will better 
represent the species, commonly used analysis tools cannot currently accept 
them and the addition of multiple haplotypes across the genome may 
increase compute time for already time-consuming parts of analyses such as 
alignment and variant calling. For these to become more commonly used, the 
community will need to put considerable effort into creating and validating 
new tools and agree on file formats, this will likely delay their uptake. One of 
the benefits of linear genomes is the fixed co-ordinate system that allows for 
simple recording and visualisation of additional data such as gene 
annotation. The visualisation of graph genomes in particular would be 
difficult. Currently linear genomes are presented as one or more sequences 
with “N”s indicating gaps where the assembly is incomplete, visualisation 
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tools are designed to display genomes with a variety of annotation tracks 
(Gundersen et al., 2011). If a simple way of visualising graph genomes and 
associated information cannot be designed, this may discourage their use. 
New methods have been used to create phased, diploid genome assemblies 
of diploid species using long reads to better represent the haplotypes present 
in the individual being sequenced (Chin et al., 2016). Recently advances 
have been made in the phasing of large genomes in individuals that are 
hybrids of two highly divergent breeds. Hi-C sequencing of the individual 
allows the two divergent haplotypes to be largely separated, effectively 
producing two haploid, phased assemblies, one representing the haplotype 
received in the gamete from each parental breed. This has recently been 
incorporated into the Falcon assembly pipeline as an optional module and is 
known as Falcon-Phase (Kronenberg et al., 2018). Trio binning can also be 
used without Hi-C data, where the F1 individual and both of its parents are 
sequenced without additional scaffolding information, the F1 animal using 
long reads and the parents using short reads. The haplotypes can be 
effectively separated using only this data by identifying k-mers from each 
parental genome in the short read data and associating the long reads with 
these. The effectiveness of this method depends on the heterozygosity of the 
F1 animal (Koren et al., 2018). Traditionally, individuals that were particularly 
inbred were preferred for genome assembly to try to reduce heterozygosity 
as much as possible and reduce the impact of switching from one haplotype 
to another in the linear assembly. In the future, it is likely more F1 hybrid 
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individuals will be sequenced and haplotype resolving methods employed to 
establish two haploid genomes. 
Furthermore, with advances in assembly techniques and long read 
sequencing length, accuracy, throughput, and affordability, some speculate 
that reference genomes will become obsolete with genomes being 
assembled de-novo on a project-by-project basis. While this is technically 
possible, particularly for species with smaller, less complex genomes, this 
comes with high costs and a computational burden both in terms of carrying 
out the assembly and in storing and analysing the data, with additional 
challenges in terms of annotation and the lack of fixed coordinates which will 
impact on communication of results. For extremely large genomes (Leitch et 
al., 2010) and for repetitive and/or polyploid genomes, as is the case in many 
plant genomes such as the wheat genome (hexaploid, >50% repetitive 
content; Garbus et al. (2015)), this is extremely unlikely to be feasible any 
time soon. Another option, however, is reference-guided assembly. By 
aligning relatively low coverage long-read data and Illumina WGS data to the 
species’ reference genome, small and large structural and base-level 
variation can be found and the reference genome can be modified to 
represent a new individual (Schatz, 2018; 
https://github.com/schatzlab/crossstitch). It is not entirely clear how well this 
method would handle large translocations or spans of sequence that are 
present in the new individual, but absent in the reference, which would 
essentially require a small de-novo assembly. However, this may be a much 
more cost-effective way to produce multiple genomes. 
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1.5 The Pig Genome 
The importance of the pig in agriculture and as a biomedical model has 
driven a large amount of research on the pig genome (Groenen, 2016). 
Previously, linkage maps have been used to aid identification of quantitative 
trait loci (QTL) in the pig genome (Archibald et al., 1995, Rohrer et al., 1996), 
these maps provided researchers with a number of microsatellites to use in 
mapping experiments for important traits (Rathje et al., 1997). Subsequently, 
chips for genotyping thousands of single nucleotide polymorphisms (SNPs) 
were developed (Ramos et al., 2009) and exploited in genome-wide 
association studies (GWAS) to map QTL. To date 26,076 QTL representing 
647 different traits and published in 601 papers are recorded for pigs in the 
Animal Quantitative Trait Loci Database (AnimalQTLdb; 
https://www.animalgenome.org/cgi-bin/QTLdb/index, accessed 19th April 
2018). Research using comparative mapping suggested a high degree of 
similarity between the pig and human genomes, though with gene order 
variations between the two species (Sun et al., 1999). This degree of 
similarity is not observed between humans and mice. 
Sanger sequencing technologies were applied to the pig genome with an 
initial assembly using 0.66X coverage (Wernersson et al., 2005), this 
assembly further supported the previously observed similarities between 
human and pig sequences and suggested a high similarity in isochore 
structure. More recently the Swine Genome Sequencing Consortium (Schook 
et al., 2005) published the Sscrofa10.2 draft reference genome assembly of a 
Duroc sow using BAC-by-BAC assembly techniques similar to those used to 
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complete the first human genome (Groenen et al., 2012). While the assembly 
used the best tools available at the time, evidence suggests there are a 
number of errors (Warr et al., 2015b) including an unexpectedly large number 
of structural variations occurring across all individuals in studies (Paudel et 
al., 2013) and likely misplaced sequence creating false signals in genome 
wide association studies (van Son et al., 2017, Yang et al., 2013). In addition 
to not being entirely accurate this assembly still has gaps, portions of 
sequence on unplaced scaffolds and portions of sequence completely 
missing. However, it has allowed for extensive analysis of the genome and, 
with the continued decrease in sequencing costs, many resequencing studies 
have been carried out that would not be possible without the assembly and 
associated annotation. In addition to the publication of the assembly, 
analyses by Groenen et al. (2012) provided evidence of genomic changes 
involved in the evolution of the suid lineage; evidence of at least two 
independent centres of domestication in Europe and Asia, respectively; and 
signatures of selection in the genome. Another genome assembly of a 
Chinese breed, the Wuzhishan miniature pig has also been produced (Fang 
et al., 2012). This assembly is said to more closely resemble other Chinese 
breeds than the Duroc breed assembly does, it is however even more 
fragmented than Sscrofa10.2 as it was assembled using Illumina short-reads.  
Recognising that the reference genome is incomplete, Li et al. (2017a) 
sequenced nine pig breeds (Hampshire, Berkshire, Landrace, Pietrain, Large 
White, Bameim Jinhua, Meishan and Rongchang) using 100X Illumina 
sequencing and assembled them using SOAPdenovo. While these 
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assemblies are highly fragmented, the authors were able to identify over 
1000 genes in each assembly that were missing in Sscrofa10.2 including 871 
that were assembled in all nine genomes and the Tibetan wild boar genome 
(Li et al., 2013a) and are likely erroneously missing from Sscrofa10.2.  
The use of genomic data, currently largely in the form of SNP chips, is 
becoming very common in pig breeding, and owing to the relatively short 
generation interval and the high number of individuals per litter, has the 
potential to increase the frequency of beneficial variants and purge 
detrimental variants at a rapid rate. The use of technologies such as SNP 
chips relies on variants from a stretch of the genome being inherited 
together, or linkage disequilibrium (LD).  The level of LD depends on a 
number of factors relating to population history including the size of the 
founding population, the level of inbreeding and the level of migration. LD is 
also influenced by natural and artificial selection, genetic drift and effective 
population size. LD is not constant across the genome and is affected by 
patterns of recombination. Studies have demonstrated that there are 
genomic features that influence the rate of recombination, these include GC 
content, repeat elements, gene density, level of gene expression, 
nucleosome formation and epigenetic modification. Recombination rates also 
vary by position on the chromosome, sequence complexity, location of 
specific sequence motifs and the gender of the individual (Tortereau et al., 
2012, Paigen and Petkov, 2010, Myers et al., 2008, Kong et al., 2002). In 
pigs, recombination rates have been shown to be higher in females than 
males, with the exception of chromosome 1 which is likely due to a large AT 
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rich region on the chromosome. Recombination in females is substantially 
reduced in AT rich regions, with males being less sensitive to this sequence 
context (Tortereau et al., 2012, Meunier and Duret, 2004). Regardless of 
gender, the highest recombination rate in pigs occurs on chromosome 12, 
with the lowest occurring on chromosome 1 (Tortereau et al., 2012). As has 
been found in other species, recombination hot spots in pigs tend to cluster 
around the chromosome end regardless of the position of the centromere 
(Tortereau et al., 2012). There is evidence in domestic breeds of increased 
LD in regions under strong selection for production traits, particularly where 
previous studies have reported QTL and genes that may be associated with 
important production traits (Amaral et al., 2008, Nsengimana et al., 2004). 
The different population histories of Chinese and European breeds are 
evident in the differing level of LD between these groups. Chinese breeds 
tend to have lower LD than European breeds (Amaral et al., 2008, Ai et al., 
2013), which is consistent with Chinese breeds being more diverse than 
European breeds. This likely ties in with both the differing breeding and 
selection practices between Western and Asian farms, and the differing sizes 
of the founding populations (Amaral et al., 2008). European wild boar have 
LD between that of domesticated European and Chinese breeds, this 
relatively high LD in wild boars is likely due to a population bottleneck that 
caused extinction of wild boars in the British Isles and Northern Europe 
leading to higher levels of inbreeding in the wild populations (Amaral et al., 
2008). Amaral et al. (2008) reported a maximum haploblock size of 400kb in 
European breeds and 10kb in Chinese breeds. Similarly, Veroneze et al. 
37 
 
(2013) found that in six commercial pig lines the average block size was 
~395kb with blocks of 100-400kb being most common in all lines. Studies 
have found that the rate of LD decay in pigs is slow, which is beneficial to 
selective breeding efforts as SNP associations with causative variants will 
break down less often, reducing the need for frequent marker reassessment 
and allowing for the use of relatively low density SNP chips (Amaral et al., 
2008, Akanno et al., 2014, Badke et al., 2012, Veroneze et al., 2013).  
1.6 Interrogating a Genome 
1.6.1 Why use genomics in animal breeding? 
Historically in agriculture, selection for improvement has centred around 
breeding high performing individuals together to produce high performing 
offspring (Hill, 2014). The problem with this method, particularly in livestock, 
is that it is very time consuming and expensive. For this method the animal 
must be kept until the phenotype of interest can be measured, with the 
potential of wasting money rearing poor performers. One way around this is 
to use an estimated breeding value (EBV), using known data of the 
performance of the parents and siblings to estimate the performance of the 
individual using best linear unbiased prediction (BLUP; Henderson, 1975). 
Usually an EBV incorporates a number of different phenotypes and may 
include data from individuals in different environments. This method is faster 
than traditional methods, however with no information on the underlying 
causes of differences in phenotype it is not entirely efficient. In specific cases 
where a genetic cause or strong association with a marker is known, these 
specific loci can be tested using PCR-based or restriction fragment length 
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polymorphism methods for application in marker assisted selection (Muir, 
2007, Southern, 1982, Saiki et al., 1988). Genome-wide estimated breeding 
values (gEBV) are now popular among animal breeders. These breeding 
values are based on an array of genotyped loci spread across the genome 
and phenotype data may be used both for selection for markers associated 
with traits and for discovery of new associations (Meuwissen and Goddard, 
1996, Meuwissen et al., 2001, Xu, 2003, ter Braak et al., 2005, Goddard et 
al., 2016). While the causative variant is often not known, the information 
gained from interrogating the genome is more accurate than EBV and 
sufficient to bring about a rapid change in the phenotype of a population.  
1.6.2 SNP chips 
In animal breeding the most common method of interrogating the genome is 
using a SNP chip (Ramos et al., 2009, Meuwissen et al., 2001, Matukumalli 
et al., 2009). SNP chips are arrays designed to identify the genotype of 
specific SNPs spread across the genome. Oligos that target the alleles of 
biallelic SNPs are fixed on an array, and DNA of the animal to be tested is 
introduced, the DNA will preferentially bind to the oligo that matches its 
genotype and thus by measuring the DNA binding to each oligo, the 
genotype can be predicted with high accuracy (Ragoussis, 2009). Sometimes 
the SNPs on a chip are specific SNPs known to be relevant to a trait, but the 
majority are SNPs spread at roughly equal distances across the whole 
genome (Ramos et al., 2009). Though it is unlikely that these SNPs are 
causative of a phenotype themselves unless they have been specifically 
selected for inclusion on a chip for this reason, it is possible to find a 
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causative region based on the LD between the tested SNP and the causative 
variant. Depending on how strongly a trait is being selected for and how 
inbred a population is, associating a phenotype with these SNPs can point to 
very large regions of the genome, as more SNPs will be in LD with causative 
variants. Additionally, complex traits are influenced by multiple genes across 
the genome and rarely just one specific variant, this leads to multiple 
quantitative trait loci (QTLs) being associated with a trait with the causative 
variants of each not being identified. It is not necessary to know the exact 
causative variant for selective breeding, however, as long as the tested SNP 
and the variant remain in LD, the causative variant will be selected 
for/against as well (Villumsen et al., 2009). One problem with this is that it is 
likely that this connection between the SNP and the cause only apply to the 
population in which the haplotype is circulating and cannot necessarily be 
applied to other populations, additionally, it is possible for the SNP and the 
causative variant to become disassociated over time through recombination. 
Knowing what the causative variant is allows for stronger and more reliable 
selection of a phenotype and may also allow for a better understanding of the 
mechanism behind how the variant causes the change in phenotype. 
Identification of the causative gene also has the potential of allowing the 
information to be applied to other species, which may be of particular interest 
in medical models. 
1.6.3 Sequencing 
With the falling price of sequencing (Beckmann, 2015, Drmanac, 2011, 
Snyder et al., 2010), it is now possible to affordably shotgun sequence whole 
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genomes with short reads. By comparing these sequences with the reference 
genome of the species, or a closely related species, it is possible to identify 
SNPs, indels and some large structural variants, some of which may be 
causative of a trait. One of the limiting factors of this method is that large 
cohorts may be needed to find specific variants and, particularly in species 
with large genomes, WGS is still very expensive. WGS data takes a lot of 
computer power to process and a large amount of disc space to be stored 
(Xuan et al., 2013). In species with a high level of repetitive content in the 
genome, much of these data and associated processing are essentially 
useless. It is difficult or often impossible to accurately map short-reads in 
repetitive regions. Additionally, the function of the majority of the genome is 
poorly understood and analyses tend to focus on protein coding genes. For 
studies involving small numbers of individuals, WGS offers rich data, 
however for large cohorts the cost and resources required remain prohibitive.  
An alternative method is exome sequencing. The exome traditionally 
comprises of all exons of protein coding genes and typically covers between 
1% and 2% of the full size of the genome, depending on the species. The 
target region may also be extended to target functional non-protein coding 
elements (e.g. miRNA, lncRNA etc.) as well as specific candidate loci. This 
can be done by using probes designed to capture the target region and 
enrich the sample for the fragments containing target sequence. Following 
exome capture, the fragments must be sequenced, which is usually done 
using a short-read sequencing platform in a similar manner to WGS. While 
focussing on the exons loses information from regulatory regions it allows for 
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sequencing of the most well understood regions of the genome. Variants can 
be identified in these regions that are likely to have a direct impact on the 
function of proteins and potentially phenotypes. Variants associated with 
phenotypes in these regions that are not expected to be causative may be in 
LD with causative variants that are outside of the exome and can be used in 
a similar manner to SNP chip variants to select against detrimental 
phenotypes. However, the ultimate goal is to find the direct cause of different 
phenotypes which should allow for the most efficient selection against 
detrimental phenotypes. 
1.7 Alignment tools 
Once sequencing data are obtained, mapping is the first step for most 
bioinformatic pipelines and often has the longest runtime. The aim of 
mapping is to find the original genomic location of each read relative to a 
reference genome. This must be done as accurately as possible while 
allowing for true variation and sequencing errors, but must be balanced with 
the reasonable use of time and resources. Importantly, this process relies on 
the accuracy of the reference genome. Errors in the reference genome cause 
inaccurate mapping and false positives in downstream analysis (Salzberg 
and Yorke, 2005, Phillippy et al., 2008, Warr et al., 2015b). 
For most of the available mapping tools the first step is to create an index 
which can be searched, this can either be an index of the genome, an index 
of the reads or both (Li and Homer, 2010). Hash table-based tools were the 
first to be used on short-reads from NGS and involve making a hash table 
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index of k-mers which can then be searched for the locations of k-mers in the 
query sequence. The query sequence is usually a seed consisting of an 
adjustable number of bases from the 5’ end of the read which is the most 
accurate end of the read in short-reads as the 3’ end is subject to phase 
errors. Most hash table-based aligners now use gapped seeds in which only 
a certain number of positions in the seed need to match the k-mer allowing 
for a specified number of mismatches and indels in the seed to account for 
sequencing error and true variants in the DNA. A seed-and-extend paradigm 
is applied with the rest of the read being allowed either a specified number of 
mismatches or a specified base quality score threshold to allow for 
mismatches. Examples of hash table-based mappers include MAQ (Li et al., 
2008a), SOAP (Li et al., 2008b) and BLAST (Altschul et al., 1990, Altschul et 
al., 1997). Another common indexing method is the FM-index based on a 
Burrows-Wheeler Transformation (BWT). The BWT was originally a method 
for compressing data, but can be used to greatly reduce the search space 
and find the location of a sequence using a prefix-tree. Similarly to the hash-
table based tools, BWT-based tools often use a seed-and-extend paradigm 
using mismatch counts or quality score thresholds. Examples of BWT-based 
aligners include Bowtie (Langmead et al., 2009), BWA (Li and Durbin, 2009) 
and SOAP2 (Li et al., 2009c). 
Mapping tools face challenges from constantly evolving sequencing 
technology. Mapping algorithms must be able to cope with inherent biases in 
the sequencing platforms and increasing read lengths. As a result there are a 
large number of mapping tools available, with frequent releases of new tools 
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designed to keep up with the changing landscape. Pressures from the 
evolving sequencing technology, the wide variety of downstream applications 
and constraints on runtime and memory footprints require tools to offer a 
variety of modifiable parameters to widen the tools’ applications. While 
flexibility allows the experienced user to adapt tools to specific purposes, for 
the novice user the additional parameters can add to the confusion of which 
tool to use and how. Multiple mapping tools run with default settings on the 
same data set invariably return different results, owing to the different 
methods and default settings used in each tool (Hatem et al., 2013, Bao et 
al., 2011, Li and Durbin, 2009, Cornish and Guda, 2015). Even when tools 
are run with parameters set to match one another they can return quite 
different results in different runtimes with different memory footprints (Hatem 
et al., 2013). This makes the choice of mapping tool an important first step in 
a pipeline and one should consider the strengths and weaknesses of each 
tool and modify parameters to suit the experiment’s purpose and resources.  
Some tools such as BWA-mem (Li, 2013), GraphMap (Sović et al., 2016), 
BLASR (Chaisson and Tesler, 2012), Minimap2 (Li, 2018) and NGMLR 
(Sedlazeck et al., 2018) are able to handle the longer reads and lower 
accuracy of the latest technologies. BWA-mem is not specifically designed 
for long reads but for short reads and assembly contigs, however with 
recommended modifications to the parameters it performs well when 
mapping long, error-prone reads. BWA-mem works using BWT and a seed-
and-extend paradigm as described previously (Li, 2013). GraphMap was 
designed with long reads in mind, but is designed to be agnostic of error 
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profiles, it uses multiple gapped seeds to reduce the search space and find a 
rough region the read should align to, the loci of the seeds are then refined 
and these are used as anchors which are chained together by the longest 
common subsequence before the location of the entire read is determined by 
linear regression. There can be multiple candidate locations per read and the 
best one for each read is selected at the end of the process (Sović et al., 
2016). BLASR has been designed specifically for long reads from single 
molecule sequencing. Similarly to GraphMap, BLASR generates multiple 
short matches to give an approximate location of the read, however BLASR 
does not use gapped seeds and instead relies on seeds with exact matches. 
Sparse dynamic programming is used to generate a rough alignment from 
the exact matches and this is then refined (Chaisson and Tesler, 2012). 
Minimap2 also finds a series of exact matches from a hash table to use as 
anchors and identifies collinear anchors as chains to find the approximate 
location of the read and then uses dynamic programming to extend the 
chains and join the gaps between anchors for base-level alignment (Li, 
2018). NGMLR is designed specifically to be able to align across structural 
variations between long reads and a reference. It splits the reads into 256bp 
segments, aligns them independently to the reference and groups collinear 
segments from each read into long segments which are aligned to base-level 
with dynamic programming with a convex gap-cost scoring scheme. Finally, 
the highest scoring, non-overlapping alignment for each read is selected 
(Sedlazeck et al., 2018). 
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Some tools such as Minimap (Li, 2016) and MUMmer (Kurtz et al., 2004), 
allow for low accuracy and high speed alignment. While these aren’t useful 
for identifying small variants, they can allow for a very quick, rough alignment 
between two long sequences which can be visualised. These alignments can 
be useful for quickly aligning whole genomes to whole genomes, effectively 
revealing large structural variation between the two sequences. They can 
also be used to quickly find the genomic context of a long sequence when 
high levels of accuracy are unnecessary. Both of these tools can handle 
noisy long-read data. 
1.8 Variant Calling Algorithms 
Most algorithms for variant callers are based on Bayesian probability, they 
calculate the probability of a genotype given the background data. The main 
categories of variant caller are: germline callers – used in identification of 
mutations causing disease or phenotype changes; somatic callers – used in 
cancer studies which compare tumour cells’ sequences with a normal cell’s 
sequence; and structural variant callers – used to identify structural variants 
(SVs) such as large indels, inversions and translocations.  
Callers vary in how they handle data, the metrics they consider and the 
criteria they use to identify variants (Yu and Sun, 2013). This results in 
different callers giving different results for the same dataset, making it 
important to understand some of the major differences between them. 
Currently, the most popular variant caller is Genome Analysis Toolkit (GATK; 
McKenna et al., 2010) which is frequently found to be the most sensitive and 
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specific in comparisons of the performance of different tools and analysis 
pipelines (Yu and Sun, 2013, Pabinger et al., 2014, Yi et al., 2014, O'Rawe et 
al., 2013, Warden et al., 2014). Other tools include Atlas2 (Evani et al., 
2012), Samtools (Li, 2011) SOAPsnp (Li et al., 2009b), VarScan 2 (Koboldt 
et al., 2012), SNVer (Wei et al., 2011), Platypus (Rimmer et al., 2014) and 
FreeBayes (Garrison and Marth, 2012).  
Some of the best variant callers have shifted the focus from the genotype to 
the haplotype. Bayesian formulae are applied to the haplotype to determine 
which alleles are most likely to be true, this haplotype is then broken down 
into its constituent variants. Examples of haplotype-based callers are GATK’s 
HaplotypeCaller (GATK-HC; Poplin et al., 2017), FreeBayes (Garrison and 
Marth, 2012) and Platypus (Rimmer et al., 2014). In Platypus and GATK-HC, 
local reassembly of haplotype windows using de Bruijn-like graphs allows the 
caller to be more robust to indels and other structural variants. This also 
allows for the acceptance of lower accuracy in the mapping stage as the 
caller will reconstruct the region regardless of the quality of the original 
mapping. Additionally, Platypus allows for the calling of multiple nucleotide 
variants (MNVs), SNVs that are consistently found on a single haplotype. 
Calling MNVs in protein-coding regions will allow for more accurate 
annotation of the effect these variants have on protein structure and function. 
GATK-HC best practices involve many stages that rely on the availability of 
databases of additional resources such as known SNVs and indels to 
improve the accuracy of the calls. While these resources are available for 
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humans, many stages of the best practices need to be modified or excluded 
for other species where fewer resources are available. 
Haplotype-based callers have not yet been thoroughly tested in tool 
comparison studies, though one study found that GATK-HC called similar 
numbers of SNVs to GATK-UG, but significantly more indels, it is unclear 
how many of these were false positives (Warden et al., 2014). In a study by 
Lescai et al. (2014) only 55.9% of GATK-HC indel calls assessed were 
successfully validated. Hwang et al. (2015) attempted to use a gold standard 
set of variants to determine which caller was the most accurate on Illumina 
data, while GATK-HC came out on top with Freebayes and Samtools 
producing the most false-positives, the gold standard indel set was generated 
using this GATK-HC and is likely to have biased the results. Cornish and 
Guda (2015) compared 5 variant callers: GATK-HC, GATK-UG, Samtools, 
Freebayes and SNPSVM. They found that Freebayes produced the most raw 
variant calls, but also the most false-positives. GATK-UG was found to be the 
most sensitive caller, outperforming GATK-HC. As was found by Warden et 
al. (2014), similar numbers of SNVs were observed, but GATK-HC called 
more indels. None of the tested callers performed well for indels. They also 
found that the choice of aligner had an impact on the results, with burrows-
wheeler based aligners (BWA mem, BWA sampe, Bowtie2) behaving 
similarly to one another, and other aligners (MOSAIK and CUSHAW3) 
producing different variant calls downstream. 
Concordance between SNVs called by variant callers is often low (O'Rawe et 
al., 2013, Yi et al., 2014, Yu and Sun, 2013), although recently the 
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concordance may be improving due to updates (Hwang et al., 2015) . It has 
been suggested that best practice is to use more than one variant caller to 
ensure all true variation is detected (Pabinger et al., 2014, Yi et al., 2014). 
This is particularly important when looking for specific disease causing 
mutations, as any SNV could be relevant (O'Rawe et al., 2013). Some tools 
such as Consensus Genotyper for Exome Sequencing (CGES), have been 
developed which combine multiple tools, in this case GATK v2.8, Atlas-
SNP2, Samtools and Freebayes. This allows the user to choose whether to 
accept variants called by all four callers; three or more of the four; two or 
more; or called by at least one caller and provides detailed quality statistics to 
aid in this decision (Trubetskoy et al., 2015).  
Filtering following the calling process is particularly important to reduce the 
number of false positives, particularly if multiple callers are to be used 
(MacArthur et al., 2012) or if there are likely to be inaccuracies in the 
reference genome.  
There are several types of large SV including large insertions, large 
deletions, interspersed duplications, tandem duplications, inversions, 
translocations, inverted duplications and unbalanced translocations, and 
combinations of these (Guan and Sung, 2016). In cancer research, methods 
that do not rely on the reference genome can be used, comparing normal 
and tumour samples, for example SMUFIN (Moncunill et al., 2014), but most 
SV callers do utilise mapping to a reference. These callers generally identify 
discordant mapping of paired reads, i.e. reads that map in unexpected 
orientation, with unexpected insert size, with ends on different chromosomes, 
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with one end not mapped, or soft clipped reads. Examples of tools for SV 
calling include LUMPY (Layer et al., 2014), SVachra (Hampton et al., 2017), 
Ulysses (Gillet-Markowska et al., 2015), SVMiner (Hayes et al., 2012), GASV 
(Sindi et al., 2009), CLEVER (Marschall et al., 2012), ClipCrop (Suzuki et al., 
2011) and PRISM (Jiang et al., 2012). Mapping algorithms are designed to 
map concordant reads and mapping across break points for SV detection is 
often unreliable, impacting the reliability of downstream analyses (Lim et al., 
2015). An alternate approach is to assemble contigs from reads and call SVs 
by comparing these to the reference, however this is computationally 
expensive and comes with the flaws associated with assembling short-read 
data. Some tools assemble targeted regions based on abundance of soft-
clipped reads, but this again relies on the mapping algorithm’s ability to 
properly map them and sufficient coverage for assembly. Examples of tools 
that use contig assembly to find SVs include TIGRA (Chen et al., 2014), 
SVMerge (Wong et al., 2010), SOAPindel (Li et al., 2013b) and CREST 
(Wang et al., 2011b). SVs such as deletions and duplications can be 
detected through changes in coverage. Large deletions of sequence present 
in the reference can be detected, assuming accurate mapping and unbiased 
sequencing, by identifying regions with half the expected coverage or no 
coverage depending on zygosity. Duplications where there are two or more 
copies of a single region in the reference genome can be identified through 
increased coverage and number of copies estimated from the fold increase in 
coverage, however these may be obscured by pile ups of reads in repetitive 
or low-complexity regions. In the case of large insertions, the sequence of the 
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insertion is missing from the reference genome and so these reads are not 
mapped and are unlikely to be identified. Using coverage in this way is more 
reliable using WGS than WES, as WES probes create non-uniform coverage 
(Lelieveld et al., 2015). Tools that use coverage in this way include CNVnator 
(Abyzov et al., 2011), ReadDepth (Miller et al., 2011), BIC-seq (Xi et al., 
2011), Ximmer (Sadedin et al., 2018) and EXOMESNV (Sathirapongsasuti et 
al., 2011). All of the methods for SV detection discussed so far, with the 
exception of cancer studies comparing normal and tumour samples, rely on 
an accurate and contiguous reference genome. Inaccuracies and contig 
breaks in the reference will show up as SVs and mask true SVs. 
Unfortunately, species with poor-quality reference genomes are also likely to 
be the species for which there is insufficient funding for WGS of large 
cohorts, making it more difficult to filter out these false SNVs. 
While long reads have error rates too high for accurate SNP and small indel 
calling, they allow for identification of large structural variants based on points 
where long read alignments consistently break. Using long reads for SV 
detection has the benefit of being more likely to cross break points and 
potentially span entire SVs. This has many of the benefits of the contig 
assembly methods of short read SV calling, but is more accurate. Tools for 
both PacBio reads and ONT reads have been designed for this purpose, they 
include PBHoney (English et al., 2014), nanoSV (Cretu Stancu et al., 2017), 
Picky (Gong et al., 2018), and Sniffles (Sedlazeck et al., 2018). These tools 
rely on the accuracy of the alignment of the long, error-prone reads and 
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choice of alignment tool will impact on the results. Even when using long 
reads, breaks and errors in the reference genome will cause false positives. 
1.9 Variant Annotation Tools 
An important step in the process of filtering called variants is variant 
annotation. Variant annotation attempts to label variants based on their 
probable effect on biological function. In its simplest form, this involves 
identifying the consequence of a variant in the protein-coding region on a 
gene’s transcripts and resultant protein products. Protein-coding genes are 
the most well understood portion of the genome and where reliable gene 
models, variant databases and transcript data are available it is relatively 
simple to predict the effect on proteins, though not necessarily the 
phenotype. Identifying the impact of variants in the non-coding regions is 
more complicated as the molecular mechanisms of the effect on phenotype 
from such variants are poorly understood. NGS studies frequently produce 
thousands of variants and manual annotation is laborious, error prone and 
impractical. Several different methods are employed to annotate variants 
computationally (Ritchie and Flicek, 2014), often in conjunction with one 
another.  
The overlap or proximity of a variant to a known functional element may 
suggest it has a functional effect, particularly if the variant is in the coding 
sequence or a splice site, in which case the change caused to protein 
products can be predicted (Adzhubei et al., 2013, Hu et al., 2013, Wang et 
al., 2010, McLaren et al., 2010). Variants that lie in certain sequence motifs 
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also have the potential to be disruptive and can be identified by annotators 
(Wang et al., 2010), these including binding sites for proteins that bind to 
DNA or RNA, disruption of which may alter regulation of gene expression. 
The use of multiple sequence aligners which identify whether or not the 
region has experienced evolutionary constraint may be used to identify 
potential functional regions. If a sequence has been highly conserved 
through evolutionary history it suggests that mutations in the region have 
been selected against and that the region has some important function, 
suggesting a variant identified in that region is likely to be deleterious 
(Adzhubei et al., 2013, Adzhubei et al., 2010, Siepel et al., 2005, Kumar et 
al., 2009). Supervised learning algorithms in which a naïve algorithm is 
trained on a list of variants that are known to be functional and a list of 
variants that are known to be benign have been used to annotate variants 
(Adzhubei et al., 2010, Adzhubei et al., 2013, Schwarz et al., 2010, Ritchie et 
al., 2014). The algorithm can then analyse novel data and predict whether 
variants are functional or not. While this method has been used successfully 
it is often not clear to the user what feature has caused the algorithm to flag a 
variant as functional. Finally, annotators can use phenotype association 
information to flag variants that appear to be associated with the phenotype 
of interest – a particularly useful method when looking for disease related 
variants (Yandell et al., 2011, Hu et al., 2013, Wu et al., 2011). 
Many annotators rely heavily on the availability of databases of variants, 
transcripts and conserved sequences, both the choice of database and the 
choice of annotation tool can impact on how the variant is annotated 
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(McCarthy et al., 2014). Importantly there is no universal definition for the 
different possible consequence types for variants and many annotators differ 
in how they classify them. Additionally, while some annotators report all 
possible consequences (e.g. McLaren et al., 2010, Cingolani et al., 2012), 
leaving the user to prioritise them, some only report the one that is 
considered the most severe and these classifications and priorities may differ 
between tools. This can lead to different annotators assigning different 
consequences to the same variant even within the coding region (McCarthy 
et al., 2014). Similarly, if a variant is located in a region where several 
transcripts overlap, the tools differ in how these are reported. To limit these 
differences and make the analysis pipeline more accessible to researchers 
without bioinformatics training, automated tools for annotating variants from 
exome data have been designed (Liu et al., 2012, Mutarelli et al., 2014) 
which may be particularly useful for medical professionals. 
Most annotators are designed for use on human data, though some are 
capable of analysing data from other species (Cingolani et al., 2012, 
McLaren et al., 2010). Notably Ensembl’s Variant Effect Predictor (VEP) can 
be used on any species in the Ensembl genome browser and its output 
provides links to loci, transcripts and genes in the genome browser (McLaren 
et al., 2010). 
Some annotators, such as Vcfanno (Pedersen et al., 2016), will attempt to 
annotate SVs, however this is difficult and imperfect as the precise location 
and nature of SV breakpoints are often not known. 
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1.10 Consequences of Variants on Proteins 
During translation from messenger RNA (mRNA) to proteins, nucleotides are 
read in sets of three, these sets are called codons. There are 64 possible 
codons combinations of the four nucleotides (figure 1-9) which translate into 
the 20 amino acids, the start codon (AUG) and the stop codons (UAA, UAG, 
UGA). If a codon is changed or the reading frame shifts, this can have a 
number of effects on the resulting protein. Following annotation of small 
variants (SNPs and indels), the variant is labelled with a consequence and a 
predicted severity. Annotators will annotate variants across the whole 
genome and many variants in promoters, enhancers, splice sites, and other 
regions of the genome may have a phenotypic effect, but the protein-coding 
regions are the most well understood and can often be more readily 
associated with a phenotype in genes with known functions. The main 
consequences of variants in protein coding regions are: 
 Synonymous - a SNP that does not change the coded amino acid due 
to redundancy in codon translations (figure 1-9). Often a substitution of 
a SNP in the last nucleotide of a codon does not change the amino 
acid. 
 Missense - a SNP that changes one amino acid in the protein. 
 Nonsense or stop-gain - a SNP that introduces a premature stop 
codon, truncating the protein. 
 Start-loss - a SNP that alters the start codon and may prevent the 
protein from being translated. 
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 Frameshift - an indel that has a length that is not divisible by 3 and 
causes the reading frame to shift. This causes significant changes in 
coded amino acids for the remainder of the transcript and usually 
modifies several amino acids and introduces a stop codon somewhere 
in the sequence. 
 In-frame insertion/deletion - an indel with a length that is a multiple of 
3 that may insert or delete one or more amino acids from the protein, 




Figure 1-9- Codon translation table. Note that there is a high level of 





Synonymous SNPs are considered the lowest severity variant in protein 
coding sequence. While there is some evidence that certain synonymous 
variants can have a strong phenotypic effect, including disease phenotypes, 
due to alterations in mRNA splicing (e.g. Gallego-Bustos et al., 2016, 
Claverie-Martin et al., 2015, Agashe et al., 2016), the majority of synonymous 
variants are thought to be benign or very minor in their impact. 
Missense SNPs and in-frame indels are considered moderate impact 
variants. There are numerous examples of these variants causing 
phenotypes including disease phenotypes (Yntema et al., 2002, Craig et al., 
2009) and non-detrimental phenotypes (Fontanesi et al., 2006), but a 
phenotype is not always apparent. 
The highest impact coding region variants are those which truncate the 
protein or prevent initiation of translation such as stop-gain, start-loss and 
frameshift variants. If a protein is truncated early in translation it is likely to be 
non-functional. Protein truncating variants, sometimes called loss-of-function 
(LoF) variants, are known to be causative of a number of disease phenotypes 
(e.g. Cutting, 2014, Aartsma-Rus et al., 2016). Logically, it would be 
expected that true LoF variants would be rare, particularly in the homozygous 
state, and largely confined to non-essential genes. Research by MacArthur et 
al. (2012), however, found that on average healthy humans carry ~100 
putative LoF variants with ~20 genes homozygous for putative LoF variants. 
While some of these variants may cause non-detrimental variation in 
phenotypes, the variants found in the MacArthur et al. (2012) study were not 
limited to non-essential genes suggesting potential LoF-tolerance through 
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redundancy of genes and protein functions in humans. Some variants in the 
study had been previously associated with disease phenotypes that were not 
present in the subjects, suggesting there is some unknown genomic or 
environmental context in which these variants cause disease. Alternatively 
there may be some mechanism of correcting some of these variants at the 
mRNA stage and rescuing the protein. Groenen et al. (2012) identified >150 
putative LoF variants in 48 pigs representing 8 domestic pig breeds and the 
wild boar, averaging only 30 per individual. This is fewer than were found in 
humans, despite the relatively high nucleotide diversity in pigs (Bosse et al., 
2012), the authors suggest this reflects the higher effective population size in 
pigs compared to that of humans. Of course, it may also reflect the limitations 
of a draft assembly and a higher proportion of both false positives and false 
negatives when seeking to identify putative LoF variants. 
The results of variant annotation should be treated with caution, low severity 
variants can be causative of disease and high severity variants can have no 
observable effect on phenotype. However, high severity variants are more 
likely to cause a detectable phenotype and for the protein coding region 
these remain the most promising starting point for finding causative variants. 
1.11 Application of whole exome sequencing 
1.11.1 WES Applications in Humans 
The first successful use of WES to diagnose and alter treatment in a human 
patient was in the identification of the causal variant of a rare form of 
Inflammatory Bowel Disease (IBD) in an infant (Worthey et al., 2011). In this 
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case conventional diagnostics had failed to find an explanation for the 
patient’s severe symptoms and doctors needed to understand the underlying 
cause of the symptoms before they could decide how to treat the child. A 
multidisciplinary team combined clinical phenotyping, exome sequencing, 
bioinformatics and functional studies, and eventually found the causative 
mutation which influenced the treatment of the child. Through filtering and 
manual inspection the candidate pool was reduced to 70 genes exhibiting 
hemi- or homozygous variants. Of these only eight variants were novel and 
predicted to be damaging to protein function. Analysis of evolutionary 
conservation identified two variants that were highly conserved and one of 
these had a high null genotype frequency. This left a single hemizygous, non-
synonymous variant in the X-linked inhibitor of apoptosis (XIAP) gene. The 
child was diagnosed with X-linked lymphoproliferative disease 2, exhibiting a 
novel IBD-like manifestation caused by loss of tolerance to commensal 
organisms in the digestive system. This allowed for effective treatment 
through allogeneic hematopoietic progenitor cell transplant. The unusual 
manifestation of the condition meant that a diagnosis for the patient was 
unlikely without the exome sequencing data. 
Following the success of this initial diagnosis, exome sequencing has been 
used extensively to diagnose novel diseases and find novel causative 
mutations of known diseases. Exome sequencing is useful in human 
medicine for diagnosis of particularly difficult to diagnose patients, diagnosis 
of young patients who may not exhibit a full spectrum of symptoms yet 
(Iglesias et al., 2014), prenatal diagnosis (Xu et al., 2014, Iglesias et al., 
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2014) and early diagnosis of debilitating disease (Sassi et al., 2014, Bras and 
Singleton, 2011). In addition to finding a diagnosis, finding the causative 
mutation can allow for alteration of treatment, prevention of further invasive 
testing, accurate prognoses, and confirmed diagnoses which are essential for 
eligibility for benefits and access to clinical trials (Taneri et al., 2012, Rabbani 
et al., 2012, Iglesias et al., 2014, Grossmann et al., 2011) and in the future 
may allow for more targeted treatment. Recently, a study found that of 278 
infants in intensive care units that were referred for exome sequencing, 
36.7% were given a molecular diagnosis and over half of those diagnosed 
saw informed redirection of care, initiation of new subspecialist care, 
medication/dietary modifications, and furthering life-saving procedures (Meng 
et al., 2017a). The study also found that for roughly half of infants who were 
deceased, genetic disorders were diagnosed allowing risk of recurrence 
counselling for the parents. 
Exome sequencing in human medicine benefits from the availability of large 
databases of known SNPs, known pathogenic variants and control genomes, 
during analysis variants found in these databases can generally be excluded 
when looking for novel variants significantly reducing the variant pool. The 
Exome Aggregation Consortium (ExAC) has created a user-friendly database 
containing the exome sequences of over 60,000 unrelated individuals, which 
is freely available from Exome Aggregation Consortium (ExAC) (2014). The 
exomes have been analysed using a uniform bioinformatic pipeline and are 
from individuals with adult-onset diseases. This provides researchers with a 
large set of reference exomes which should be free from homozygous 
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variants that cause childhood-onset Mendelian diseases. The database 
provides a wealth of information such as depth of coverage, genotype quality, 
allele frequency and variant consequences. The filtering capabilities and 
large number of exomes will simplify the process of prioritising variants when 
using exome sequencing as a diagnostic tool, particularly in children.  
Where many unrelated, affected individuals are available, an ‘overlap’ 
strategy can be used to simplify analysis and search for common variants 
likely to affect gene function (Johansson et al., 2012). If there is a known 
inheritance pattern this can be used to search for specific genotype zygostiy. 
Sequencing of multiple affected related individuals can also increase the 
power of the analysis (Johnson et al., 2010, Shi et al., 2011). In rare 
diseases, case-parent trios can be used to exclude non-pathogenic variants 
found in the parents (Smith et al., 2014). However, single patient sequencing 
may be sufficient to identify the causative mutation (Worthey et al., 2011, Xu 
et al., 2014, Wang et al., 2011a). Analysis examining how conserved an 
amino acid sequence is through evolution and between genes in a family can 
help to increase the confidence of a found mutation having a deleterious 
effect (Xu et al., 2014, Wang et al., 2011a, Johansson et al., 2012, Sassi et 
al., 2014, Smith et al., 2014).  
Examples of diseases for which exome sequencing has been used to detect 
a causative variant include Leber Congenital Amaurosis (Wang et al., 
2011a), Alzheimer’s Disease (Sassi et al., 2014), Maturity-Onset Diabetes of 
the Young (Johansson et al., 2012), High Myopia (Shi et al., 2011), 
Autosomal Recessive Polycystic Kidney Disease (Xu et al., 2014), 
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Amyotrophic Lateral Sclerosis (Johnson et al., 2010), immunodeficiency 
leading to infection with human herpes virus 8 causing Kaposi Sarcoma 
(Byun et al., 2010), Acromelic Frontonasal Dystois (Smith et al., 2014) and a 
number of cancer predisposition mutations  (e.g. Kiiski et al., 2014, Snape et 
al., 2012, Greif et al., 2012, Yan et al., 2011, Cai et al., 2015) and variants 
linked to developmental disorders (Wright et al., 2015, Gecz and Corbett, 
2015). 
1.11.2 WES Applications in Non-Human Species 
As with exome sequencing in humans, exome sequencing in other mammals 
has been largely aimed at discovering variants associated with health traits. 
WES has been used in conjunction with a genome wide association study to 
identify a frameshift mutation causing blindness in Phalène dogs (Ahonen et 
al., 2013).  In cattle (Bos taurus), WES has successfully been used to identify 
strong candidate variants for haplotypes relating to reduced fertility rates in 
Holsteins which can be used to selectively breed against these detrimental 
haplotypes (McClure et al., 2014).  The kit used in this study can also be 
applied to other bovid species. Cosart et al. (2011) demonstrated that the kit 
could be successfully used to capture the exomes of, and identify SNPs in, 
zebu (Bos indicus) and American Bison (Bison bison). This transferability of 
exome capture kits, as also demonstrated in studies involving the sequencing 
of Neanderthals and non-human primates using human capture kits (Burbano 
et al., 2010, Vallender, 2011), is possible because despite millions of years of 
divergence, functional elements tend to be highly conserved. 
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Plant genomes can be extremely complex, repetitive and are often polyploid, 
as a result high quality reference genomes are often not available and even 
where they are, the size and amount of repetitive content makes them 
expensive to sequence for variant discovery. Bread Wheat (Triticum 
aestivum) has an allohexaploid (AABBDD) genome around 17 Gb in size. 
While the wheat genome has been assembled (Clavijo et al., 2017), it is likely 
too large for subsequent resequencing studies at the current price of 
sequencing and data storage. Wheat is an extremely important crop for both 
human and livestock consumption and genetic improvement is slow. An 
exome capture kit has been designed based on the accumulated 
transcriptome data for wheat (Winfield et al., 2012). The capture region for 
this kit is 56.5Mb, which is around the lower estimated size of one diploid 
wheat exome, and owing to similarity between the three genomes this may 
be sufficient to capture most of the exome data from the whole allohexaploid 
genome. The kit has allowed for discovery of previously unidentified markers 
in the genome which can be used in future genetic studies and marker 
assisted selection (Allen et al., 2013). The kit has also been used to identify 
induced mutations in the genome to aid in studies investigating gene 
function, a use that was also applied to the rice (Oryza sativa) exome in the 
same study (Henry et al., 2014) and the soybean (Glycine max) exome in a 
separate study (Bolon et al., 2011). WES in soybean has also been used to 
identify unwanted intracultivar genetic heterogeneity in the exome that may 
affect the plant’s phenotype (Haun et al., 2011). 
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The genome of barley (Hordeum vulgare L.) has recently been assembled 
(Mascher et al., 2017). Barley’s genome is smaller than wheat’s at around 
5Gb, but is still larger than is practical and contains many repetitive elements. 
Previously, a gene space assembly was produced (The International Barley 
Genome Sequencing Consortium, 2012) and a barley exome capture kit has 
been developed based on this assembly (Mascher et al., 2013). The kit has 
since been used to identify a mutation involved in early maturation, a trait 
relevant to production (Pankin et al., 2014). The kit has also been used to 
differentiate between markers of H. vulgare L. and H. bulbosum L., H. 
bulbosum L. is a wild species that has superior pathogen resistance and 
tolerance compared to the domestic species and the two can be crossed to 
improve the domesticated crop, however negative linkage drag on production 
traits has hampered its use in elite barley lines. Using exome sequencing to 
identify specific markers can allow selective crossing to be used to 
incorporate the beneficial variants without incorporating linked variants that 
are detrimental to production (Wendler et al., 2014).  
Exome capture in barley has also been used to identify a gene causative of 
many-noded dwarfism (mnd) using mapping-by-sequencing (Mascher et al., 
2014). The mnd phenotype is a shorter plant with more, narrower leaves than 
the wild type. The mutant in this study was created using X-ray mutagenesis, 
a technique which often causes large deletions. An F2 population between 
mutant and wild type phenotypes was created and 18 mutant individuals and 
30 wild type individuals were exome sequenced. From these sequences 
SNPs were identified and allele frequencies of these were used to identify an 
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allele over represented in the mutant group. Researchers queried the 
sequencing reads for exome targets that were present in the wild type but not 
the mutant. This lead to the identification of a candidate gene 
(MLOC_64838.2, now HvMND), which has a homologue known to play a role 
in a similar phenotype in rice. Screening of other mutants showing this 
phenotype found a variety of null mutations in this gene. The family to which 
this gene belongs is known to have effects on important production traits and 
may include good selection targets to improve production. 
In addition to plants important in food production, black cottonwood (Populus 
trichocarpa) has had an exome capture kit designed (Zhou and Holliday, 
2012). P. trichocarpa is a model organism and was the first tree to have its 
whole genome sequenced (Tuskan et al., 2006). The tree is used in lumber 
production and in cosmetics. There is potential to use the identified SNPs to 
improve production in this species. 
So far, exome sequencing has not been widely used to identify variants 
related to production in mammals. However, Robert et al. (2014) have 
designed exome capture probes for the pig, used these to sequence the 
exomes of 96 healthy pigs and using bioinformatic tools identified potentially 
deleterious variants in these sequences. Bioinformatic analysis identified 
236,608 high confidence predicted variants and 28,115 predicted indels in 
the target region. This work revealed notable gaps in the current Ensembl 
S.scrofa genome annotation and identified a large number of potential protein 
truncating variants.  As the pigs tested were healthy, it is possible that some 
of these protein truncating variants are having a phenotypic effect on traits 
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other than those relating to the health of the pigs, such as those relevant to 
production. This work is an important step in identifying phenotype altering 
variants in the pig: a production animal and medical model. 
1.11.3 Benefits of WES over WGS 
With the price of sequencing falling as rapidly as it has done over the past 
decade (figure 1-10), questions have been raised concerning WES’s 
usefulness in the era of affordable WGS. The costs of WES consist of the 
cost of the capture plus the cost of sequencing, whereas WGS consists only 
of the sequencing costs. If we assume that the cost of capture remains fixed, 
then as the costs of sequencing fall, the cost of WGS will approach the cost   
of WES.  However, at present that is not the case and it is unlikely that the 
cost of sequence capture will not also reduce. Illumina’s HiSeq X platform 
offers a cost-per-Gb far less than other platforms. However, even given that 
advantage, the $1000 price tag for a 30X human genome is two to three 
times the cost of a 40X human exome (depending on scale). While WGS 
does have benefits over WES, the cost of this technology is more than simply 
the price of sequencing. Sequencing technology has been improving at a 
much faster rate than would be predicted by Moore’s law (a prediction of 
improvement in computing hardware, but often also applied to other 
technologies), but the technology for storing and analysing the data has not 
seen a matching acceleration in improvement (Mardis, 2010, Sboner et al., 
2011). WGS produces around one hundred times the data that WES does at 
the same coverage. The infrastructure needed to store, manage and analyse 




Figure 1-10- The falling cost of sequencing. Data from the NHGRI Genome Sequencing 
Program (Wetterstrand, 2017) 
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WGS produces a much larger number of variants than WES does, not only 
because of the size of the sequencing space, but because regions outside 
the exome are less well conserved. While this number might include a variant 
of interest, the larger data set significantly increases the computational 
burden for analysis. Additionally variation in non-coding regions is currently 
more poorly understood than variation in the coding region (Ward and Kellis, 
2012, Mu et al., 2011, Maurano et al., 2012), making it more difficult to 
predict which might be relevant to a trait of interest in WGS datasets. The 
majority of causative variants identified so far in Mendelian disease have 
been found in coding regions (Botstein and Risch, 2003), although 
ascertainment bias is likely to play a role in this. Variants in regulatory 
regions are increasingly being associated with quantitative traits (Schaub et 
al., 2012) including variants linked to economically important traits such as 
muscle growth (Laere et al., 2003, Cockett et al., 2005). With the continuous 
decrease in sequencing cost, new studies making use of WGS to investigate 
causative variants will lead to the discovery of additional mutations in 
regulatory elements that contribute to the pool of disease-associated 
variants. In that context, the sampling bias currently observed towards coding 
variants is likely to be reduced by WGS investigations of non-coding genomic 
regions. 
Cost is not the only consideration.  WGS covers the whole genome at more 
consistent coverage than WES, can provide more accurate detection of 
structural variants and does not exhibit reference sequence bias caused by 
probe sequences in WES (Majewski et al., 2011, Meynert et al., 2014, 
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Belkadi et al., 2015). Recent studies have highlighted the importance of 
promoters (The Fantom Consortium et al., 2014) and enhancers (Andersson 
et al., 2014) in a range of different cell types, and these are not traditionally 
captured by exome sequencing.   
WGS is now being widely applied in human studies, including the sequencing 
of large cohorts (Erikson et al., 2016, Gilly et al., 2018), and plans are in 
place to sequence the genomes of 500,000 individuals in the UK Biobank 
(Baras, 2018). WGS will eventually take a leading role in genome 
interrogation in agriculture, however to sequence large cohorts accurately 
and at high coverage, it will likely have to wait for costs to reduce and data 
storage and analyses to improve before it can be feasibly used to its full 
potential. In the meantime, WES provides many of the benefits of WGS with 
lower storage requirements and computational burden, at an affordable price. 
This is particularly useful in large scale studies, for example, a recent study 
sequenced the exomes of over 9,000 people (Schick et al., 2015). It is also 
useful for the sharing of information such as in the ExAC database where 
there are over 60,000 human exomes stored. WES will likely also remain the 
method of choice in species with exceptionally large genomes, for example in 
some polyploid plant species. 
An alternative to carrying out high-coverage sequencing on a large cohort of 
animals is to use genotyping-by-sequencing to target specific markers in the 
genome, which can give comparable accuracies to SNP array at as low as 
~1X coverage (Gorjanc et al., 2015). This is a much cheaper alternative to 
WGS thanks to the potential to multiplex high numbers of individuals. This 
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can be further extended to low-coverage WGS of large numbers of 
individuals with high-depth sequencing of minimal key individuals which 
maximally represent the genetic diversity of the population (Gonen et al., 
2017, Ros-Freixedes et al., 2017). The high coverage sequencing allows for 
the most common haplotypes in the population to be assembled, and the 
accumulated low-coverage sequencing can capture the less common 
haplotypes and variants allowing for accurate imputation of whole genomes 
to the population (Ros-Freixedes et al., 2017). As it is already common 
practice for SNP array data to be collected and pedigrees to be recorded in 
agricultural species, this can be used to select key individuals that share 
large numbers of haplotypes with the rest of the population for deep 
sequencing and allows for allocating the highest proportion of a fixed 
sequencing budget to the most informative individuals (Gonen et al., 2017). 
While an interesting option, this low coverage sequencing approach is still 
theoretical and has not yet been applied to real data. 
1.12 Conclusions 
Genome sequencing and assembly have come a long way since the first 
human genome, and with reducing costs and advances in technology these 
projects are no longer limited to large consortia, even small labs can afford to 
sequence their species of interest. While assembly tools have improved 
greatly, it has been necessary to constantly adapt these tools to work with 
the different biases and characteristics of the data produced by new and 
improving sequencing technologies. Assembly of large genomes, while 
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cheaper, faster and easier than it once was, can still not be considered trivial. 
However, as these tools and technologies continue to improve it is essential 
that scientists are not only able to sequence their species of interest, but to 
assemble its genome well. Reference genomes greatly improve the chances 
of finding genetic variants that influence a phenotype, but inaccuracies in 
references lead to false-positives in downstream analyses. The introduction 
of errors in such an early stage of analysis greatly increases the amount of 
work needed to find meaningful results in downstream analyses and the 
extreme filtering that must be used increases the chances that a true-
positive, important variant will be removed from the data set. 
Genomic analysis is computationally expensive and large scale studies using 
whole genome sequencing are less feasible for large cohorts at the current 
cost of sequencing. Exome sequencing is a technology that allows 
interrogation of the most well-understood portion of the genome: the protein-
coding region and functional elements. Variants of interest don’t necessarily 
fall within the exome, but most of the known variants responsible for 
Mendelian disease have been found in the coding region and the target 
region can be extended to include other regions of interest. While the falling 
price of sequencing may soon make WGS the more attractive of the two 
techniques, data handling and downstream analysis increases the cost. 
The amount of data produced by WES is far more manageable than WGS, 
particularly for small research groups and groups studying organisms with 
large genomes. WES has established itself as an important method in 
disease gene identification in humans, and increasingly in domestic species. 
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The applications of WES in crop research is allowing genomic techniques to 
be used in species with complex genomes, potentially identifying variants 
important for production that can be incorporated into marker-assisted 
selection.  At present, WES is a useful and powerful method for variant 
discovery within coding regions offering most of the benefits of WGS while 
allowing for easier and faster analysis of the data produced. 
The usefulness of both WES and WGS depend on the quality of the 
reference assembly that the sequenced reads are mapped to. In the future, 
the improvement of reference assemblies, bioinformatic tools and 
sequencing technology will be necessary to improve the power of variant 
discovery techniques.  
Pigs are an important species for both the food industry and for medical 
modelling. Pork is the most consumed meat globally and demand will likely 
increase as the population grows and wealth in developing countries 
increases. Pigs are far more similar biologically to humans than the other 
commonly used animal models. If null mutations are found in the breeding 
population that through purging could improve pork production or through 
selection could cause a phenotype that mimics human disease, these can be 
used to breed superior producers or medical models.
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1.13 AIMS AND OBJECTIVES 
This project aims to find genetic variants that may be of relevance to the pork 
production industry or be of use in medical modelling and to provide 
improved resources for genomic analysis in the pig. In order to do this, the 
following objectives will be addressed: 
1. An assessment of the quality of the pig reference genome, Sscrofa10.2 
will first be carried out to identify any regions that may be poorly 
assembled and likely to increase the chances of false-positives in 
analyses.  
2. Following identification of these regions, they will be applied as a filter 
to exome sequencing data previously produced by Robert et al. (2014). 
These data from the exomes of 96 individuals contain over 236,000 
SNPs and 28,000 indels, many of which will be benign or false 
positives. Filtering is needed to identify potentially phenotype-altering 
variants. In addition further filtering based on variant annotation and 
phenotype association will be carried out to identify putative 
detrimental variants.  
3. An alternative approach to avoiding false-positives will be used to 
identify putative causative variants through sequencing the genomes of 
a trio of individuals with filtering based primarily on the genotypes of 




4. Finally, in order to reduce the filtering required in similar analyses in 
the future, a new and more accurate reference genome will be 





CHAPTER 2: IDENTIFICATION 
OF LOW-CONFIDENCE 























"Never mind what should be or what might be or what ought to be. It's what 
things are that's important." 




Identifying natural sequence variants and testing the variants for associations 
with phenotypic variation is key to forward genetics approaches to linking 
genotype to phenotype and subsequent predictions in genomic selection. 
Effective variant discovery, however, is dependent upon the quality of the re-
sequence data and the framework, typically the reference genome for the 
species of interest, against which the variants are discovered. Therefore in 
order to identify high quality, usable variant information among variant calling 
data, they must be filtered. It is common to filter variants based on alignment 
quality scores and sequencing depth to remove any false positives caused by 
sequencing or alignment errors. In research on rare human diseases or 
phenotypes, openly available variant databases mean that further filtering 
can be done to remove alleles commonly observed in healthy individuals, 
greatly reducing the number of candidate causal variants. For other species, 
however, hard filtering must be used to cut down on candidates and remove 
false-positives. Hard filtering involves stricter thresholds on a number of 
filters. Filters recommended by GATK include QualityByDepth (variant 
confidence divided by the unfiltered depth of non-hom-ref samples), 
FisherStrand (This is the Phred-scaled probability that there is strand bias at 
the site), StrandOddsRatio (estimate strand bias using a test similar to the 
symmetric odds ratio test), RMSMappingQuality (the root mean square 
mapping quality over all the reads at the site), MappingQualityRankSumTest 
(the u-based z-approximation from the Rank Sum Test for mapping qualities) 
and ReadPosRankSumTest (the u-based z-approximation from the Rank 
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Sum Test for site position within reads). How strict these filter thresholds 
need to be is generally decided by the researcher. For many non-human 
species the available reference genome sequence assembly is only of draft 
quality and is more likely to contain errors and missing sequence. This 
limitation of the reference genome increases the likelihood of false positives 
making these filters particularly important. 
Following exome sequencing on a cohort of 96 pigs, and hard filtering 
recommendations for exome sequencing data, Robert et al. (2014) were left 
with a large number of putative variants including >236,000 SNPs and 
>28,000 indels. In order to find any variants that might be of importance to 
the pig breeding industry or for medical modelling, these needed to be filtered 
further and prioritised. Both users of the draft pig genome sequence 
(Sscrofa10.2; Groenen et al., 2012) and leading members of the Swine 
Genome Sequencing Consortium under whose auspices the draft genome 
assembly was produced have identified and recognised flaws in the 
Sscrofa10.2 assembly (A. L. Archibald, personal communication). Therefore 
many of the putative variants discovered in the exome data and in whole 
genome shotgun sequence data, including variants deposited in the public 
variant databases (dbSNP, European Variation Archive (EVA)), may be 
unreliable. If regions in the genome can be identified as low-confidence or 
poor mappability regions, any of the exome variants that fall in these regions 
can be filtered out to reduce false-positives. 
The following publication was written by the author of this thesis with 
suggestions and minor revisions from co-authors and reviewers. All methods 
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were carried out by the author with guidance from supervisors. It is published 
in Frontiers in Livestock Genomics.  
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Regions in the Pig Reference
Genome (Sscrofa10.2)
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Many applications of high throughput sequencing rely on the availability of an accurate
reference genome. Variant calling often produces large data sets that cannot be
realistically validated and which may contain large numbers of false-positives. Errors
in the reference assembly increase the number of false-positives. While resources are
available to aid in the filtering of variants from human data, for other species these do
not yet exist and strict filtering techniques must be employed which are more likely to
exclude true-positives. This work assesses the accuracy of the pig reference genome
(Sscrofa10.2) using whole genome sequencing reads from the Duroc sow whose
genome the assembly was based on. Indicators of structural variation including high
regional coverage, unexpected insert sizes, improper pairing and homozygous variants
were used to identify low quality (LQ) regions of the assembly. Low coverage (LC) regions
were also identified and analyzed separately. The LQ regions covered 13.85% of the
genome, the LC regions covered 26.6% of the genome and combined (LQLC) they
covered 33.07% of the genome. Over half of dbSNP variants were located in the LQLC
regions. Of copy number variable regions identified in a previous study, 86.3% were
located in the LQLC regions. The regions were also enriched for gene predictions from
RNA-seq data with 42.98% falling in the LQLC regions. Excluding variants in the LQ, LC,
or LQLC from future analyses will help reduce the number of false-positive variant calls.
Researchers using WGS data should be aware that the current pig reference genome
does not give an accurate representation of the copy number of alleles in the original
Duroc sow’s genome.
Keywords: missassembly, copy number variable regions, structural variation, draft assemblies, false positives
INTRODUCTION
Contemporary genetics research benefits from genomics tools and resources, including DNA
sequencing and single nucleotide polymorphism (SNP) chips, which facilitate detailed quantitative
molecular characterization of genetic variation at the population and individual level. A high
quality reference genome sequence for the species of interest is an invaluable asset for the discovery
of molecular genetic variants. Most reference genome sequences for species with large, complex
genomes are incomplete representations of the genome sequence of a single individual or a small
number of individuals. Given the extent of insertion/deletion (indel) polymorphisms and copy
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number variation (CNV) within species, such individual
reference genomes do not contain all the sequences present in the
species of interest. Thus, there are two major flaws in the current
single linear model for reference genomes as a framework for
discovery and analysis of genetic variation: (1) errors and gaps in
the reference genome assemblies most of which are incomplete
drafts; and (2) using a haploid genome of one individual to
represent the genome(s) of a species. In this paper we focus solely
on the former.
Studies that employ variant calling from sequencing data to
find variation in the genome produce large variant call sets
(Robert et al., 2014; Belkadi et al., 2015; Bianco et al., 2015;
Gudbjartsson et al., 2015). Most of these calls will be either
false-positive, not relevant to the phenotype under investigation
or benign (MacArthur et al., 2012). Failure to detect true
variants (i.e., false-negatives) will also occur either as a result
of insufficient sequence depth or gaps in the reference genome
(real or technical). Filtering these datasets reduces the number of
variants to a level which can be validated, however, in the process
researchers risk discarding the variants they are looking for.
Many applications of high throughput sequencing rely heavily
on the accuracy of the available reference genome for the
species. Errors in the reference genome increase the number
of false-positive variant calls in data, resulting in a need for
more stringent filters which may increase the risk of removing
true-positives. Shortcomings in the reference genome will also
increase the risk of missing true variants (i.e., false-negatives).
The human genome is more accurate than that of many other
species and more resources are available to aid in the filtering
of false-positive variants. Many reference genomes have a draft
status and gaps and misassemblies are not uncommon (Kelley
and Salzberg, 2010). Identifying misassembled regions in the
reference genomes of non-human species and excluding them
from analysis will help to reduce false-positives in variant calling
data.
Whole genome sequencing (WGS) produces fairly consistent
coverage across the genome (Belkadi et al., 2015), however,
the PCR step in the Illumina library preparation pipeline is
known to introduce bias, particularly in regions of high or low
GC content (Kozarewa et al., 2009). Modifications have been
introduced to protocols to reduce this bias (Aird et al., 2011),
however, sequencing depth and quality in GC-rich and -poor
regions remain unreliable when using protocols involving a PCR
step. Previous work has shown that CNV can be accurately
detected in WGS data by looking for areas of excessively
high or low read counts following adjustment for GC content
(Yoon et al., 2009; Zhang and Backstrom, 2014). To identify
misassemblies in the chicken genome, a previous study used
a pool of multiple birds to account for true variation between
individuals, treating regions where all individuals show low read
counts as false tandem duplications (Zhang and Backstrom,
2014).
In this paper, we look to identify low-confidence regions in
the reference genome assembly Sscrofa10.2 using WGS reads
from T. J. Tabasco (Duroc 2-14), the Duroc sow whose DNA
was used in the assembly (Groenen et al., 2012). The assembly
was constructed using a BAC-by-BAC method, covers 18
autosomes and 2 allosomes (with the Y chromosome constructed
separately from the DNA of male pigs), and contains many
gaps and sequences on unplaced scaffolds. Ideally, an individual’s
sequencing reads mapped to that individual’s own assembled
genome would show no true structural variation and any areas
of structural variation could be considered a misassembly.
But the reference genome is a haploid representation and
cannot reflect areas of true heterozygous structural variation
accurately. However, a conservative approach would treat variant
calls in these areas as low-confidence until further verified.
Regions with no structural variation between the sequencing
reads and the reference genome can be considered high-
confidence.
In addition to using coverage to detect potential duplications
or collapses, we use other indicators to identify different kinds of
structural variation such as inversions, deletions and insertions as
has been done previously to identify potentially disease causing
structural variation in human genomes (Tuzun et al., 2005).
Illumina paired-end sequencing generates read-pairs from the
same DNA fragment that are a known distance apart (usually
following a normal distribution), and in a known orientation with
respect to the reference genome. Therefore, when read pairs are
mapped to a reference, if they are not in the expected orientation,
or are an abnormal distance apart, this may also be an indication
of errors in the assembly.
Finally, when mapping reads from the same animal to the
reference genome created from that animal, there should be no
homozygous variant calls.
In this work, regions with abnormally high or low coverage
(LC), with high proportions of reads with unexpected insert
sizes or a high proportion of reads which were improperly
paired were identified. In addition, SNP and indel calling
was carried out. Regions were considered low quality (LQ)
if they had high coverage, a high proportion of unexpected
insert sizes or improperly paired reads or if they were in
proximity to a homozygous variant. LQ regions are the most
likely to represent misassemblies in the genome. Regions
which had LC were analyzed separately; these regions may
not necessarily be misassembled, but have poor coverage and
may therefore be unreliable for accurate variant calling. Both
regions were also analyzed together in a combined dataset
(LQLC).
Following identification of regions of the reference which may
be unreliable, publicly available data sets were downloaded and
overlap with the regions calculated. The data sets downloaded
were the coding region, dbSNP variants, copy number variable
regions (CNVRs) identified by Paudel et al. (2013) using a
method that assesses read depth, and gene predictions based
on data obtained using RNA-seq methods. These data sets
allowed for identification of the proportion of the coding region
overlapping the unreliable regions, and to assess how commonly
used methods of SNP and indel calling, CNVR calling and
RNA-seq may have been affected by unreliable regions of the
genome assembly. We would expect the coding region to be
under represented in the LQLC regions because the coding region
is generally more complex, which should make assembly more
accurate. If the unreliable regions are enriched for calls in these
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datasets, it may suggest that analysis of these regions produces a
higher level of false-positives than the rest of the genome.
MATERIALS AND METHODS
Sample, Sequencing, and Alignment
Eight sets of paired-end, whole-genome, Illumina sequencing
reads from a single sample from T. J. Tabasco, the sow whose
genome was used to construct Sscrofa10.2, were used in this
study1. BWA (v0.6.2: Li and Durbin, 2009) was used to align
the reads to the Sscrofa10.2 reference assembly using default
parameters. The reads were mapped to both the chromosomes
and the unplaced scaffolds from the assembly. Any reads which
mapped to chromosome Y were excluded as the sequences were
from a female pig; consequently, we are unable to comment on
the quality of the assembly of chromosome Y.
Identifying Regions with Abnormal
Coverage
SAMtools was used to filter the data to remove reads with a
mapping quality less than 2 or which were improperly paired.
BEDtools (v2.16.2: Quinlan and Hall, 2010) bamtobed was used
to extract the chromosome, start positions and the end positions
of whole sequencing fragments. BEDtools GenomeCov was then
used to find per-base fragment coverage across the genome.
BEDtools MakeWindows was used to make windows of 1000bp
across the whole genome. Gap data was downloaded from the
UCSC table browser (Karolchik et al., 2004) and BEDtools
intersect was used to remove windows intersecting gap data.
The median coverage for each 1000 base window across the
genome was calculated. GC content is known to have a significant
effect on coverage in sequencing methods that involve a PCR
stage (Kozarewa et al., 2009). Coverage was normalized by GC
content as described by Yoon et al. (2009). Briefly, the read
coverage in each 1 Kb window (w) was adjusted by a multiplying
factor f, with f equal to the ratio of the overall median across
all windows divided by the median of all windows with the
same GC percentage as that of the window w. Using the median
instead of the mean prevented these values from being inflated by
extreme outliers, as described by Zhang and Backstrom (2014).
Any window with a normalized coverage over 55 or under 27
(2 SD from the mean; 41) was defined as having an abnormal
coverage.
The removal of multimappers prior to coverage analysis may
cause the detection of LC regions in certain sequence contexts
in the genome that are more likely to contain multimappers
(e.g., repetitive regions). Multimapped reads were extracted from
the original bam file and read counts for these were calculated
using Bedtools Coverage and the same 1000 bp windows used
in the above coverage analysis; additionally raw read counts for
each window were calculated in the same way from the original
bam file. The percentage of reads in each window which were
multimapped was calculated. Windows with >50%multimapped
reads are likely to have been identified as LC due to the removal
1http://www.ebi.ac.uk/ena/data/view/ERP010190
of these reads before coverage analysis. The regions with >50%
multimappers were merged and intersect with the LC regions was
calculated using Bedtools.
Identifying Regions with Abnormal Insert
Sizes
The mean and standard deviation of the insert sizes was
calculated using Picard InsertSizeMetrics2 (v1.113). Insert sizes
were considered abnormal if they were more than 2 SD from
the mean (427 bp). The merged BAM file was filtered for
abnormally large (above 588 bp) and small (below 266 bp) insert
sizes. BEDtools coverage was used to find the read count of
the abnormal reads and the original BAM file using 1000 base
windows with 200 overlap created with BEDtools MakeWindows.
These data were used to calculate the percentage of abnormal
reads in each window. A high proportion of small insert sizes
was defined as a window with over 9.47% small insert sizes (2 SD
above the mean of 4.22%) and a high proportion of large insert
sizes was defined as a window with over 1.86% large insert sizes
(2 SD above the mean of 0.12%).
Identifying Regions with a Low
Proportion of Properly Paired Reads
The mapped reads were filtered using SAMtools for the SAM
flag 0×2, removing reads which were flagged as improperly
paired. The percentage of properly paired reads was calculated as
described for insert sizes. Any window with fewer than 70.59%
(2 SD below the mean of 92.5%) properly paired reads was
considered abnormal.
Variant Calling
Single nucleotide polymorphism and indels were called using
SAMtools mpileup, BCFtools and vcfutils varFilter. The resultant
vcf file was filtered for homozygous variants, indicative of errors
in the reference genome or sequencing errors. In order to include
the entire regions covered by reads overlapping each variant, the
regions spanning from 100 bases before to 100 bases after each
variant were considered low quality.
Merging
BEDtools was used to merge the regions identified by the above
parameters into LQ, LC, and LQLC regions. BEDtools intersect
was used to find regions of each group which overlapped with the
coding region (regions downloaded from UCSC table browser;
Karolchik et al., 2004). Sanger’s gEVAL website3 was used to
inspect BAC and fosmid end alignments in a number of the
identified regions.
Assessing Effect of Identified Regions on
Public Data
Known variant data were downloaded from dbSNP (Sherry et al.,
2001) and the number of variants overlapping the abnormal
regions were calculated. To assess the potential effect of these
2http://sourceforge.net/p/picard/wiki/Main_Page/
3http://geval.sanger.ac.uk/index.html
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regions on WGS resequencing studies in pigs, the regions
identified as CNVRs in Paudel et al. (2013) were downloaded and
the number of regions overlapping the abnormal regions from the
current study were calculated. Gene predictions based on RNA-
seq data were downloaded from Ensembl (Cunningham et al.,




582,271,856 reads mapped to the reference and 94.66% of these
were properly paired (551,173,366 reads).
Abnormal Regions
The effect of GC content on median coverage was as expected,
with both high and low GC content regions having poor median
coverage (Figure 1A).
While the coverage following GC normalization did follow a
normal distribution, several extreme outliers inflated the mean
and standard deviation. R (R Development Core Team, 2009)
was used to find the mean and standard deviation of the
majority of the data by overlaying a normal distribution on the
data (Figure 1B). Using this method, we determined the mean
coverage to be 41X and the standard deviation to be 7.
Regions identified by the parameters measured are
summarized in Table 1. In total, 2.6% of the genome had
abnormally high coverage, and 26.6% of the genome abnormally
LC. Regions with a high percentage of fragment pairs with
abnormally low and high insert sizes cover 3.99% and 1.52%
of the genome, respectively. Regions with a low percentage
of properly paired reads cover 4.95% of the genome. One of
the largest regions identified (77.8 Kb) has abnormal coverage,
insert sizes and read orientation (Figure 2A), and this is not
uncommon, further examples are shown in Figures 2B,C.
There were a total of 62,463 regions with >50%multimappers
and of these 99.3% overlapped with the LC regions. 66% of
the regions identified as LC overlapped with the multimapped
regions. The remaining LC regions had an unremarkable
distribution of GC contents (data not shown) and the majority
(81%) had 0 multimappers. The median read count per window
for the whole genome was 264 and the median read count
per window for the LC regions excluding those with >50%
multimappers was 161.
We identified a total of 583,093 homozygous variants.
Following merging, there were 245,972 regions identified as
abnormal due to proximity to these variants covering 63,085,828
bases (2.25% of the genome).
FIGURE 1 | Plot showing median coverage of windows against percentage of GC content (A). Histogram showing the distribution of window coverage, red
line represents a normal distribution (B).
TABLE 1 | Table summarizing the regions identified by different parameters measured.
No. of features Mean feature size Percentage of genome
High coverage 60,281 1,202 2.6
Small insert 82,097 1,363 3.99
Large insert 31,833 1,343 1.52
Improperly paired 77,785 1,786 4.95
Homozygous variants 245,972 256 2.25
Low quality (LQ) 409,905 949 13.85
Low coverage (LC) 119,251 6,275 26.6
Total (LQLC) 337,276 2,753 33.07
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FIGURE 2 | Plots showing examples of abnormal regions for multiple parameters on Chromosomes 6 (A), 12 (B), and X (C) (top). GC normalized
coverage (red) uses the left Y axis. Percentage of properly paired reads (blue) and percentage of high insert sizes (green) use the right Y axis. Means are represented
by solid lines and 2 SD from the mean are represented by dashed lines. Bottom shows same regions viewed on the gEVAL browser with poorly mapped fosmids
(top) and bac ends (bottom) shown in red.
Merged Regions
After merging the regions with abnormal insert sizes, abnormal
read orientation, and homozygous variant calls, we were left with
409,905 regions identified as being LQ, covering 13.85% of the
genome.
In total, 337,276 regions were identified as being LQLC and
the regions covered a total of 928,664,896 bases (33.07% of the
genome). If the multimapped regions are excluded from the LC
regions and the remaining LC regions are merged with the LQ
regions these cover 17.3% of the genome.
The coding region data downloaded fromUCSC table browser
covered 587,219,382 bases (excluding chromosome Y) and of
these 81,566,904 (13.89%) intersected with the LQ regions.
Of the coding region, 154,875,678 bases (26.37%) intersected
with the LQLC regions.
Impact on Public Data
The proportion of variants from publicly available data sets from
Paudel et al. (2013) and dbSNP (Sherry et al., 2001) that fall in the
abnormal regions are summarized in Table 2.
Paudel et al. (2013) identified 61,761 multi-copy regions
(MCR), and from these identified 3,118 CNVRs. Of the CNVRs
1,081 (34.66%) lie in the LQ regions and 2,692 (86.3%) lie in the
LQLC regions identified here.
The data downloaded from dbSNP (Release 104. Accessed:
05/05/2015) contain 52,634,111 known variants. In total,
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TABLE 2 | Table summarizing the proportion of called variants in publicly available data that fall in the abnormal regions identified in the current study.
Total LQ LC Combined (LQLC)
% of genome – 13.85% 26.6% 33.07%
% of coding region – 13.89% 17.72% 26.37%
dbSNP variantsa 52,634,111 19,121,760 (36.33%) 15,483,445 (29.42%) 27,009,232 (51.3%)
CNVRsb 3,118 1,081 (34.66%) 1,706 (54.71%) 2,692 (86.3%)
RNA-seq genesc (intersecting bases) 41,788,900 11,155,280 (26.69%) 11,360,980 (27.19%) 17,959,798 (42.98%)
aData from dbSNP database (Sherry et al., 2001).
bData from Paudel et al. (2013).
cData from Ensembl (Cunningham et al., 2015).
19,121,760 (36.33%) dbSNP variants were located in the LQ
regions, 15,483,445 (29.42%) dbSNP variants were located in the
LC regions and 27,009,232 (51.3%) dbSNP variants were located
in the LQLC regions.
The gene predictions based on RNA-sequencing data covered
41,788,900 bases, 26.69% of these bases were in the LQ region
(11,155,280), 27.19% were in the LC region (11,360,980) and
42.98% were in the LQLC regions (17,959,798).
DISCUSSION
This work emphasizes the importance of accuracy in reference
genomes in variant discovery research. Previous work by Zhang
and Backstrom (2014) used sequencing reads from multiple
chickens to detect misassemblies in the chicken genome. Here
we used data from the same individual used to construct the
pig reference assembly. We are therefore able to assess the
assembly without introducing potential true variation that may
be present by chance in multiple individuals; however, regions of
the genome may have been incorrectly identified as low-quality
due to true structural variation at heterozygous sites.
Regions of Sscrofa10.2 identified in this study were enriched
for variants from dbSNP. The fact that the regions identified
were enriched for variants in dbSNP, with the LQLC regions
containing over half of the dbSNP variants, supports the
assertion that these regions are enriched for false-positives;
dbSNP contains large numbers of SNPs that are not validated and
are potentially false-positives (Mitchell et al., 2004; Musumeci
et al., 2010).
In the CNVR study by Paudel et al. (2013), 61,761 MCRs
were identified and the authors state that the majority of these
were common in all individuals sequenced; in this study 60,281
regions were identified as having high coverage and it is likely
that there is overlap between these results. Studies looking for
copy number gains may benefit from excluding the LQ regions
from analysis. From the MCRs, 3,118 CNVRs were identified.
The authors estimated that of these 2,664 (85.43%) were likely
to be neutral or nearly neutral as they were common between
different groups or were in non-genic regions, which is very
similar to the number of CNVRs in the data that overlap the
LQLC regions in the current study (2,692; 86.3%). CNVRs are
called from sequencing data by comparison of read counts for a
region with the average across the genome; it is likely that there
are many false tandem repeats or collapsed repetitive regions
in the assembly that would cause false copy number loss or
gain calls. While regions identified as CNVRs are potentially
variable regions between populations, breeds and individuals,
calls based solely on comparison with the reference will give false-
positives and false estimates of the copy numbers in true variable
regions. Paudel et al. (2013) used copy number comparisons
between individuals from different populations to identify MCRs
that were variable between groups, which likely removed the
majority of the false-positives. Other studies have used array-
based methods to detect CNVRs in the pig genome (Chen
et al., 2012; Wang et al., 2012) and of the regions identified
in these studies, almost all of them fall in the LQLC regions
(data not shown). This suggests these regions truly are enriched
for CNVRs; however, enrichment of the unreliable regions for
CNVRs may also suggest unreliable assembly around large
duplications. In studies using whole genome resequencing, often
small sample sizes are used and too much confidence may
be given to the reference. It would be advisable in studies
using Sscrofa10.2, and references of other species that may
contain similar inaccuracies, not to call CNVRs based solely
on comparison with the reference, but from regional variation
in read count between individuals as has been done previously
for genomes which lack a reference following co-assembly
(Nijkamp et al., 2012) and when comparing sequences from
cancer cells to healthy cells (Chiang et al., 2009; Koboldt et al.,
2012). Similarly, researchers using other techniques that rely
on counting reads mapped to the reference genome such as
ChiP-seq and RNA-seq should be aware that these errors may
cause inaccurate calling or expression estimates. In RNA-seq,
read counts are used to estimate expression levels; unexpected
CNV between the reference and the sample sequence could cause
over- or under-exaggerated read counts, potentially resulting in
false-positives or false-negatives. RNA-seq is prone to off-target
mapping (Mortazavi et al., 2008), particularly at higher depth
(Tarazona et al., 2011); true peaks can often be distinguished
from off-target mapping using an expression threshold. However,
misrepresentation of the copy number of a region in the
reference assembly may exaggerate off-target peaks above the
threshold and cause false-positives, exaggerate true peaks causing
inaccurate expression estimates, or reduce true peaks causing
false-negatives or underestimation of expression. The regions
identified here were enriched for RNA-seq gene predictions,
more so than the annotated coding region, which may suggest
an increased false-positive rate in these regions from this
method.
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A large amount of the genome showed LC. While these
regions may suggest errors in the reference genome, such as false
tandem duplications (Zhang and Backstrom, 2014), they do so
with less confidence than the other parameters measured. The
study by Paudel et al. (2013) reported a considerable number
of copy number losses and subsequently excluded these from
further analysis as they were likely enriched for false-positives;
the fact that this excess of LC regions has been encountered
by other researchers may suggest that the problem is with the
quality of the genome assembly or region mappability rather than
the quality of the data used in the current study. Regions with
LC were analyzed separately as LC may be an indicator of the
quality of the sequencing data, PCR bias or poor mappability
and not necessarily inaccuracy in the reference. The majority
of the LC regions were explained by their large proportion
of multimappers; the regions were identified as LC because
multimappers were excluded from the coverage analysis. These
regions may not be misassembled, but rather of poor mappability
due to, for example, low complexity or repetitive sequences.
Of the LC regions which were not explained by multimappers
there was no evidence of extreme GC content causing the
reduced coverage and the majority contained no multimappers;
the LC in these regions likely relates to misassembled areas
in the reference genome, or potentially heterozygous structural
variants in the individual. Where the LC is explained by poor
mappability, it may still be advisable to exclude these regions
from SNP and indel analyses as this is likely to yield LQ
variants with a high rate of false-positives. Studies requiring
identification of only the highest quality variants would reduce
computational burden and false-positive rate by excluding the
LC regions. In studies more concerned with finding variants
relating to a specific phenotype, if LC regions are included,
variants identified in them may be treated as low-confidence,
but not necessarily excluded entirely. The percentage of dbSNP
variants in the LC region is not as high as in the LQ region,
however, fewer variants may be called in poor mappability
regions due to the common practice of filtering out low mapping
quality reads before proceeding to variant calling, reducing
depth and subsequently the chances of calling a variant in
these regions. The proportion of the genome identified here as
LQ is likely to be an over-estimation of the proportion that
is misassembled. The individual may have true, heterozygous
structural variation that cause some of these regions to appear
misassembled and this analysis has been intentionally strict to
allow downstream bioinformatic analysis to focus on only the
highest confidence regions of the genome by excluding LQLC
regions. The number of variants identified in studies employing
variant calling is often extreme and strict filtering techniques are
employed to reduce the number to a more tractable level for
validation (MacArthur et al., 2012; Ai et al., 2015). Excluding
regions which are likely to be enriched for false-positives may
significantly reduce computational burden and increase accuracy.
Strict filtering after variant calling may cause the loss of variants
of interest and it is desirable to reduce the initial number of
variant calls as much as possible to reduce the need for excessive
filtering. While variants of interest may lie in the low-confidence
regions identified here, the excess of false-positives in the region
make it unlikely that they will be easily identified. However,
discovery of variants outside of these regions will benefit from the
reduced number of false-positives in the dataset. Many variant
callers and filtration methods will consider depth and mapping
quality and are likely to exclude a number of false-positive
variants from these regions by default; however, computational
burden would be decreased by excluding unreliable regions,
which will be particularly relevant with large datasets. Other
methods that use regional read count data need to be aware that
Sscrofa10.2 does not accurately represent the copy number of
alleles in the original Duroc sow’s genome. Clearly in studies
searching for CNVRs, excluding the LQLC regions, which are
potentially enriched for true CNVRs, is not an option. In such
studies it would be beneficial to compare individuals in a study
with one another rather than with the reference, as is done in
somatic variant calling comparisons between healthy cells and
cancer cells (Roberts et al., 2013), to filter out variation that
is common in all individuals, or to exclude the LQ regions
only. The degree to which misassemblies will affect research
results depends on a number of factors including the tools
used, the type of misassembly and the type of analysis; for
example, the incorrect order of contigs will negatively affect read-
pair mapping and collapsed duplications may cause incorrect
calling of SNPs – though SNP callers may accurately filter many
of these. Similar inaccuracies to those found here are likely
to be present in the reference genomes of other non-human
species. With the price of sequencing continuing to fall, the
number of large-scale sequencing studies on species with draft
genomes will undoubtedly increase; awareness of inaccuracies
in these references will decrease computational burden and
increase accuracy. Identifying regions that are inaccurate and
producing new, more accurate assemblies will greatly increase
the power of whole-genome resequencing studies in non-human
species.
Availability of Data
The regions identified in this study have been made
available as three bed files: LQ regions, LC regions,
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The analysis to identify potentially misassembled or unreliable regions in the 
draft pig reference genome (Sscrofa10.2) identified a very large percentage 
of problem regions. These regions can now be used as a filter to reduce 
false-positives in datasets from NGS in pigs when the Sscrofa10.2 assembly 
is used as the reference. This work suggests that there are major flaws in this 
widely used reference genome. The overall impact of these flaws is not clear, 
but they may have obscured phenotypically relevant regions in past research.  
The use of SNP chip data in animal breeding, for example in genomic 
selection, is generally robust against small errors in the genome. However, 
as exome and whole genome sequence (WGS) data are increasingly used in 
genetics studies or applications, the importance of the reference genome’s 
accuracy increases. Applications in animal breeding include the use of WGS 
(Daetwyler et al., 2014), genotyping-by-sequencing (De Donato et al., 2013), 
and imputation of genome sequence information from SNP genotypes 
(Marchini et al., 2007). Additionally, with increased use of technology such as 
CRISPR gene editing in pigs (Whitworth et al., 2015, Wells and Prather, 
2017, Burkard et al., 2017, Burkard et al., 2018), the reference must be 
reliable both in terms of completeness and accuracy in order to design guide 
RNA and reduce the chance of off-target effects. 
This work highlights the fact that reference genomes are not necessarily 
reliable. Many workflows assume that the reference genome is a truth 
against which to compare other individuals, however it is usually neither an 
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accurate representation of a polyploid species, nor of the haploid genome. In 
the case of the pig, the reference genome was assembled using a method 
considered the gold standard at the time, yet it has an abundance of 
structural errors. What level of accuracy then can be expected of assemblies 
from WGS shotgun Sanger or Illumina data? 
The methods described here are also applicable to the improved reference 
genome sequences being developed for pigs and other farmed animals. 
These new reference genomes have greatly improved contiguity they have 
been assembled primarily from third generation long read sequencing 
technology. As the raw sequence data from these technologies has a high 
error rate, the filtering methods described here remain relevant. 
The work in this chapter has been cited 22 times (as of 18/07/2018; Google 
Scholar). This includes the use of the defined LQLC regions to filter datasets 
for low-quality structural variants in both European (Keel et al., 2017) and 
Chinese (Yang et al., 2017) pig breeds. The methods described for adjusting 
short-read coverage for GC content have been used to estimate the size of 
the genomes of two butterfly species, Heliconius melpomene (Davey et al., 
2016) and Leptidea sinapsis (Talla et al., 2017). In both cases the genome 
size estimate agreed with estimates from other methods, and in the case of 
H. melpomene, revealed that most of the sequence missing from the 
assembly was in collapsed repeats of sequence already represented in the 
assembly that could likely be resolved from the short-read data alone. 
Additionally, Wu et al. (2017) included use of the GC content adjustment and 
coverage limits defined in this chapter to identify errors in genotyping from 
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short-read data. The coverage limits identify likely false heterozygote calls, 
where unexpectedly high coverage over a heterozygous site may indicate a 
CNV or paralogous site. 
The pig is an important agricultural species, and it is likely that the falling cost 
of sequencing will lead to an increase in sequencing data produced by the 
community for this species. For these data to be used to their full potential 
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“I don’t know what I’m looking for.” 
“Why not?” 
“Because… because… I think it might be because if I knew I wouldn’t 
be able to look for them.”  
“What are you, crazy?” 
“It’s a possibility I haven’t ruled out yet.” 




The relatively short gestation time of ~114 days and the large litter sizes 
of pigs allow for efficient promotion of beneficial traits through artificial 
selection (Zak et al., 2017). Selection can be done based on the 
performance of the individual, or more commonly the performance of 
close relatives and progeny of the individual. Variability of traits within a 
herd allow for selection of the most successful individuals for breeding, 
leading to improvement of the performance of the population as a 
whole. Commercial pig breeding populations usually have a pyramidal 
population structure (figure 3-1), with a nucleus herd of a relatively 
small population of high performers which feeds into multiplier farms, 
and eventually commercial farms for pork production (Visscher et al., 
2000, Shepherd and Kinghorn, 1992). Genetic variants that cause 
reduction in reproductive performance circulating in nucleus herds can 
have an impact on the progress of improvement in these herds.  
Improvements to important agricultural traits in the nucleus herd can 
take years to reach the commercial farms at the bottom of the pyramid.  
Selection in the nucleus herd is largely driven by information from an 
individual’s genotype and phenotypic history, including the success of 
their progeny. Discovery of phenotype associations and the process of 
SNP-chip based selection itself depends on the presence of haplotypes 
that contain both a marker gene and a causative locus. The number of 
haplotypes in a nucleus herd is difficult to determine as it is a function of 
the diversity of the population and the typical length of the haplotypes 
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and will be specific to the herd. There are typically several thousand 
individuals in a nucleus herd, however the number of haplotypes also 
depends on the size of the founding population and how long the 
population has been established, with the number of haplotypes 
typically being fewer in young populations and populations with small 
founding populations and therefore high inbreeding. This is further 
complicated by migration in and out of the population which will have an 
impact on the number of haplotypes. Importantly, however, the majority 
of haplotypes will be common, with new haplotypes being formed 
relatively infrequently. This has been proposed as a benefit for the 
whole genome sequencing entire populations as the sequences of the 
majority of individuals can be imputed by sequencing a few individuals 
specifically targeting focal individuals that carry the rarer haplotypes 
(Gonen et al., 2017, Hickey, 2013). 
Reproductive success can be influenced by a number of genetic 
factors, including factors affecting the male reproductive system, the 
female reproductive system or the development of embryos. In the 
male, chromosomal defects or smaller defects in specific genes may 
impact on numbers of sperm cells in the ejaculate, ejaculate volume 
and sperm motility (Zak et al., 2017, Smital et al., 2005). In females, 
ovulation rate, age at puberty, wean-to-oestrus interval, number 




Figure 3-1- Pyramidal structure of 
animal breeding programs 
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piglets surviving to weaning are common phenotypes targeted by 
selection (Zak et al., 2017), but these traits are generally controlled by 
many genes and molecular mechanisms behind these traits are 
complex. Litter size may be a phenotype of the female associated with 
ovulation rate, immunological factors, or uterine quality and capacity. 
However litter size can also be reduced by genetic defects of foetuses 
inherited from one or both parents that impact on survival. This includes 
variants that are incompatible with life, which may cause death before 
implantation, after implantation, or post-parturition. Additionally, variants 
in the dam and/or the offspring that might reduce the success of 
implantation and the efficiency of the maternal/foetal interface may 
cause death or stunted growth of foetuses in utero as has been 
observed in humans (Pardi et al., 2002, Burton et al., 2009, Chelbi et 
al., 2012, Shan et al., 2015, Parle‐McDermott et al., 2005). Survival to 
weaning is an even more complex trait, including factors such as litter 
size, farrowing survival and mothering ability of the sow (Zak et al., 
2017).  
Ideally, when specific variants that directly cause a detrimental trait can 
be identified and selected against, they may be purged from the 
population. More commonly, marker variants physically close to the 
causative variant, but not causative themselves can be identified and 
used for selection as a genotype “linked” to the causative variant, the 
effectiveness of which depends on the level of linkage disequilibrium 
(LD) between the marker and the causal genetic variant (van den Berg 
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et al., 2016) and the complexity of the phenotype. Breeding based on 
genetic markers alone can be successful in reducing prevalence of an 
unwanted trait, but this may not completely purge any causative genetic 
variants due to recombination events creating new haplotypes and 
disassociating the variants (Morrell et al., 2006). While causative 
variants may be identified by investigating candidate genes from 
knowledge in other species or candidate regions from association 
analyses, sequencing of the genome or exome can be used to identify 
likely candidates without such prior knowledge. Additionally, while 
causative variants circulating in one line of commercial pigs are unlikely 
to be found in another line, identifying the genes involved provides 
candidate genes for other lines which may have a different variant 
affecting the same gene or molecular pathway. 
Whilst most of the traits of interest to the pig industry are controlled by 
many genes each with small effects on the trait, genetic variants in a 
single gene can have major deleterious effects, including compromised 
development and lethality. Examples of such major gene effects are the 
monogenic inherited diseases in humans. For many of the common 
human inherited diseases, the genes involved have already been 
identified. Often the causal genetic variant for such monogenic inherited 
diseases can be classified as Loss of Function (LoF) variants and 
include frameshifts or premature stop codons that result in alleles that 
no longer encode a functional protein. Putative LoF variants can be 
identified in genome or exome sequence data. Pigs are highly similar to 
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humans in a number of ways, as discussed in the literature review of 
this thesis, and are of interest for use as medical models. Thus, 
scanning pig exome and genome sequence data for putative LoF 
variants, especially in genes already associated with a human inherited 
disease, may not only address pig industry issues such as embryo 
survival, but also potentially yield pigs with relevant genotypes as 
animal models for human diseases. These individuals may be of use in 
research to understand the mechanisms, manage, and potentially cure 
these diseases in humans (Prather et al., 2013, Perleberg et al., 2018).  
The exome sequencing of 96 boars by Robert et al. (2014) identified 
over 250,000 variants after hard filtering, of which over 38,000 were 
predicted by Ensembl VEP (McLaren et al., 2016) to alter a protein. 
While variant annotation can help to identify variants that might cause 
an observable phenotype, on its own it still produces a list of thousands 
of candidates that may be of interest and it cannot further prioritise the 
variants. The majority of the variants identified are likely to be false-
positives or benign variants, the task of reducing the variants to a 
manageable list of prioritised candidates remains with the researcher. 
In human research, in cases where the cause of a highly specific 
phenotype is sought, often candidate genes are investigated first. 
These are genes that have been associated with similar phenotypes in 
other individuals or species, or those located within a region flagged by 
another method such as a genome wide association study (GWAS). In 
the case of the pig exomes, relatively non-specific phenotypes are 
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under investigation with only the aim of improving reproductive 
efficiency in pig breeding. These complex phenotypes may be strongly 
influenced by the environment and likely involve interplay between 
multiple genes. In order to find candidates for these phenotypes, 
variants must be filtered based on their likely impact on the coded 
protein and the importance of that protein to the phenotype. For 
example, the loss of a single amino acid from the end of the protein is 
unlikely to render it non-functional, and a disruption in genes from a 
multigene family with redundant functions or with non-essential 
functions, such as olfactory receptors, are unlikely to cause lethality. 
As previously discussed in Chapter 1 of this thesis, within the protein-
coding region, protein truncating variants are considered the most likely 
to cause an observable phenotype. As protein truncating variants 
disrupt the protein’s reading frame, their position within the protein 
coding region of a gene will determine how much of the protein is lost, 
so protein truncating variants that occur early in the coding sequence 
are likely to have the largest effect on the protein’s function. 
Additionally, variants that are observed in the homozygous state in 
healthy adults cannot be the sole cause of embryonic lethality.  
While bioinformatic approaches to identify underrepresented variants 
that may truncate a protein can produce useful candidates, without 
further phenotypic information it cannot reveal whether they are 
associated with an observable detrimental or beneficial effect. A 
common method for locating variants associated with a trait in livestock 
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is a GWAS. GWAS involve looking for evidence of associations 
between genetic variants and variation in the trait of interest. Such 
GWAS typically involve the use of SNP arrays to genotype a large 
number of SNPs fairly evenly dispersed across the genome for 
individuals with phenotypic data which can be associated with the 
genotypes. GWAS does not directly identify causative variants, but 
relies on LD between loci in the genome causing a number of variants 
to coincide on a haplotype with the causative variant. Identifying 
significantly associated SNPs narrows the search space from the whole 
genome to one or more loci, the size of which depends on the number 
of animals (or more accurately the number of informative meioses) in 
the study, the number of informative genetic markers (typically SNPs) 
and the level of LD in the population. The success of GWAS depends 
on how many loci are involved with the phenotype, the effect size of 
each locus, allele frequencies, the sample size, the SNP array used and 
how heterogeneous the phenotype under investigation is in the 
population (Visscher et al., 2017). GWAS typically involve thousands of 
individuals to increase the power of the analysis (Spencer et al., 2009). 
Often, to increase the number of individuals in the analysis while 
keeping costs low, a large population is genotyped with a low density 
SNP array and a subset of the same population, the reference 
population, is genotyped on a higher density SNP array. Using the data 
from the reference population, haplotypes in the population can be 
identified and genotypes for the SNPs missing from the lower density 
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array can be imputed (Wu et al., 2016, Habier et al., 2009, Weigel et al., 
2009, Wiggans et al., 2012, Corbin et al., 2014, Bolormaa et al., 2015). 
While imputation reduces the accuracy of the GWAS, this is usually 
acceptable to achieve the increase in power from the larger pool of 
individuals. Imputation accuracy depends upon the relatedness of the 
individuals, the extent of linkage disequilibrium in the population and the 
correct ordering of the genetic markers in the genome, i.e. the quality of 
the reference genome. In contrast, the correct ordering of the markers 
is not essential for the association analysis, although errors make 
interpretation of the results more challenging. 
A benefit of GWAS is that it can take all variants into account including 
those predicted to be of lower consequence by variant annotators, 
whereas the filtering of exome variants alone must first focus on only 
those with the highest predicted consequence to produce a 
manageable list of candidates to follow up on. GWAS enables 
potentially causative missense variants and non-coding variants that 
might affect splicing or the regulation of expression to be investigated. 
Additionally, if variants that have been predicted to have a high impact 
on the protein also appear to have an association with a phenotype, this 
increases the confidence that the candidate may be causative of an 
observable phenotype. However, both imputation and GWAS are 
unreliable where variants have a low minor allele frequency (MAF), with 
lower frequency variants being more prone to inaccurate imputation 
(Zheng et al., 2015) and misleading GWAS results (Tabangin et al., 
101 
 
2009). In a commercial herd under strong selection, we would expect a 
low MAF for variants with a strong detrimental phenotypic effect due to 
selective pressures against undesirable phenotypes, but variants with a 
more quantitative effect may be more common. By both identifying rare 
protein truncating variants and performing GWAS to identify variants 
associated with traits, both common and rare candidates can be 
prioritised for further investigation. 
In this chapter, filters are placed on the variants called from 96 pig 
exomes to create a short list of candidate variants on which to focus 
further work with emphasis on those that may cause reduced 
reproductive success or embryonic lethality. Additionally, variants in 
genes known to be associated with human disease are identified for 
their potential as use for naturally occurring medical models. In order to 
identify associations between variants and two reproductive 
phenotypes, imputation from 60K SNP chip to the exome variant data 
set is used followed by GWAS. The majority of the work in this chapter 
was done by the author, apart from additional sequencing of candidate 
variants from 27 dams following DNA extraction & whole genome 
amplification which was carried out by Jennifer Dzelil at Genus Pig 





Exome sequencing data from 96 purebred boars from a commercial 
synthetic line were the primary dataset in this chapter. The data are 
those presented by Robert et al. (2014) in their paper describing the 
development of a porcine exome capture platform. These data had 
been produced from exome sequence data mapped to Sscrofa10.2 
using BWA aln (Li and Durbin, 2009) and variant calls were made using 
GATK UnifiedGenotyper (McKenna et al., 2010) recommended 
practices including the use of the following tools: 
RealignerTargetCreator, IndelRealigner, FixMateInformation, 
BaseRecalibrator and UnifiedGenotyper. Base recalibration was done 
using Ensembl release 72 as known sites.  Hard filters already applied 
to the data using GATK VariantFiltration as described in the paper are: 
remove variant calls located within a cluster where three or more calls 
are made in a 10 bp window; remove if there are at least four 
alignments with a mapping quality of zero (MQ0) and if the proportion of 
alignments mapping ambiguously corresponds to 1/10th of all 
alignments; remove variants which are covered by fewer than 5 reads; 
remove variants with a quality score below 50; remove variants with low 
variant confidence over unfiltered depth of non-reference samples 
(QD<1.5); filter based on strand bias using Fisher's exact test: FS > 
60.0 for SNP calling, FS > 200.0 for indel calling.  
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In addition to the exome sequencing data, PorcineSNP60v2 BeadChip 
(Illumina) genotyping data for 351 individuals from the same line were 
provided by Genus PIC as well as two estimated breeding values 
(EBVs) for all 447 pigs for two phenotypes: number born in a purebred 
cross (Born to purebred; BTP) and number stillborn (NSB). Genus PIC 
use an internally developed two-trait multivariate mixed model 
augmented to predict random animal effects for animals without 
recorded phenotype data. The more data available to predict an 
animal’s EBV, the more reliable the EBV is, with reliability scores 
ranging from 0 to 1. Both of these EBVs use the fixed effects of farm, 
week of farrowing, year of farrowing, parity, random animal effect, and a 
random repeat effect of the sow. Details of pedigrees were also 
provided for the 447 pigs detailing any 1st and 2nd generation 
relationships between individuals. While a larger dataset than this one 
with more individuals and a wider range of phenotypes could provide 
more accurate and detailed results, the pigs are from a commercial line 
and the data access was restricted accordingly.  
As the initial set of 96 exomes were not chosen for extreme phenotypes 
and comprise a relatively small group of individuals, these will be used 
as a reference population to impute exome variants for the additional 
animals for which EBVs and SNP chip genotypes are available so that a 
GWAS can be performed for the two EBVs. 
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3.2.2 Bioinformatic filtering and validation 
Unless stated otherwise, tools were run using default parameters. 
Ensembl VEP (v.80; McLaren et al., 2016) was used to annotate the 
exome variants.  
The first filter applied to the exome variant data set was the removal of 
variants falling within the LQLC regions described in Chapter 2 of this 
thesis. These were filtered from the vcf using BEDtools intersect 
(v.2.16.2; Quinlan, 2014). GATK (v.2.3.9) VariantEval was used to 
calculate the transition/transversion (Ts/Tv) ratios for the original set of 
variants, those that were excluded and those that were not. The Ts/Tv 
ratio for coding exons in humans has been reported to be close to 3:1 
(Heinrich et al., 2013, Mistry et al., 2015), so a change in Ts/Tv towards 
3:1 may suggest an increase in accuracy.  
The output from Ensembl VEP allows for the selection of variants that 
cause a stop gain or a frameshift (the major classes of protein 
truncating variants) or otherwise flagged as high impact and to select 
for those variants which occur in an exon that is within the first 50% of 
the total exon number for the gene or variants in genes where there is 
only one exon. 
VCFtools (v. 0.1.12a; --hardy tool; Danecek et al., 2011) was used to 
calculate the expected Hardy-Weinberg Equilibrium (HWE) of the 
frameshift and stop gain variants and to find whether the observed 
genotypes were significantly different from this (exact test, p<=0.05) 
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Those that deviated from the expected HWE and had no alt 
homozygotes were prioritised and literature searched for relevant 
phenotypes. These variants were enriched for olfactory receptors, as 
these were unlikely to be relevant to the phenotype of interest and tend 
to be redundant in function, not strongly conserved and in poorly 
assembled gene clusters they were excluded at this stage. The HWE 
filter produced a very short list and was not used to exclude any 
variants from the main dataset. 
An additional filter was applied to remove variants where fewer than 
70% of the individuals carrying the variant had at least 40X coverage 
over the variant position. The remaining variants were prioritised by 
removing variants with no gene name in Ensembl or NCBI’s annotation 
of Sscrofa10.2 and no clear ortholog in Ensembl. Variants with 
homozygotes for the alternative allele present were also removed.  
To further validate prioritised variants, a 6-frame translator 
(https://web.expasy.org/translate/) was used to confirm the 
consequence predicted by Ensembl VEP. Read alignments for these 
variants were visualised using IGV (v2.3.88; Thorvaldsdóttir et al., 
2013) to confirm that these agreed with the variant call.  
A literature search was done to identify genes associated with common 
human diseases including cystic fibrosis, haemophilia, muscular 
dystrophy, sickle cell anaemia, Angelman syndrome, phenylketonuria, 
polycystic kidney disease, Tay-Sachs, spinal muscular atrophy type 1, 
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factor V Leiden thrombophilia and Graucher’s disease, and the 
unfiltered exome variant set was searched for variants in these genes 
that were ranked deleterious according to SIFT (Ng and Henikoff, 
2003). Two missense variants in CFTR, the gene associated with cystic 
fibrosis, were added to the short list of variants of interest due to their 
potential use in medical models if an altered phenotype is present.  
Two further variants were selected for validation despite not meeting 
the above criteria. The variants in IL1RAP and TGFB2 do have 
homozygotes present in the population. As the individuals sequenced 
are adult pigs, these cannot be the sole cause of lethality, however 
based on previously published work they may have an impact on 
economically important phenotypes, namely embryo implantation and 
immune response (Mathew et al., 2016, Orelio et al., 2008, Dinarello, 
2000), and growth and development (Memon et al., 2008).  
3.2.3 Variant validation by sequencing 
 All of the lab work in this section was carried out by the author at the 
ABS/Genus lab in Wisconsin, USA. 
3.2.3.1 Primer design, resuspension and sample 
selection 
In order to validate the list of 21 prioritised variants, primers were 
designed for 20 regions (one pair of variants, the missense SNPs in 
CFTR, were within a short distance of one another and could be 
captured in a single amplicon) in order to amplify and resequence the 
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variants to confirm the initial variant discovery. Primers were designed 
using the BLAST primer design tool (Ye et al., 2012) aiming for a PCR 
product >500 bp long. The list of 96 PIC boars was reduced to a set of 
20 boars that included at least one individual heterozygous for each of 
the variants. The primers were ordered from Integrated DNA 
Technologies (Iowa, USA) and upon delivery were resuspended in 
UltraPure Distilled Water (Invitrogen; California, USA) to make a stock 
dilution of 100 μM. Each tube was thoroughly vortexed and allowed to 
stand at room temperature for at least 10 minutes before re-vortexing to 
ensure resuspension. Working stock was diluted by transferring  
 10 μl of stock dilution to a new 1.7 ml microcentrifuge tube, adding 90 
μl of UltraPure Distilled Water and vortexing thoroughly. Primers were 
stored at 4ºC prior to PCR. 
3.2.3.2 DNA extraction 
For each of the 20 boars, a small piece of tissue, roughly 0.3-0.4 cm³ 
was cut off either an ear or tail tissue sample that had been stored at -
20ºC. The tissue was shredded with a clean razor and placed in a 1.7 
ml microcentrifuge tube. Extraction was carried out on the Qiagen 
(Hilden, Germany) EZ1 Advanced using an EZ1 Advanced DNA Tissue 
Card. To prepare for this, 190 μl of Buffer G2 was added to each 
sample, followed by 10 μl proteinase K. These were then incubated in a 
water bath at 56ºC overnight to lyse the tissue. 200 μl of lysate was 
transferred into a 2 ml screw cap tube, discarding any remaining solid 
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tissue. Loading of the machine was done according to manufacturer's 
instructions and the DNA was eluted into 100 μl elution buffer. The DNA 
was stored at 4ºC prior to PCR. 
3.2.3.3 PCR 
PCR was carried out for between 1 and 4 DNA samples per primer pair. 
Where a variant was carried by only one individual, this individual was 
amplified in duplicate, where a variant was carried by 2-4 individuals, all 
individuals were used, where a variant was carried by more than 4 
individuals, a random set of four carriers were selected. A master mix 
was made using 5 μl of Long Amp Buffer (New England Biolabs; 
Massachusetts, USA), 1 μl dNTPs, 16.75 μl UltraPure Distilled Water, 
and 0.25 μl Long Amp (New England Biolabs) per well to be used plus 2 
to allow for pipetting error. The mix was vortexed and briefly spun down 
in a centrifuge. PCR plates were arranged to have one pair of primers 
per column and to each well 23 μl of master mix and 0.5 μl each of the 
appropriate forward and reverse primer were added. 1 μg of DNA was 
added to the wells in the rows of the primer pairs according to which 
individuals carry the variant. The PCR plates were sealed with Adhesive 
BioRad (California, USA) Microseal 'B' PCR plate seals. The PCR 
plates were placed in GeneAmp PCR System 9700 thermocyclers 
(Applied Biosystems; California, USA) with the following conditions: 
94ºC for 5 minutes, 35x(94ºC for 30 seconds, 58ºC for 30 seconds, 
65ºC for 1 minute 30 seconds) 65ºC for 7 minutes, hold at 4ºC. PCR 
product was stored at 4ºC. 
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3.2.3.4 Gel electrophoresis 
3% agarose gel was prepared by mixing 18 g agarose (VWR 
Biotechnology; Pennsylvania, USA), 60 ml 5xTBE and 540 ml pure H20, 
swirling the bottle to mix, and microwaving for around 10 minutes on 
50% power, stopping to swirl again at 5 minutes. The mixture was 
allowed to cool slightly (~5 minutes), then 16 μl 1% Ethidium Bromide 
was added and the mixture was swirled again. The gel was poured into 
a large gel tray with three rows of 40 well combs and left to set for ~40 
minutes. 10 μl of each PCR product and 2 μl Amaranth loading dye 
(Sigma; Missouri, USA) were mixed by pipetting before being added to 
the wells. 3 μl of 100bp ladder (New England Biolabs Quick-Load 
100bp) and 1 Kb ladder (New England Biolabs Quick-Load 1Kb) were 
added to the two leftmost wells and two central wells of each row. The 
gels were run at 50 V for 3 hours on the BioRad (California, USA) 
PowerPac HC before being visualised AlphaImager software 
(ProteinSimple; California, USA) using the MultiImage Light Cabinet 
(Alpha Innotech Corporation; California, USA).  
3.2.3.5 DNA clean up 
Fresh 80% ethanol was prepared by combining 40 ml of absolute 
ethanol with 10 ml UltraPure Distilled Water in a tornado tube. For each 
primer set, successfully amplified samples were pooled into a single 1.7 
ml microcentrifuge. 25 μl of each sample were transferred into an 
Abgene storage plate (ThermoFisher; New Hampshire, USA) and 25 μl 
of AMPure XP beads (Agilent Technologies; California, USA) were 
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added. The plate was shaken at 1800 rpm for 2 minutes on the 
BioShake iQ (VWR Biotechnology; Pennsylvania, USA) and incubated 
at room temperature for 5 minutes. The plate was placed on a magnetic 
stand for ~2 minutes until the liquid was clear and the supernatant was 
discarded. The sample was washed twice with the 80% ethanol by 
adding 200 μl to each well, waiting 30 seconds, and then removing it. 
Excess ethanol was removed and the samples were allowed to air dry 
for ~5 minutes. The plate was removed from the magnetic stand and 25 
μl UltraPure Distilled Water was added to each well. The plate was 
shaken at 1800 rpm for 2 minutes on the BioShake iQ and incubated at 
room temperature for 2 minutes. The plate was placed back on the 
magnetic stand until the liquid was clear. The supernatant was 
transferred to strip tubes and stored at 4ºC. 
3.2.3.6 DNA quantification and normalisation 
Qubit (Invitrogen; California, USA) working solution was made by 
mixing the Qubit broad range reagent 1:200 in Qubit buffer, preparing 
200 μl of working solution per sample, plus 200 μl for each of the two 
high sensitivity standards. 199 μl of working solution were added to 
Qubit assay tubes with 1 μl of sample per tube. For the standards, 190 
μl of working solution were added to each tube with 10 μl of standard 
from the Qubit broad range kit. All tubes were vortexed for ~3 seconds 
each and allowed to stand at room temperature for 2 minutes. The 
concentrations in the tubes were read on the Qubit instrument as per 
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the manufacturer’s instructions. 5 μl of each sample was diluted with 
UltraPure Distilled Water to a concentration of 0.2 ng/μl. 
3.2.3.7 Tagmentation 
For this section, all reagents came from the Illumina (California, USA) 
Nextera XT kit unless stated otherwise. 10 μl of Tagment DNA buffer 
and 5 μl of normalised DNA were added to strip tubes, with each 
addition the pipette was used to mix. 5 μl Amplicon tagment mix was 
added to each tube and this was mixed with the pipette. The tubes were 
then placed in a centrifuge (VWR Galaxy MiniStar) at 2000 x g for ~20 
seconds. The tubes were sealed with dome caps and placed on the 
GeneAmp PCR System 9700 thermocycler (Applied Biosystems; 
California, USA) at 55ºC for 5 minutes, and hold at 10ºC. 5 μl Neutralise 
Tagment Buffer was added to each tube and the tubes were centrifuged 
as described previously. The samples were then incubated at room 
temperature for 5 minutes. 
3.2.3.8 Library indexing 
For this section, all reagents came from the Illumina Nextera XT library 
prep kit unless stated otherwise. Illumina Experiment Manager software 
was used to create a sample plate, giving each sample a unique index 
based on its row and column. To index and amplify the library, first 5 μl 
of index1 (i7) adapters were added to the columns of a PCR plate, one 
index per column. Next, 5 μl of the index 2 (i5) adapters were added to 
the rows of the PCR plate, one index per row. This provided each well 
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with a unique identifier based on which pair of indexes were in each 
well. 15 μl of Nextera PCR Master Mix were added to each well. For 
each sample, the entire sample from the tagmentation step was added 
to one of the wells with the well positions corresponding to the positions 
of the samples on the sample plate from Illumina experiment manager. 
The plate was sealed with Adhesive BioRad Microseal 'B' PCR plate 
seals. The plate was centrifuged on the Phenix (North Carolina, USA) 
Microplate Centrifuge for 1 minute and was then placed in the 
GeneAmp PCR System 9700 thermocycler (Applied Biosystems; 
California, USA) and run using the following conditions: 72ºC for 3 
minutes. 12 x (95ºC for 10 seconds, 55ºC for 30 seconds, 72ºC for 30 
seconds), 72ºC for 5 minutes. hold at 10ºC. DNA clean up was then 
performed as described previously in section 3.2.3.5 with the following 
alterations: the full 50 μl from the PCR plate were used for each 
sample, 30 μl of beads were used, the DNA was resuspended in 50 μl 
UltraPure Distilled Water. 
1% agarose gel was prepared by mixing 6g agarose (VWR 
Biotechnology), 60 ml 5 x TBE and 540 ml pure H20, swirling the bottle 
to mix, and microwaving for around 10 minutes on 50% power, stopping 
to swirl again at 5 minutes. The mixture was allowed to cool slightly (~5 
minutes), then 16 μl Ethidium Bromide was added and the mixture was 
swirled again.  A medium sized gel plate was used to run gel 
electrophoresis on the samples using the 1% agarose gel in a BioRad 
Wide Mini-Sub Cell. The gel was run at 70V for 1 hour and 30 minutes 
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on the BioRad PowerPac Basic before being visualised on AlphaImager 
software using the MultiImage Light Cabinet (Alpha Innotech 
Corporation). 
3.2.3.9 Library denaturation, PhiX spike and loading the 
Illumina Miseq 
The Qubit was used as described previously in section 3.2.3.6 to 
quantify the concentration of DNA in each tube. The samples were then 
diluted to 4nM. 5 μl of each diluted sample was then pooled in a library 
in a microcentrifuge tube. 
0.2 N NaOH was prepared by combining 800 μl UltraPure Distilled 
Water with 200 μl of 1.0 N NaOH, mixing by inversion. Illumina 
hybridisation buffer, HT1, was removed from the freezer and thawed 
and stored in a cool water bath until use. To denature the library, 5 μl of 
the library was combined with 5 μl of 0.2N NaOH. This was vortexed 
briefly and spun down in a centrifuge (VWR Galaxy MiniStar) for 30 
seconds. The library was left at room temperature for 5 minutes, then 
990 μl of HT1 was added, resulting in 1 ml of 20pM denatured library. 
The library was then diluted to 12pM by combining 360 μl of 20pM 
library with 240 μl HT1 in a new microcentrifuge tube. Stock 20pM 
denatured PhiX was diluted to 12.5pM by combining 75 μl PhiX with 45 
ml HT1. In a new microcentrifuge tube, 594 μl denatured library was 
mixed with 6 μl 12.5pM denatured PhiX resulting in a 1% spike of PhiX 
as a control. 
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An Illumina sample sheet was created by following manufacturer's 
instructions and named using the barcode of the reagent cartridge 
being used for the sequencing run. 
For loading the Miseq, the Illumina MiSeq Reagent Nano Kit v2 (300 
cycle) was used. The reagent cartridge was thawed in a room 
temperature water bath for just over an hour. The reagent cartridge was 
gently inverted 10 times. A pipette tip was used to pierce the foil over 
the sample loading well. 600 μl of sample was pipetted into the sample 
loading well. The flow cell was rinsed with laboratory-grade water and 
gently dried with a tissue. The flow cell was loaded into the flow cell 
compartment of the Miseq as per manufacturer's instructions. 
Incorporation buffer (PR2) and the reagent cartridge were placed in the 
reagent compartment as per manufacturer's instructions and the waste 
bottle was emptied. The sequencing run was started as per 
manufacturer's instructions. 
3.2.3.10 Bioinformatics 
Unless stated otherwise tools were used with default parameters. The 
fastq files produced by the MiSeq run were aligned to Sscrofa10.2 using 
BWA mem (v.0.7.15; Li, 2013) and output bam files were sorted and 
indexed using samtools sort and index (v. 1.2; Li et al., 2009a). Variants 
were called using Freebayes (v. 1.01; Garrison and Marth, 2012), the 
variant caller that was at the time being used as standard by the 
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industrial partner where this work was carried out, and visualised with 
IGV (v2.3.88) to confirm presence of variants. 
3.2.4 Follow-up sequencing of sows 
For this section the author selected the sows to sample, extracted and 
amplified the DNA and designed the primers, but the PCR and 
sequencing of the selected samples was carried out by Genus ABS 
employee Jennifer Dzelil. Bioinformatic analysis was carried out by the 
author. 
Following validation of the variants, a subset of variants was selected 
as the focus of further investigation largely due to restricted time and 
resources. The selection of these variants was done through the 
methods described by Howard et al. (2017) to identify haplotypes in a 
different set of Genus pigs that, when present in sire and maternal 
grand sire, were significantly associated with litter size. Five of the 
prioritised variants were found by David Howard’s work to occur within 
significant haplotypes. The five variants were in the genes 
ENSSSCG00000007065 (RPLP1), EXOG, LRRFIP2, SERPINA3 and 
LPIN3. Using Genus PIC’s database, the litters of all of the boars 
carrying these variants were identified and information on litter size, 
number stillborn, number of mummies, identity of dam, among other 
details were obtained for all litters. For each variant, the 10 litters with 
the highest number of dead piglets were identified excluding those with 
a live litter size >15 (dead piglets may be due to lack of resources in a 
larger litter). The dams of these litters were identified and where 
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available tissue samples were retrieved from storage. All of the variants 
had at least one dam from the 10 litters selected for each variant with 
tissue available for sequencing, however tissue sample availability was 
severely limited. DNA was extracted from the tissue of 27 sows and 
quantified using the method described above for the boars. The 27 
sows were from 5 different lines, only three individuals were from the 
same line as the boars. If one of the five variants is directly responsible 
for the increase in dead piglets, and a heterozygous cross can be 
found, the litter associated with this cross may be smaller or have a 
higher number stillborn than average.  Unfortunately, due to a relocation 
of the Genus ABS/PIC lab, the tissue samples have since been lost and 
this DNA is all that remains from these sows. 
3.2.4.1 Whole genome amplification 
In order to conserve DNA from these sows, a whole genome 
amplification was carried out using the REPLI-g Mini Kit 
(Qiagen;Germany). While unamplified DNA is preferred, this DNA 
served as a backup. Buffer D1 and buffer N1 were prepared according 
to manufacturer’s instructions, all reagents were vortexed and spun 
down briefly in a centrifuge prior to use. DNA was diluted to 40 ng/μl 
prior to use using UltraPure Distilled Water. 2.5 μl of each sample was 
combined with 2.5 μl Buffer D1, mixed by gentle pipetting and incubated 
at RT for 3 minutes. 5 μl Buffer N1 was added to the samples and 
mixed by gentle pipetting to neutralise the reaction. A master mix was 
created using the following volumes for each sample: 10 μl UltraPure 
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Distilled Water, 29 μl reaction buffer and 1 μl DNA polymerase. 40 μl of 
the mix was added to each sample 
3.2.4.2 Primer design and resuspension 
For this second sequencing run, the same set of primers were used as 
the validation sequencing with the exception of the variants that failed to 
sequence or validate previously, for which new primers were designed 
as described previously, these were the primers for variants in 
ENSSSCG00000004427 (NPM1-like), TRRAP and FAM216B. 
Additional primers were also designed for the VCAN variant, which 
failed to amplify on some of the samples using the previously designed 
primer pair. Although five variants were the main focus for these mating 
pairs, primers were ordered for all 20 regions of interest. The primers 
were designed with Illumina adaptors. These primers were designed, 
ordered and resuspended as described previously. 
3.2.4.3 PCR 
PCR was carried out using 12.5 μl NEB 2x taq, 1 μl forward primer (25 
μM), 1 μl reverse primer (25 μM), 2 μl DNA and 8.5 μl UltraPure 
Distilled Water per primer pair, per individual. PCR was run on the 
MultiGene OptiMax Thermal Cycler TC9610 (Thermo Fischer) for 94ºC 
for 4 minutes, 30 x (95ºC for 30 seconds, 54ºC for 30 seconds, 72ºC for 
90 seconds) and 72ºC for 5 minutes, holding at 4ºC. For most primer 
pairs, WGA DNA was used, but for the primer pairs for variants in 
LAMA4, MTHFD1, MST1R, ENSSSCG00000017574 (RDM1), LAMB3, 
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ENSSSCG00000004427 (NPM1-like) and FAM216B, the unamplified 
DNA was available and was used. 
3.2.4.4 Library indexing and clean up 
Amplicons from each individual were pooled into a single sample and 
were normalised based on quantification results from Qubit, which was 
carried out as described previously. Nextera XT Library Prep Kit was 
used according to protocol to create dual-indexed libraries, reagents are 
from the Nextera XT library prep kit unless stated otherwise. 10 μl of 
Tagment DNA Buffer (TD) was added to wells of a hard-shell skirted 
PCR plate. 5 μl of normalized sample was added to each well and 
mixed via pipetting. 5 μl of Amplicon Tagment Mix (ATM) was added to 
each well and mixed via pipetting. Samples were incubated at 55°C for 
5 minutes on MultiGene OptiMax Thermal Cycler TC9610 (Labnet 
International) and then held at 10°C. Once the sample was cooled to 
10°C, 5 μl of Neutralize Tagment Buffer (NT) was added to each well, 
pipetting up and down to mix, and incubated at room temperature for 5 
minutes. 5 μl of Index 1 (i7) adapter was added to each column of 
samples. 5 μl of Index 2 (i5) adapter was added across each row. 15 μl 
of Nextera PCR Master Mix (NPM) was added to each sample and 
mixed via pipetting. Samples were then amplified on MultiGene 
OptiMax Thermal Cycler TC9610 (Thermo Fischer) with the following 
conditions: 72°C for 3 minutes, 95°C for 30 seconds, 12 x (95°C for 10 
seconds, 55°C for 30 seconds, 72°C for 30 seconds), 72°C for 5 
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minutes, 4°C hold. A gel electrophoresis was run to check for the 
presence of amplicons. 
A bead clean-up was performed as follows to try to reduce the dimer in 
the sample. For each pool, 50 μl was taken and placed in a column of a 
deep well midi plate and 60 μl in-house magnetic beads (as described 
by Rohland and Reich, 2012) were added to each well. The plate was 
shaken at 1800 rpm for 2 minutes on the BioShake iQ and incubated at 
room temperature for 5 minutes. The plate was placed on a magnet, the 
beads were allowed to pellet, and the supernatant was discarded. 200 
μl fresh 80% ethanol was added to each well without disturbing the 
pellet, left for 30 seconds, and was discarded, this was done twice. 
Excess ethanol was removed and the plate was left at room 
temperature for 5 minutes before being removed from the magnet. 25 μl 
Resuspension Buffer (RSB) was added to each well, the plate was 
shaken at 1800rpm for 2 minutes and incubated at room temperature 
for 2 minutes. The plate was placed back on the magnet for 2 minutes 
and the eluted samples were transferred to a fresh plate. All samples 
were pooled into one tube and quantified using Qubit as described 




3.2.4.5 Library denaturation, PhiX spike and loading the 
Illumina Miseq 
Reagents are from the Illumina Miseq v3 kit unless stated otherwise. To 
denature the library, 5 μl was transferred to a new tube and 5 μl 0.2 N 
NaOH was added. The tube was vortexed and briefly centrifuged before 
being incubated at room temperature for 5 minutes and 990 μl chilled 
HT1 was added resulting in a 20 pM denatured library. The library was 
diluted to 10 pM by combining 300 μl library with 300 μl chilled HT1. 
PhiX was diluted to 4 nM by combining 2 μl 10nM PhiX with 20 mM 
Tris-Cl, pH 8.5 with 3 μl 0.1% Tween 20. 5 μl of 4 nM PhiX was 
combined with 5 μl 0.2N NaOH and briefly vortexed and centrifuged. 
This was incubated at room temperature for 5 minutes. The denatured 
PhiX was diluted to 20 pM by combining 10 μl with 990 μl of chilled 
HT1. The PhiX was diluted to 10 pM by combining 300 μl with 300 μl of 
HT1. The libraries were combined with the PhiX to make a 600 μl final 
library, the first library had a 25% PhiX spike in, and the second library 
had a 15% PhiX spike in. 
A sample sheet was created by following manufacturer's instructions 
and named using the barcode of the reagent cartridge being used for 
the sequencing run. 
For loading the MiSeq, the Illumina MiSeq Reagent Nano Kit v3 (600 
cycle) was used. The reagent cartridge was thawed in a room 
temperature water bath for just over an hour. The reagent cartridge was 
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gently inverted 10 times. A pipette tip was used to pierce the foil over 
the sample loading well. 600 μl of sample was pipetted into the sample 
loading well. The flow cell was rinsed with laboratory-grade water and 
gently dried with a Kimtech tissue (Kimberly-Clark; Texas, USA). The 
flow cell was loaded into the flow cell compartment of the MiSeq as per 
manufacturer's instructions. Incorporation buffer (PR2) and the reagent 
cartridge were placed in the reagent compartment as per 
manufacturer's instructions and the waste bottle was emptied. The 
sequencing run was started as per manufacturer's instructions. 
3.2.4.6 Bioinformatics 
Unless stated otherwise, tools were run using default parameters. The 
fastq files produced by the MiSeq run were aligned to Sscrofa10.2 using 
BWA mem (v.0.7.15; Li, 2013) and bam files were sorted and indexed 
using samtools sort and index (v1.2; Li et al., 2009a). Variants were 
called using Platypus (v. 0.8.1; Rimmer et al., 2014), at the time the 
variant caller being used by the industrial partner where this work was 
carried out, and visualised with IGV (v2.3.88; Thorvaldsdóttir et al., 
2013) to confirm presence of variants. A Fisher’s exact test was used to 
identify significant differences in the presence of alleles between males 
and females, however these differences may in part reflect differences 
in breeding lines. 
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3.2.5 Imputation and phenotype association 
3.2.5.1 Data 
As the two available phenotypes are only subtly different, the EBVs 
were plotted against one another to check for any correlation. 
Available EBVs were filtered to keep only those individuals with a 
reliability score >0.5. While the higher reliability EBVs have the most 
accurate phenotyping, there are a reduced number of individuals with 
phenotypes for the association analysis which will make the association 
analysis less accurate. The filtered dataset has EBVs for only 204 
individuals for NSB and 224 individuals for BTP. 
3.2.5.2 Imputation 
The 96 exome pigs were used as a reference population, the variants 
from exome sequencing (excluding variants from the LQLC regions) 
were used as the more high density genotype data set and Beagle (v 
3.3.2; Browning and Browning, 2009) was used to impute genotypes for 
the test population from the PorcineSNP60 BeadChip (Illumina) to the 
exome set. 
3.2.5.3 Phenotype association 
Plink (v 1.07; Purcell et al., 2007) was used with default parameters to 
run a whole genome association analysis of the alleles against the two 
EBVs. Power was estimated for these GWAS using R (v.3.3.3; R 
Development Core Team, 2009) using the following commands: 
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N = 204 (or 224 for BTP) 
alpha = 0.00000025 
H2 = 0.04 (or 0.07 for BTP) 
 
threshold = qchisq(alpha, df = 1, lower.tail = FALSE) 
power = pchisq(threshold, df = 1, lower.tail = FALSE, ncp = N * R2) 
 
This method is described at 
https://genome.sph.umich.edu/wiki/Power_Calculations:_Quantitative_T
raits (Accessed 18/04/19). Where N is the number of individuals, alpha 
is 0.5/the number of markers and H2 is the heritability of the trait as 
estimated by Holm et al. (2004). The power was found to be 0.0107 for 
NSB and 0.1154 for BTP. This makes the power of these analyses 
extremely low, unfortunately no further data was available to increase 
the power. The power was also estimated for a range of Ns to 
demonstrate how many additional individuals would be needed to 
increase the power for future experiments for BTP, as an example.  
3.2.5.4 Candidate variant selection 
A cut off for p-values was set based on the Bonferroni correction of 
0.05/N. For each phenotype, a bed file was made of 5Kb either side of 
the coordinates of the significant variants and the regions were merged 
using BEDtools merge. From the original VCF of variants from the 
exome data prior to LQLC filtering, variants that overlapped these 
regions were extracted using BEDtools intersect. Local misassemblies 
of the genomes in significant regions may have led to causative variants 
being filtered out in the LQLC filter, or may disrupt accurate 
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identification of haplotypes during imputation. Variants in these regions 
that were predicted to have a moderate or high impact on the protein 
were identified. A literature search was carried out for named genes 
containing these variants to find any functional association with 
reproductive traits or embryonic survival.  
3.2.5.5 Candidate gene selection 
Regions of the genome that showed a strong association were 
searched for candidate genes. An associated region may be linked to a 
regulatory element or splice site disruption that influences the 
expression of a gene, however these are likely outside of the exome 
region and further investigation of these is outside the scope of this 
project. Additionally, variants from the exome data were subsequently 
filtered out of the dataset to see if the same candidates are identified 
without the additional data from exome sequencing. 
3.3 Results 
3.3.1 Candidates based on filtering without phenotype data 
3.3.1.1 Filtering out LQLC regions 
26.37% of the coding region was classified as LQLC as defined in 
chapter 2. Removing variants found in the LQLC regions reduced the 
number of SNPs from 236,530 to 150,600 and the number of indels 
from 28,976 to 12,544, a reduction of 36.33% and 43.3%, respectively. 
The Ts/Tv ratio of the SNPs prior to this filter was 2.82, following 
filtering the Ts/Tv ratio increased to 2.92, suggesting an increase in 
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accuracy assuming the expected value of 3 in the protein coding 
regions. The variants in the LQLC regions had a Ts/Tv of 2.64, further 
suggesting this set contains a higher proportion of errors compared to 
the unfiltered set. 
3.3.1.2 Variant annotation and consequence filtering 
Table 3-1 shows the number of variants in each consequence category 
for SNPs and indels in the original data set, the data set after filtering 
out LQLC regions, and after filtering for variants in the first half of the 
exons and annotated as having a high impact. 
Following filtering for variants where at least 70% of the carriers have at 
least 40X coverage there are 145 high impact SNPs and 310 high 
impact indels.  
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Table 3-1- Table showing the breakdown of variant types in the 96 exomes as 
annotated by Ensembl VEP including raw data, data filtered for LQLC regions, 
and data filtered for LQLC, position in the exon, and predicted impact. 
Table 3-2- Indels that are not in Hardy-Weinberg Equilibrium and are in named 
genes. Parentheses are used to differentiate between multiple variants identified 
in the same gene. 
Gene Expected Observed 
SUB1(1) 38.13/44.74/13.13 25/71/0 
SUB1(2) 49.59/38.81/7.59 42/54/0 
DSTN 27.63/47.74/20.63 7/89/0 
CALM1 25.01/47.98/23.01 2/94/0 
DTNB(1) 24.00/48.00/24.00 0/96/0 
DTNB(2) 34.44/46.12/15.44 19/77/0 














Stop gain 720 411 180 33 10 4 
Start loss 134 71 1 35 8 8 
Frameshift - - - 4,292 958 546 
Missense 41,527 22,923 - - - - 
Inframe indel - - - 784 375 - 
Stop lost 283 144 - 38 6 - 
Splice 2,822 1,545 - 817 125 - 
Synonymous 64,991 38,076 - - - - 
Total 236,530 150,600 180 28,976 16,431 547 
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3.3.1.3 Prioritising based on Hardy-Weinberg Equilibrium 
Of the high consequence variants in the first 50% of the total exons of 
the gene, with 0 homozygotes, 7 SNPs and 29 indels were not in HWE. 
Of the 7 SNPs, two are in known olfactory receptors and two are in loci 
that show sequence similarity to olfactory receptors in other species. Of 
the remaining SNPs, one is in a loci with sequence showing similarity to 
a ribosomal protein gene, one is in an unnamed gene and has no clear 
orthologue and the final one is within gene SERPINA3, which has an 
expected genotype distribution of 58.59/32.81/4.59 and an observed 
distribution of 54/42/0 with a p value of 0.00519 (exact test). Of the 29 
indels, five are in known olfactory receptors and 12 show sequence 
similarity to olfactory receptors in other species. Of the remaining 
indels, four are in unnamed genes with no clear orthologues and the 
remainder have a P value <0.00001 are listed in table 3-2. No variants 
were excluded based on HWE. 
3.3.1.4 Filtering and prioritising based on gene function 
After removal of genes related to olfactory functions, 77 SNPs and 128 
indels remain. Priority was given to named genes in either the Ensembl 
or NCBI annotation of Sscrofa10.2, and those with orthologues 
identified through the Ensembl website, for which no homozygous 
individuals were found in the sample population. These include 27 
SNPs affecting 27 genes and 38 indels affecting 35 genes. From this 
list several variants were excluded due to 6-frame translations or 
visualisation of the alignments disagreed with Ensembl VEP. An 
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example of variants excluded during this process are frameshifts in the 
gene KDM5A, where two frameshifts 4 bases apart were consistently 
called on the same haplotype and in 6-frame translations the second 
frameshift rescued the protein by shifting the translation back into the 
correct frame. The SNP in SERPINA3 is the only variant that was 
significant for deviation from HWE and passed these filters. From these 
restrictions variants were prioritised and are listed in table 3-3. These 
variants, along with those discussed previously in CFTR (x2), IL1RAP 
and TGFB2 were taken forward to the validation stage. 
3.3.2 Validation of prioritised variants 
19 of the prioritised variants were present in amplicons from 
resequencing the regions in the boars, with three failing to validate. One 
of those that failed to validate, the indel in ENSSSCG00000004427, did 
not successfully amplify, suggesting the primers failed.  
The other two variants in TRRAP and FAM216B were not seen in the 
alignments of the sequenced amplicons. In the case of the indel in 
TRRAP, a nearby SNP on the same haplotype in the exome data was 
also absent. Two individuals were sequenced for this variant, but it is 
possible that through human error the wrong individuals were 
sequenced. In the case of the SNP in FAM216B, There are two 
neighbouring SNPs that in some exome alignments appear to be on the 
same haplotype as the variant, and in others appear to be independent. 
Two individuals were sequenced here and while the neighbouring SNPs 
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appear heterozygous, the SNP of interest is absent. It is not clear why 




Table 3-3- Table listing the genes containing variants that were followed up on 
following filtering. Hom=homozygous reference, Het=heterozygous. Only the 
last three rows have any homozygous alt individuals (not shown). 





LRRFIP2 LRR Binding FLII 
Interacting Protein 2 
SNP Stop gain 80 16 
LAMA4 Laminin Subunit 
Alpha 4 
SNP Stop gain 84 12 
SERPINA3 Serpin Family A 
Member 3 
SNP Stop gain 54 42 
WDR36 WD Repeat Domain 
36 




SNP Stop gain 94 2 







SNP Stop gain 90 6 
LAMB3 Laminin Subunit Beta 
3 
SNP Stop gain 93 3 
EXOG Exo/Endonuclease G SNP Stop gain 94 2 
FAM216B Family With 
Sequence Similarity 
216 Member B 




(Nucleophosmin) Indel Frameshift 82 14 
TPT1 Tumor Protein, 
Translationally-
Controlled 1 






Lateral Stalk Subunit 
P1) 








Indel Frameshift 90 6 









e Synthetase 1 
Indel Frameshift 95 1 





SNP 41 42 
IL1RAP Interleukin 1 Receptor 
Accessory Protein 
SNP Missense 83 11 
TGFB2 Transforming Growth 
Factor Beta 2 








3.3.3 Selection and follow up sequencing of sows 
The average litter size (dead + alive) of all of the litters sired by all of the 
males carrying one of the five prioritised variants was 12.5, with an 
average percent dead of 9.57% (1.2 observed dead per litter). The 
average litter size (dead + alive) of the females selected for follow up 
sequencing was 13.6 with an average percent dead of 28.4% (3.9 
observed dead per litter). The number dead per litter ranged from 1 to 
9, and the percent dead per litter ranged from 7.7% to 81.8%. 54 dams 
were identified that were mated with males carrying the primary focus 
variants in LPIN3, ENSSSCG00000007065 (RPLP), EXOG, LRRFIP, or 
SERIPNA3 as described in 3.2.4, however only 27 of these had tissue 
available for sequencing and these did not equally represent all five of 
the variants. While dams from 27 litters were genotyped, these 
represent offspring from only 9 males as 2 of the males sired 10 of the 
litters each, with fewer tissue samples available for the dams of litters 
from other sires. Crosses between individuals that were carriers of the 
same putative LoF variants were observed for the variants in EXOG, 
LRRFIP2, SERPINA3 and LAMB3 and while all of these litters had 
average litter sizes above that of all of the litters sired by the boars at 
14.5, 13.8, 13 and 13.6, respectively, they also had a higher than 
average percent of the litter dead at 14.5%, 28.7%, 40.6% and 21%, 
respectively. The highest average number of dead piglets per litter in a 




Table 3-4- Table showing difference in allele frequencies of exome candidate 
variants between males and females. P-values from Fisher’s exact test for 










LRRFIP2 0.185 0.083 +10.2% 0.032 
LAMA4 0.093 0.063 +3.0% 0.527 
SERPINA3 0.241 0.219 +2.2% 0.827 
IL1RAP 0.019 0.078 -6.0% 0.3 
MST1R 0.000 0.010 -1.0% 1 
TGFB2 0.204 0.234 -3.1% 1 
RDM1 0.241 0.031 +20.9% 2.05E-06 
LPIN3 0.000 0.005 -0.5% 1 
EXOG 0.111 0.010 +10.1% 0.0056 
FAM216B  0.000 0.021 -2.1% 0.575 
NPM1 0.019 0.073 -5.4% 0.187 
TPT1 0.000 0.036 -3.6% 0.346 
RPLP1 0.093 0.005 +8.7% 0.033 
CPT1A 0.463 0.031 +43.2% 2.75E-18 
VCAN 0.000 0.005 -0.5% 1 
TRRAP 0.111 0.026 +8.5% 0.014 
MTHFD1 0.130 0.005 +12.4% 0.00041 
WDR36 0.019 0.068 -4.9% 0.3 
LAMB3 0.185 0.016 +17.0% 0.00001 
CFTR(1) 0.000 0.047 -4.7% 0.204 
CFTR(2) 0.296 0.354 -5.8% 1 
EXOG RPLP1 RPLP1 MTHFD1 CFTR(2)
Dam genotype 1/1 1/1 1/1 1/1 1/1
Sire genotype 0/1 0/0 0/0 0/0 0/0
Litter size 14 18 13 15 9
Number 
observed dead 5 3 2 4 7
Percentage dead 35.71% 16.67% 15.38% 26.67% 77.78%
Table 3-5- Table showing the litters where a dam was identified as 
being homozygous for a variant. 
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for all of the litters of the sires, and was associated with the variant in 
SERPINA3. No correlation was observed between parental genotypes 
of any of the variants and the litter size or percent dead of the litters in 
the 27 litters. 
There were some notable differences in allele frequencies between the 
males and females, the most striking of which was the indel in 
ENSSSCG00000012880 (CPT1A), which was only seen 6 times in the 
exome data (allele frequency of 0.031), but was seen in 25 of the 27 
females (allele frequency of 0.463) and had a Fisher’s exact test p-
value of 2.75E-18. Table 3-4 shows the differences in frequencies 
between the males and females for all of the variants. Four of the 
variants were seen in the homozygous form, these are shown in table 
3-5. This suggests that these four variants are not lethal or else do not 
have full penetrance. However, the second missense variant in CFTR, 
which is very common in both the males and the females, is 
homozygous in only one of the females and is associated with one of 
the least successful litters with only 2 surviving offspring. This may 
suggest a maternal phenotype, however with only one example of a 
homozygous female it is impossible to say if this is related. Two of the 
variants that failed to validate in the exome pigs were found in the sows, 





3.3.4 Candidates from imputation and phenotype 
association 
Following imputation from SNP chip to exome, GWAS were carried out 
for the two EBVs number stillborn (NSB) and number born to purebred 
(BTP) to search for association between genomic loci and these traits. 
The power of this analysis was very low and further individuals were not 
made available for this thesis to increase the power. Figure 3-2 shows 
how the power for BTP would increase in the analysis with the addition 
of individuals. 
There is no correlation between NSB and BTP (p=0.255; figure 3-3).  
Only 4 variants reached significance for BTP. 5Kb either side of these 4 
variants were merged resulting in three regions. Within these regions 
were 15 variants from the exome dataset. None of these variants were 
high or moderate impact variants. The genes within, or closest to, these 
regions include COL11A1, ZFYVE27, and SFRP5.  
102 variants reached significance for NSB, merging of 5Kb either side 
resulted in 46 regions. Within the 46 regions were 241 variants from the 
exome data set of which there were three high impact variants and 23 
moderate impact variants, 11 of which had no observed homozygotes. 
Two of the high impact variants were in unnamed genes, 
ENSSSCG00000004082 (SYNE1) and ENSSSCG00000026692 (likely 
ARHGEF10), and the third was in TSHZ1, however this third variant 
was homozygous in all individuals and is likely benign or a false-
positive. Of the 11 missense SNPs with no observed homozygotes, 4 
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were not marked tolerated by SIFT. Of these variants, two were in 
unnamed genes and two were in named genes and both of these were 
marked deleterious by SIFT. These were in the genes CORO2B (SIFT 
score 0) and SERPINB8 (SIFT score 0.05). There were 5 variants that 
were not marked tolerated by SIFT, but did have homozygotes present. 
These were all in unnamed genes, one of which is likely MYOM2 
(ENSSSCG00000015747) and is marked deleterious (0.02) by SIFT, 
while the others are in unidentified refseq genes. 
Figure 3-4 shows a Manhattan plot for BTP. Two peaks reach genome-
wide significance, however the plot is very noisy likely due to the 
limitations of the available data.  
Figure 3-5 shows a Manhattan plot for the BTP data without the exome 
data included. A peak on chromosome 10 that only approached 
genome-wide significance when the exome data was included does 
reach significance with the lower p-value from the reduced number of 
tests when they are excluded. 
Figure 3-6 shows a Manhattan plot for NSB. Several regions in the plot 
reach genome-wide significance and appear to be stronger peaks than 





Figure 3-3- Plot of NSB against BTP showing no 
















Figure 3-2 Figure showing the effect on the estimated power of increasing 
the sample size for BTP. 
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A region containing a significant variant at 15:138464069 next to an 
assembly gap is a ~21 Kb contig containing fragments of SFXN5 and 
RAB11FIP5, both of which also appear fragmented on chromosome 3. 
The contig on chromosome 15 is misplaced and should be located on 
chromosome 3 at ~73 Mb, where there is a peak approaching 
significance over SFXN5. The placement of the contig on chromosome 
3 is supported by the gene order observed in the genomes of other 
species. 
Figure 3-7 shows the same NSB data without the exome data included. 
In this case most of the significant regions in figure 3-6 are also present 
here, with a gain of a significant variant on chromosomes 3 and 10.  
Table 3-6  describes the genes found under the peaks in figures 3-4 to 






Figure 3-4- Manhattan plot showing association between exome and SNP chip 
variants and BTP. Red dashed line shows genome-wide significance level. 
Figure 3-5- Manhattan plot showing association between SNP chip variants and BTP. 




Figure 3-6- Manhattan plot showing association between exome and SNP chip variants 
and NSB. Red dashed line shows genome-wide significance level. 
Figure 3-7- Manhattan plot showing association between SNP chip variants and NSB. 
Red dashed line shows genome-wide significance level. 
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Table 3-6- Table showing the location of the most significant variant and genes 
located under peaks for each peak in figures 3-4 to 3-7. Regions marked 














4: 127489069 COL11A1 
14: 118637605 ZFYVE27, SFRP5 
Without exome 10: 47043706 ARHGAP12, 
ENSSSCG00000011025 
(ZEB1) 
2: 132097143 CEP120, PRDM6 
14: 23840807 ZNF268, ZNF84 
15: 84843754 DHRS9 
17: 54169497 ELMO2, SLCR2 




variants in LD) 
SERPINB cluster 
5: 2157220 PARVB 
7: 123675137 SERPINA cluster, 
TCL1A, TCL1B, GLRX5, 





variants in LD) 
GABRG1, GABRA2, 
GABRA4 
8: 139878201 HERC3 
15: 37979158-
38266589 (13 













Many of the most significant variants were in the exome data, and the 
loss of these data results in different or less specific regions being 
highlighted. For example, in the major peak on chromosome 15, the 
most significant variant in the SNP chip data occurs at 15: 53557174, 
whereas in the exome data the most significant variants cluster over 2 
genes, ENSSSCG00000015747 (MYOM2 orthologue) and 
ENSSSCG00000023419 (ARHGEF10 orthologue), including the most 
significant variant at 15: 37993862.  
On chromosome 8, the SNP chip variants highlight a region of over 1 
Mb as shown in the Ensembl Genome Browser (Zerbino et al., 2018) in 
figure 3-8 with the most significant of the three at 8: 37838817. 
The exome variants highlight a smaller region of 2.5Kb (figure 3-9), with 
the majority of the significant variants falling within GABRA4 and the 




Figure 3-8- Ensembl genome browser visualisation of 1Mb region on chromosome 8 
containing SNP chip variants associated with NSB. 
Figure 3-9- Ensembl genome browser visualisation of 2.5 Kb region on chromosome 8 




Reproductive traits are an important target for selection in the pig. 
Detrimental variants in the nucleus herds of pig production companies 
can have a knock on effect on the productivity of the rest of the 
breeding pyramid. Identification of variants that effect these traits can 
allow for purging of detrimental variants. Reproductive phenotypes are 
complex and careful filtering combined with an understanding of gene 
functions and identification of associations with phenotypes can aid in 
identifying variants of interest.  
3.4.1 Exome filtering 
For the pig genome, there is relatively little variant calling data available 
to assist with variant quality control and filtering and the data that exists 
may not be reliable. Over 50% of Sscrofa10.2 variants reported in 
dbSNP (Sherry et al., 2001) in unreliable regions of the genome and 
likely enriched with false-positives (Warr et al., 2015b). One method for 
assessing the accuracy of variant calling data is to look at the ratio 
between transitions and transversions, which in humans has been 
reported as 3:1 in the coding regions (Heinrich et al., 2013, Zhang et al., 
2015, Bainbridge et al., 2011). A transition is a substitution of either a 
purine (A,G) with the other purine or pyrimidine (T,C) with the other 
pyrimidine, and a transversion is a substitution of a purine to a 
pyrimidine or vice-versa. Transitions are more common than 
transversions due to the mechanisms through which the substitutions 
are formed. Transitions are even more common than transversions in 
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the coding region as they are less likely to change the amino acid 
thanks to the redundancy in codon translations, often creating a 
synonymous variant and avoiding the negative selection that limits 
transversions (Griffiths et al., 2015). In the pig, the Ts/Tv ratio for the 
whole genome has been reported to be around 2.04:1 (Bianco et al., 
2015) which is similar to the 2:1 ratio seen in humans (Bainbridge et al., 
2011). As the data in this project deals with exome sequencing data, 
the Ts/Tv would be expected to be closer to 3:1 as it is in the coding 
region in humans (Bainbridge et al., 2011). In this project, the original 
data set had a Ts/Tv of 2.82:1, the exonic variants that fall within the 
LQLC region previously identified have a Ts/Tv of 2.64:1, and removing 
these variants increased the Ts/Tv of the dataset to 2.92:1, suggesting 
this filter reduced the false positive rate. The LQLC region covered 
26.37% of the coding region and eliminated 36.33% of the SNPs and 
43.3% of the indels. While many of these eliminated variants may have 
been true positives, the elevated proportion of variants located in these 
regions further suggests that they were enriched for false-positives. 
While the LQLC filter greatly reduced the number of variants, a 
combined total of over 170,000 remained. Annotating the variants 
allows for elimination of variants that are the least likely to have a direct 
impact on the protein, and prioritise those that may truncate the protein. 
By selecting for variants that occur early in the gene, the chance of a 
variant knocking out the functional portion of the protein is increased. 
Additionally, the confidence that the variant is not a false-positive call is 
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increased by prioritising variants that have at least 40X coverage in at 
least 70% of the individuals that carry it. These filters reduced the 
number of variants to a more manageable 455 variants. 
HWE is a model for predicting expected genotype frequencies in a 
population given the frequencies of the two alleles. Deviation from the 
equilibrium may suggest genotyping error, a copy number variation, or 
natural or artificial strong selective pressures for or against a haplotype. 
While the HWE filter did find one SNP that may be interesting to follow 
up on, in SERPINA3, many of the variants identified had very unlikely 
genotype frequencies, for example, those variants where almost all 
individuals are heterozygous. In these cases of heterozygote excess, it 
is possible there is some kind of duplicated region or paralog, which 
may not be represented in the genome assembly, causing the site to 
look like a heterozygous SNP when in fact there is no variant but rather 
sequences from two regions aligning to one (Wu et al., 2017). HWE has 
been used as a method of removing wrongly genotyped SNPs from 
analyses (Wittke-Thompson et al., 2005, Fajardo et al., 2012, 
Pongpanich et al., 2010, Waples, 2015). It has also been used to 
identify regions associated with phenotypes, particularly those under 
strong selective pressure (Piel et al., 2016, Nielsen et al., 1998, 
Lachance, 2009, Alvarez, 2008). As this work is looking for alleles that 
may affect phenotypes relevant to production and the population in 
question is under strong selection for productive traits, using this as a 
filter may remove relevant loci. However, unsurprisingly, prioritising 
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based on deviations from HWE appears to primarily identify false-
positives. Additionally, HWE assumes a large, randomly breeding 
population (Waples, 2015, Wittke-Thompson et al., 2005), but the 
population in question is not breeding randomly and consists of a small 
subset of individuals from multiple generations of a line under strong 
selective pressures. Therefore this method may not be appropriate in 
filtering or prioritising in this particular set of individuals. Subsequently 
this was not used to filter or prioritise. The variant in SERPINA3 was 
retained through all of the additional filters, was subsequently validated 
and remained of interest when phenotype data was taken into account. 
Thus in this particular case, the deviation from HWE may be meaningful 
and may relate to selective pressure. However this deviation may also 
relate to genetic drag and further work would need to be done to 
determine the cause. 
Filtering based on gene function was necessary to reduce the list of 
variants down to a workable number. The removal of genes related to 
olfactory function greatly reduced the list of variants, and it is unlikely 
that any of these variants have an impact on the survival of the 
individual. Variant calls in olfactory genes are very common in pigs, as 
pigs naturally rely on their sense of smell to find food and they have one 
of the largest numbers of functional olfactory receptor genes of any 
known species (Nguyen et al., 2012), and these are generally not under 
selective constraint and tend to occur in poorly assembled clusters in 
the genome. Filtering by gene function is greatly limited by the 
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annotation of the genome, which is in turn limited by the contiguity of 
the assembly in genic regions. Filtering out variants that are not in 
named genes may remove potentially interesting variants. However it is 
beyond the scope of this work to validate each of the variants in these 
unnamed genes.  
Despite the strict filtering that was carried out on these data, there were 
still false-positive calls remaining. Each variant was individually 
visualised to confirm the variant call, and 6-frame translations were 
carried out to confirm the consequence. While some of the prioritised 
genes were fragmented and not named in Ensembl, 6-frame 
translations of the sequence leading up to the variant aligned well to the 
respective proteins, and the consequence of the variants were 
supported by this. However, it should be noted that NPM1 is annotated 
elsewhere in Sscrofa10.2 and ENSSSCG00000004427 may be a 
paralog or pseudogene – however Ensembl also has supporting 
evidence for a protein aligning here. Following this in-silico validation, 
further validation was carried out to confirm the variants exist in the 
individuals through amplicon sequencing. In the majority of cases they 
were validated with only three of the 22 failing to validate. Two of the 
non-validated variants were later confirmed to exist in another set of 
pigs.  
The majority of the genes prioritised from the filtering of the exome data 
have been implicated in cancer: MST1R (Catenacci et al., 2011, 
MOSER et al., 2012), RPLP1 (Perucho et al., 2014), NPM1 
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(Grossmann et al., 2011), CFTR (Than et al., 2016), CPT1A (Pucci et 
al., 2016), IL1RAP (Ågerstam et al., 2015), LAMA4 (Wragg et al., 2016), 
LAMB3 (Jung et al., 2018), LRRFIP2 (Thorsen et al., 2008), RDM1 (Li 
et al., 2017c), SERPINA3 (Yang et al., 2014), TGFB2 (Lebrun, 2012, 
Yeung et al., 2013), TRRAP (McMahon et al., 1998), and VCAN (Yeung 
et al., 2013). Often cancers involve aberrant expression of 
developmental genes. Tumorigenesis includes increased cell 
proliferation, tissue invasion and angiogenesis, much like the processes 
involved in embryo growth and implantation (Gailani and Bale, 1997, 
Fukuda et al., 2008). However, this may be a reflection of the volume of 
research carried out on cancer, and association with more specific 
reproductive phenotypes are probably a better indicator of relevance 
here. 
From the 21 candidate genes identified from filtering the exome 
sequencing data, 11 have been directly associated with embryonic 
lethality in other species. These include CFTR (Lu et al., 2012), CPT1A 
(Nyman et al., 2005), MST1R (Muraoka et al., 1999), VCAN (Hatano et 
al., 2012), WDR36 (Gallenberger et al., 2011), NPM1 (Grisendi et al., 
2005), TPT1 (Chen et al., 2007), MTHFD1 (MacFarlane et al., 2009), 
RPLP1(Perucho et al., 2014), TRRAP (Herceg et al., 2001) and TGFB2 
(Memon et al., 2008). Most of these genes are associated with very 
early embryonic death, with the exception of NPM1 and TPT1, which 
have functions in determining embryonic stem cell fate and tend to 
cause death post-implantation in mice (Johansson and Simonsson, 
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2010). In cattle, during the maternal-to-embryo transition of the 
transcriptome, there is an almost 3-fold increase in TPT1 expression 
when the foetal genome is activated (Vigneault et al., 2009). RPLP1 
knockout in addition to being embryonic lethal is also associated with 
several phenotypes in heterozygotes, including reduced body size, 
male infertility, systemic abnormalities and an increased frequency of 
post-natal death (Perucho et al., 2014), additionally there is evidence 
that this gene is expressed abundantly in the bovine foetus (Muramatsu 
et al., 2002). RPLP1 is known to be essential for normal development of 
the nervous system in embryos (Perucho et al., 2014) and the protein 
has an important role in the elongation step of protein synthesis and 
has been directly implicated in increased cell proliferation and the 
bypassing of replicative senescence of cells (Artero-Castro et al., 2009) 
Of the genes associated with embryonic lethality, the two missense 
variants in CFTR are of particular interest, these were included in the 
final list as a number of variants in this gene are associated with cystic 
fibrosis in humans and do not need to knock out the gene to cause the 
phenotype (Bobadilla Joseph et al., 2002). Of over 1,900 CFTR 
mutations reported in humans, over 1,500 are considered potentially 
causative of cystic fibrosis symptoms, and 16.4% of Europeans carry at 
least one protein truncating allele in the gene (De Boeck et al., 2014). In 
mice, while disruption of CFTR is often lethal, some individuals do 
survive, with roughly 0.23 out of every 4 individuals from a 
heterozygous cross being homozygous for the variant. It has been 
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suggested that maternal CFTR mRNA stored in the oocyte may be 
sufficient for an embryo to survive. This may also explain how cystic 
fibrosis patients with two cystic fibrosis alleles are able to survive 
gestation (Lu et al., 2012). Human males with cystic fibrosis are usually 
infertile, due to a failure in the development of the vas deferens (Xu et 
al., 2007). In pigs, CFTR is highly expressed in the oviductal epithelium. 
Porcine CFTR mRNA is 93% identical to human CFTR mRNA, whereas 
murine CFTR mRNA is only 78% similar (Chen et al., 2010). A porcine 
model for cystic fibrosis has been developed by Welsh et al. (2009) and 
was found to have symptoms more similar to the human disease than 
previous mouse models. However the authors do not describe any 
reproductive phenotypes. The two missense variants identified here 
may not cause a phenotype as severe as embryonic lethality or absent 
vas deferens, but variants that modify the protein have the potential to 
reduce its functionality and missense variants in humans have been 
identified that cause cystic fibrosis ranging from a mild phenotype to 
severe cystic fibrosis (Krasnov et al., 2008). Pigs with a mild phenotype 
may be less productive than healthy pigs. Additionally it may be useful 
to have medical models that can mimic these different levels of severity.  
Some of the other prioritised genes have previously been associated 
with other phenotypes linked to reproduction, and these are described 
in table 3-7. 
 Some of these may be particularly interesting, for example IL1RAP 
plays a role in maternal recognition of pregnancy and in pigs reaches 
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peak expression immediately prior to implantation during the elongation 
phase of the embryo. Its ligand, IL1, increases blood cell permeability 
and leukocyte extravasation (Mathew et al., 2016). In the animals 
sequenced here there were two individuals that had homozygous 
knockouts of IL1RAP present in the population, suggesting this is not a 
lethal variant.   
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Table 3-7- Table describing genes containing short listed variants that have 
previously been associated with reproductive phenotypes 
 
  
Gene Associated phenotypes References 
IL1RAP Maternal recognition of pregnancy (Seo et al., 2011, Mathew et al., 
2016) 
LAMA4 Implantation (Shan et al., 2015, Malinda and 
Kleinman, 1996) 
MST1R Establishing maternal/foetal 
interface 
(Muraoka et al., 1999) 
NPM1 Placental disease (Grisendi et al., 2005) 
SERPINA3 Implantation, Placental disease, pre-
eclampsia 
(Chelbi et al., 2007, Chelbi et al., 
2012, Altmäe et al., 2012) 
MTHFD1 Pregnancy loss, impairment of foetal 
growth, early separation of placenta 
(Parle‐McDermott et al., 2005, Parle-
McDermott et al., 2005, Beaudin et 
al., 2012) 




 MTHFD1, while lethal in the embryo when knocked out, is also 
associated with a maternal phenotype in humans when missense 
polymorphisms are present, polymorphisms in this gene in the mother 
are associated with unexpected pregnancy loss in humans (Parle-
McDermott et al., 2005), impairment of foetal growth in mice (Beaudin 
et al., 2012), and early separation of an otherwise healthy placenta from 
the uterus in humans (Parle‐McDermott et al., 2005). Changes in 
SERPINA3 expression have been associated with a number of 
placental diseases in humans, with overexpression believed to 
decrease cell adhesion in trophoblasts. Maternal alleles of SERPINA3 
have been associated with intra-uterine growth restriction and 
preeclampsia (Chelbi et al., 2012, Chelbi et al., 2007).  
 Several genes from the prioritised list also have phenotypes linked to 
traits not directly related to early embryo survival, but may play a role in 
defects and mortality later in gestation or life. Two of the prioritised 
genes identified, EXOG (Tann et al., 2011) and RDM1(Jaroudi and 
SenGupta, 2007), are involved in the repair of breaks in DNA with the 
latter being linked specifically to this process in the embryo. While 
neither of these genes have documented lethal knockout phenotypes, 
EXOG depletion is associated with cell death through rapid 
accumulation of single stranded DNA breaks in the mitochondria (Tann 
et al., 2011, Tigchelaar et al., 2014). However, the EXOG stop gain was 
found in the homozygous form in an adult female, so can be compatible 
with life.  
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While 54 sows were selected for further sequencing, only 27 of these 
had tissue samples available, limiting any further investigation into the 
role of the candidate variants in these underperforming litters. 
Additionally, most of these sows are from different lines than the boars, 
meaning any changes in allele frequency may be from differences in 
lines rather than a higher prevalence of a variant in dams of 
underperforming litters. The indel in ENSSSCG00000012880 (CPT1A) 
had the clearest increase in allele frequency, with only six of the 96 
boars carrying the variant and 25 out of 27 of the sows carrying the 
variant. Of the three sows that were from the same line as the boars, 
two carried the CPT1A variant. Unfortunately, CPT1A is fragmented in 
Sscrofa10.2 with part of the gene (ENSSSCG00000012881) on the 
opposite strand. This makes it difficult to confirm the consequence of 
the variant and increases the chances of mismapping causing a false-
positive call. CPT1A has a role in the metabolic function of the embryo 
(Nyman et al., 2005) and it would be interesting to see the impact of this 
variant on a more complete gene model to see if it is likely to cause 
disruptions to the protein function.  
Four of the variants were found to be homozygous in some of the 
females suggesting these are not lethal, although the percentage dead 
in litters of the females homozygous for a stop-gain SNP in EXOG and 
a missense SNP in CFTR, respectively, were notably higher than 
average. While this may suggest a maternal phenotype, more data 
would be needed to test this. As has already been discussed, it has 
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been suggested that maternal CFTR is highly expressed in the porcine 
oviductal epithelium and may play an important role in early embryo 
survival. The litter from the dam homozygous for a CFTR missense 
variant had a small litter size of 9 with only 2 individuals surviving until 
birth. While it cannot be concluded that this variant is the cause of the 
poor performance of this litter, it may be worth following up on this and 
identifying more homozygous individuals in the population. It would be 
unusual for a seriously detrimental variant to be so prevalent, however it 
is possible that in the heterozygous form there is some kind of survival 
advantage. The prevalence of CFTR mutations in humans has been 
proposed to be as a result of heterozygous individuals being more 
resistant to cholera than the general population (Rodman and Zamudio, 
1991). 
Heterozygous crosses were found for four variants in EXOG, LRRFIP2, 
SERPINA3, and LAMB3, respectively. Ideally the litters of these 
crosses could be genotyped to identify any missing homozygosity, but 
unfortunately tissue samples are not available for all of the individuals 
from each of the litters. Of the data for the heterozygous cross litters 
available here, the variant in SERPINA3 was associated with the 
highest number of dead piglets at an average of 5 per litter which is 
over 4 times that of the full set of litter data available for the selected 
boars. 
The follow up sequencing of the sows was very limited due to low 
availability of samples and time restrictions. Ideally this would be done 
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with an equally representative set of females across all of the variants, 
and would include more individuals including the dams of both the worst 
litters and the best litters. With so few heterozygous crosses identified 
and so few females from the same lines as the boars it is very difficult to 
draw any conclusions. 
3.4.2 GWAS 
A GWAS was used to find variants associated with reproductive 
phenotypes. GWAS generally involves very large populations with 
genome-wide genotype data and is more successful when a small 
number of loci have a large effect on the phenotype (Stranger et al., 
2011). In this case variant genotype data was available exome-wide for 
just 96 individuals, however, the individuals in question are from a much 
larger breeding population where for many individuals SNP chip 
genotyping data and phenotype data are available. The 96 exomes 
were used as a reference population to impute variants into 351 
additional individuals and GWAS was performed against two 
phenotypes: EBVs for number born to purebred (BTP; the number born 
in a cross between two individuals from the same line) and number 
stillborn (NSB). Owing to the fact the models used in calculating these 
EBV figures were designed internally by Genus PIC, further details 
cannot be discussed here. The phenotypes available for this work are 
only subtly different, however the lack of correlation between the two 
(figure 3-3) indicates they are distinct phenotypes. NSB likely indicates 
an increase in deaths late in gestation, or during farrowing, and may be 
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more likely to be caused by non-genetic factors on the part of the foetus 
such as physical trauma, disease, or resource competition through 
overcrowding of the uterus. A potential genetic cause from the foetus 
could relate to the formation of the placenta, although this can be lethal 
early in pregnancy. It can also cause conditions such as pre-eclampsia 
in humans and lead to restricted growth through inefficient interaction 
between maternal and foetal tissue. NSB may also be a phenotype of 
the dam, as struggling or delays during farrowing may kill the piglet at or 
near parturition, often through asphyxiation (Alonso-Spilsbury et al., 
2004). BTP may indicate death earlier in gestation, when it is still 
possible for the dam to resorb the foetus. BTP may share some causes 
with NSB, but also includes foetuses that are not viable due to genetic 
defects, and zygotes with severe defects that may not survive until 
implantation. Additionally, BTP may be a phenotype of the dam with 
smaller litters being a consequence of the uterine environment or 
ovulation rate, for example. 
The accuracy of the imputation in this project would likely be higher with 
a larger reference population to increase the number of represented 
haplotypes, however this could also be increased by targeted 
sequencing of focal individuals which together cover the majority of the 
haplotypes present (Gonen et al., 2017).The power for the GWAS 
analyses was very low owing to the small number of animals with 
genotype data made available for the project. However, commercial 
breeding companies typically have more than enough individuals 
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genotyped to drastically improve the power of an association of this 
kind. Unfortunately, of the small number of genotyped individuals 
provided very few had EBVs of a high enough reliability to use in the 
association analysis, this is not ideal, and often GWAS with small 
sample sizes are enriched for false-positive associations (Hong and 
Park, 2012). GWAS from SNP chips rarely identify the causative 
variant, but one in LD with the causative variant, so exome variants in 
close proximity to significant variants were identified in addition to 
looking for candidate genes near significant regions. Whereas the 
previously discussed method of reducing the number of exome variants 
required stringent filtering that forced the analysis to focus on rare null 
variants, this method allows some more common, moderate impact 
variants to be looked at as potential candidates.   
It is likely that the imputation of variants is less reliable in regions that 
are poorly assembled, and while the regions identified as LQLC were 
excluded from the imputation, contig breaks will still interfere with the 
identification of haplotypes. Additionally, exome variants are not likely to 
be as evenly dispersed across the genome as a high density SNP 
array, and this may cause some regions to be imputed less accurately 
than others. As not all of the exome variants will have imputed reliably, 
the regions surrounding the variants with the highest associations were 
searched for moderate or high impact variants which may be 
responsible for the association. Relatively few variants were found in 
the regions identified, this may suggest that if there is a causative 
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variant in these regions they may be intergenic and play some kind of 
regulatory role. Here only variants in and close to exons are available, 
however judging by the reduced search space afforded by the exome 
variants under significant peaks, whole genome sequencing used in this 
way may help to identify these, it would however be limited by the 
accuracy of haplotype imputation in a fragmented assembly. A 
consequence of the poorly assembled genome can be seen in figures 
3-5 and 3-6, where a single variant in a region appears to be significant 
on chromosome 15, when its true genomic location is on chromosome 
3. Similar problems have been identified by other researchers using 
GWAS on the pig genome, for example researchers identified a SNP on 
chromosome 4 in complete LD with a region on chromosome 14 (van 
Son et al., 2017, Yang et al., 2013).  
The small reference population and small sample size combined with 
the unreliable genome assembly increase the likelihood that the results 
of this GWAS are unreliable. However some of the genes identified may 
be viable candidates. For several of them the literature search identified 
functions that may be relevant to these phenotypes, though further work 
would be needed to validate these and all results should be treated with 
caution. 
For BTP, no exome variants were found that looked like candidates for 
the phenotype, however several genes were identified. Most of these 
genes do not appear to be relevant to the phenotype and those with  
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Table 3-8- Table summarizing the known functions and phenotype associations 
of genes located close to significant peaks in the GWAS 














(Annunen et al., 
1999, Griffith et 
al., 1998, Hafez 
et al., 2015) 




Shaheen et al. 
(2015) 
BTP SLC35C2 Notch signalling (Lu et al., 2010) 
BTP ZEB1 Female fertility (Hasuwa et al., 
2013, Li et al., 
2015, Jimenez 
et al., 2016) 
NSB ESR1 Litter size (Li et al., 2017b, 
Munoz et al., 
2007, 
Rothschild et 
al., 1996, Short 
et al., 1997, 
Alfonso, 2005) 
NSB PARVB Adhesion, 
angiogenesis, 
implantation 
(McCallie et al., 
2016) 





(Wu and Sun, 
2015, Varshney 
et al., 2017) 
NSB ARHGAP24 Angiogenesis, 
growth, close to 
QTL for prenatal 
survival in pigs 
(Meng et al., 








NSB MYOM2 Unknown, 
expressed in 
mouse embryo 
(Ringwald et al., 
2000) 















known functions are listed in table 3-8. These are likely to be enriched 
for false positives due to the low number of individuals. 
ZEB1 has relevance to the phenotype as it has a role in several stages 
of female fertility including ovulation (in mice; Hasuwa et al., 2013); 
endometrial development and implantation (Li et al., 2015, Jimenez et 
al., 2016); and uterine quiescence and contractility (Renthal et al., 
2010). While ZEB1 is the most likely candidate out of those associated 
with BTP  the region is only approaching significance in the exome 
imputed dataset, but is significant with SNP chip data alone. If this is not 
a false signal, it may suggest that the most significant association lies 
within a region outside of the exome that may regulate this gene. 
For NSB, three variants were annotated as high impact, however two of 
these were in fragmented genes and it is unclear if the annotation 
reflects the true impact of these variants, and the third variant was 
homozygous in all individuals and likely represents an error in the 
reference or a benign variant fixed in the population. Three missense 
mutations that were not SIFT tolerated were identified, one of these was 
in a fragmented gene, and again the annotation may not be correct. The 
other two are in CORO2B and SERPINB8. CORO2B is from the 
Coronin family of actin regulators, but its role is not well defined, it is 
thought to be involved in reorganisation of the ventral neuronal actin 
cytoskeleton and cell migration (Chan et al., 2011, Rogg et al., 2017). 
There is no specific indication that CORO2B would interfere with 
reproductive traits or survival during gestation. SERPINB8 is part of the 
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SERPIN superfamily along with SERPINA3, a gene discussed 
previously. Both the SERPINA cluster and the SERPINB cluster appear 
to show some significance with NSB. The proteins in the SERPIN 
superfamily share a similar structure, but are functionally diverse, and 
many of the proteins are not well understood. Unfortunately, SERPINB8 
is not well characterised (Heit et al., 2013), however it has been shown 
to have an inhibitory activity towards furin (Leblond et al., 2006), and 
has been linked to Exfoliative Ichthyosis (Pigors et al., 2016) or “Peeling 
Skin Syndrome” in humans. Again, there appears to be no reason to 
believe this gene should cause an increase in stillbirths with the 
information currently available. SERPINA3, as discussed previously, is 
a better candidate for reproductive phenotypes. 
A number of genes appear to be associated with NSB, and these are 
summarized in table 3-9, many of them do not appear to be relevant to 
the phenotype, but some of them are supported by previous research . 
For example, a marker in an intron of porcine ESR1 was initially 
associated with litter size by Rothschild et al. (1996) who found an 
additive effect of 0.6 piglets/allele in Large White pigs from Genus PIC 
lines, and these pigs may have links to the pigs used in the work in this 
thesis. Since this initial discovery there have been a number of papers 
finding similar results (e.g. Short et al., 1997) and contrasting results 
(e.g. Dall’Olio et al., 2011), however a meta-analysis of 15 published 
studies including data on 9,329 sows supports an additive effect of the 
marker on litter size and number born alive (Alfonso, 2005). A number 
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of hypotheses have been presented for the contrasting results in the 
literature including interactions between genotype and environment, 
epistasis, or the gene not being directly causative of the phenotype but 
linked to it, with the different haplotypes in different populations 
disrupting the link. More recently a synonymous substitution in exon 5 
of ESR1 has been identified as being associated with an additive effect 
on litter size in a Chinese-European pig line (Munoz et al., 2007), while 
unlikely to be causative, it is a variant from a different population in the 
same region with the same effect as the previously identified 
polymorphism. This suggests these variants are linked to a causal 
variation, though this has yet to be identified. The most significant 
variant in that region from this work is rs321737372, a missense variant 
in a gene (ENSSSCG00000004082) with no clear orthologs. A 
significant region on SSC8 overlaps a previously identified QTL 
associated with number stillborn by Schneider et al. (2015), this region 
contains GABA receptors. GABRA4 is a GABA-A receptor, as is nearby 
GABRA2, these genes are important in brain development and function 
(Wu and Sun, 2015, Varshney et al., 2017), knockouts of other GABA 
receptors in mice are viable (Rau et al., 2009, Chandra et al., 2005). 
Another significant region on chromosome 8 is in the gene ARHGAP24, 
which has previously been associated with growth in pigs (Meng et al., 
2017b). Additionally, it is close to a region previously associated with 
prenatal survival in pigs (Hernandez et al., 2014). The significant region 
on SSC15 overlaps a previously identified QTL associated with number 
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born alive by Onteru et al. (2012), although the only candidate gene for 
the region mentioned was “novel protein”. In this case the significant 
region occurs over a fragmented MYOM2. MYOM2 is a muscular 
component and very little work has been done on this gene. MYOM2 is 
one of the genes which contained a SIFT deleterious missense 
mutation in the exome dataset, unfortunately the fragmented state of 
the gene in the assembly makes this call unreliable.  
The SERPINA3 stop-gain SNP may be the most interesting variant 
identified, with the observed litters from crosses between heterozygous 
individuals having a very high percentage dead at 40% of the litter, on 
average 5 dead piglets per litter. The SNP has a similarly high minor 
allele frequency in both the sequenced boars and the sows, but has not 
been observed homozygous. Additionally, there is a peak at the 
SERPINA cluster in the GWAS for NSB. The variant is overlapped by a 
haplotype that has previously been associated with smaller litter sizes in 
sire x maternal grand-sire carrier crosses, and the observed genotypes 
were significantly different from the genotype distribution predicted by 
the Hardy-Weinberg Equilibrium for the exome sequencing data. The 
gene’s known associations with placental disease in humans and mice 
support this variant’s potential to impact reproductive phenotypes in 
pigs. 
3.4.3 Conclusion 
While filtering out the low confidence regions of the genome did 
improve the accuracy of variant calls from the exome sequencing data, 
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it is clear that false-positives are still abundant. Additionally, throwing 
out data for over a quarter of the genome is not ideal and likely removes 
good candidates along with low-quality calls. The consequences of a 
poorly assembled genome still impact on the data even after removing 
the previously identified low-quality regions. While GWAS is fairly robust 
to small errors in the genome, large inversions, missing sequence and 
wrongly ordered contigs break the haplotypes needed to accurately 
impute variants and obscure signal in association analyses.  
Both of the methods of identifying candidate variants and genes 
described here found plausible candidates, however further work needs 
to be done to confirm the presence of the variants, their impact on the 
protein, and whether or not a phenotype can be observed. Ideally, a 
larger population would be sequenced to increase the chances of 
observing rare, but non-lethal variants in the homozygous state. This 
would allow for better filtering of the variants which may also allow for 
investigation of variants predicted to be of moderate impact in addition 
to the high impact variants. For the GWAS, a larger population would 
increase the power and accuracy of the analysis. Unfortunately the 
power of the GWAs presented here is very low, and while some of the 
regions identified may have some relevance to the phenotype and 
association cannot be confirmed. WGS rather than WES would allow for 
investigation of candidates in regulatory regions, however the cost of 
this would limit the number of individuals that could be sequenced and 
would likely result in a similarly small reference population for 
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imputation. An alternative approach being proposed by Ros-Freixedes 
et al. (2017) is to use low-coverage WGS of a large number of 
individuals as a strategy to assemble the haplotypes present in a 
population rather than only using one small set of individuals 
sequenced at depth as a reference group. This would increase the 
accuracy of imputation to the test population. 
Assuming a larger population reduced the list of candidates further, 
crosses could be done between heterozygous individuals to identify any 
reduced litter sizes or unexpected genotype distributions in the resultant 
litters. To an extent, this could be done through the records of a pig 
breeding company by identifying individuals that carry the variant and 
have already been crossed. However, this depends on the tissue/DNA 
storage practices of the company. Such records could likely only reveal 
changes in litter sizes as availability of tissue samples to genotype from 
entire litters is unlikely. For some of these variants, particularly those in 
genes with functions related to implantation such as SERPINA3, looking 
at other phenotypes such as weight at birth may be of interest as it is 
known that in humans problems at the maternal/foetal interface can 
result in reduced growth (Pardi et al., 2002). Lighter birth weight pigs 
take longer to reach market size than average (Beaulieu et al., 2010).  
For the variants in CFTR, one of the variants was found in the 
homozygous form in a number of individuals’ exome data, and the other 
was only found heterozygous. If pigs homozygous for each of these 
variants are identified they can be phenotyped for known symptoms of 
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cystic fibrosis, or a deep phenotyping approach could be taken 
(Robinson, 2012). Alternatively, these homozygous pigs can be created 
through crossing heterozygous individuals, which would be easier to 
find in the population. Cystic fibrosis in human is most commonly found 
in individuals with a deletion of a single amino acid in exon 10 (Boyle 
and De Boeck, 2013), however there are hundreds of other causative 
variants causing disease of varying degrees of severity. It is possible 
that one of the variants identified here mimics some form of human 
disease. The less common of the two variants was only seen once in 
the homozygous form, and this individual’s litter had a very low success 
rate with 9 individuals born, but only 2 alive. Many things could have 
caused this poor performance, however identification of more 
homozygous individuals and phenotyping them for reproductive traits 
would help to understand any role this variant may play. 
In Litopenaeus vannamei, LRRFIP2 knockout is associated with 
increased mortality on exposure to certain pathogens (Zhang et al., 
2013), so this variant may be of interest in studies of disease resistance 
or tolerance in pigs. The gene ENSSSCG00000004082 that is located 
close to ESR1 on SSC1 contains the most significant variant of the 
region, but the gene has no identified function and may not be reliable. 
Previous research has focussed on ESR1 as the major candidate of the 
region. As this region has evidence from multiple sources of an 
association with reproductive traits, it warrants further investigation. 
With the previous work that has been done and has failed to find a 
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causative variant, the phenotype may be caused by a structural variant 
which are harder to identify using the data that has already been 
applied to the problem, or a variant outside of the exons that regulates 
expression of ESR1. Identification of the causative variant may also 
have been hampered by the assembly of the ESR1 gene, which in 
Sscrofa10.2 is fragmented. The use of long-range PCR across the 
region accompanied by short-read and long-read sequencing of 
individuals with the causative haplotype may aid in the identification of 
the cause in this region. Short-reads are currently necessary to identify 
SNPs and indels that may have a regulatory effect, but long-reads 
would be more successful at identifying structural variants. The region 
containing ARHGAP24 has also previously been associated with 
reproductive phenotypes, and a targeted approach to investigate this 
gene and the surrounding region may be warranted. MYOM2, while not 
associated with phenotypes in previous studies, was in the most 
significant region in this work, why this variant should impact the 
phenotype is unclear and further work on understanding the gene may 
help to elucidate this.  
Ultimately, in order to prove causation for any of these variants, 
knockouts of the gene could be created in cells or pig embryos using 
gene editing technologies such as CRISPR/Cas9 to directly observe the 
resultant phenotype. Following confirmation of a detrimental variant this 
can be included in the selection criteria for breeding programs. Due to 
171 
 
the large litter sizes and short generation intervals in pigs changes such 
as this can be implemented in the nucleus herd relatively quickly. 
This chapter has focussed on identification of candidate variants that 
may be related to embryonic lethality or reduced reproductive 
performance. Using exome sequencing data, two approaches 
(identification of high impact, protein truncating variants and GWAS) 
were used to identify both rare and common variants that might be of 
importance to commercial pig production. The quality of the reference 
genome is a challenge both for variant calling methods and SNP-chip 
based GWAS, with the work here excluding over a quarter of the exome 
due to quality concerns. While a number of candidates have been 
reported here, further work is needed to confirm whether or not these 
are causative of any observable phenotype. While this work was limited 
to the exome, costs of WGS continue to decrease and in the future 
similar work including the whole genome may be feasible. Importantly, 
this would allow for regulatory regions to be explored further. The 
identification of variants related to important economic traits in the pig 
has the potential to increase productivity in the pork industry and with 
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“What do your parents know, about surviving? ”  





While the stringent filtering strategy used in chapter 3 can address some of 
the limitations of current genomic resources, it does so at the expense of 
disregarding a large portion of the exome. Additionally, by sequencing only 
the exome, variants in regulatory regions are less likely to be identified. In 
this chapter, an alternative strategy aims to include more of the genome by 
instead using whole genome sequencing and filtering primarily based on the 
variants and genotypes that are present in the sire and dam of an affected 
individual to identify candidates for a major trait of interest: embryonic 
lethality. 
In production animals, reproductive traits are an important target for 
selection. Females are bred to produce as many healthy offspring as 
possible, increased litter size and reduced foetal mortality are therefore major 
targets. Foetal mortality may result in a number of outcomes, in monotocous 
species this will often result in resorption of the foetus or early evacuation of 
the uterus. However, in certain circumstances, particularly in polytocous 
species where other foetuses are still alive, it may lead to mummification. 
Foetuses that die after calcification undergo autolysis shortly after death, 
initially swelling as serous fluid accumulates before this fluid is resorbed by 
the uterus, leaving a dehydrated, shrivelled, but otherwise preserved foetus. 
Some causes of foetal mummification have been identified, these include 
viral infection (Love et al., 2008, Joo et al., 1976, Mengeling et al., 1975), 
parasitic infection (Dubey, 1999), ectopic pregnancy (Tena-Betancourt et al., 
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2014), uterine torsion (Moore and Richardson, 1995, López and Carmona, 
2010),  and genetic or chromosomal abnormalities (Ghanem et al., 2006).  
The majority of cases of foetal mummification in pigs are attributed to 
management practices and resource limitations in utero (Wu et al., 1988, 
Lefebvre, 2015, Cozler et al., 2002). Viral infections are another major cause 
in pigs, including infections with Porcine Reproductive and Respiratory 
Syndrome virus (PRRSV -Terpstra et al., 1991, Plana et al., 1992) and 
Porcine Parvovirus (PPV -Joo et al., 1976, Mengeling et al., 1975). Limited 
research has been carried out on foetal mummification as it is rare in most 
domestic species, with the highest prevalence in swine (Lefebvre, 2015, 
Christianson, 1992) with estimates ranging from 1.5% to 6.8% of foetuses 
(Cozler et al., 2002, Schneider et al., 2012, van der Lende and van Rens, 
2003, Wu et al., 1988). Schneider et al. (2012) estimated a low heritability in 
a genome-wide association study for foetal mummification in pigs at 0.06 ± 
0.04. However, estimates of prevalence and heritability are challenging, as 
smaller mummies may be lost during farrowing leading to an inaccurate 
count. Additionally, unidentified disease in a herd and varying management 
practices between farms may cause variability in prevalence. The definition 
of “mummified” and “stillborn” may also vary between farms.  
The different estimations of prevalence between different studies may 
suggest there is a different prevalence between different breeds, although 
this may relate to the varying litter sizes and uterine space between different 
breeds (Wu et al., 1988). A study on mummified foetuses in cattle targeted a 
specific gene with a SNP known to cause foetal mortality in that species, they 
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found two out of ten mummified foetuses were homozygous for the causative 
SNP and an additional mummified foetus appeared to be missing the X 
chromosome (Ghanem et al., 2006). These results from mummified cattle 
suggest that there may be some genetic causes of mummification, though 
not necessarily a single cause for all cases. This combined with the wide 
range of non-genetic factors involved in foetal mummification may obscure 
any causative loci in a genome-wide association study. A large study by 
Derks et al. (2017) looked at 24,000 individuals from three populations 
genotyped for 80K SNPs and identified missing or depleted homozygous 
haplotypes across the populations, they found a number of regions of the 
genome that were associated with reproductive traits including 5 regions 
associated with increases in number of mummified foetuses. One of the 
regions identified by Derks et al. (2017) increased the number of mummified 
foetuses per litter 5-fold in carrier cross matings and the authors proposed 
BMPER as a candidate gene for this region. They later discovered a large 
deletion in a neighbouring gene BBS9. The deletion in BBS9 had a positive 
effect on the growth of the pigs, however it also deleted a promotor for 
BMPER, which is lethal when homozygous (Derks et al., 2018). The study 
benefited from having a very large sample size to identify regions and 
demonstrated a clear genetic cause for mummification that persists in a 
population of pigs owing to balancing selection. Mummification may be 
caused by a single variation as was found in that study, or it may be a 




In human research, it is recognised that miscarriage does not lend itself well 
to association studies, the results of which are poorly replicated. These are 
likely affected by low sample sizes, differences in study design and patient 
ethnicity, and poorly defined phenotypes. This is further complicated by 
differing and multifactorial aetiologies based on the stage of pregnancy the 
loss occurred, patient history of recurring miscarriages, and environmental 
factors (Rull et al., 2012). While the majority of sporadic pregnancy losses 
are attributed to foetal chromosomal abnormalities (Philipp et al., 2003, 
Menasha et al., 2005), these are linked to a relatively small proportion of 
recurrent miscarriages. Research has shown that in couples that are first 
degree blood relatives, miscarriages are two to seven times more common 
than the general population (Christiansen, 1996), and the siblings of 
recurrent miscarriage patients are twice as likely as the general population to 
suffer a miscarriage (Kolte et al., 2011), suggesting a heritable genetic 
component. Variants and haplotypes have been successfully linked with 
increased risk of miscarriage in humans (e.g. Ober et al., 2003, Almawi et al., 
2013, Misra et al., 2016). 
Exome sequencing has proven to be a valuable tool for affordable 
sequencing of large cohorts to identify candidate variants for a range of 
phenotypes where WGS is prohibitively expensive (Warr et al., 2015a). 
However both WES and WGS can be used in a more targeted way for 
identifying the causal variation underlying specific traits or phenotypes. In trio 
sequencing, the affected individual and two unaffected parents are 
sequenced, occasionally also sequencing one or more affected or unaffected 
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siblings. There are a number of commonly described inheritance models 
including dominant, recessive, additive, codominant and X-linked (Laird and 
Lange, 2011). In a dominant inheritance model, only one copy of an allele 
needs be present to affect a phenotype. Assuming both parents are 
unaffected this could only occur as a de novo variant in the affected offspring, 
detrimental dominant variants are unlikely to persist in a population under 
strong selection for productivity. A recessive variant will only affect a 
phenotype if two copies of the allele are present in an individual. In this case, 
both unaffected parents are heterozygous and roughly a quarter of each litter 
would exhibit the phenotype. An additive variant would increase the chances 
or severity of a phenotype with each additional allele depending on 
penetrance. In this case the phenotype would be most likely with the allele in 
the homozygous state, but may also be seen to a lesser degree in 
heterozygous individuals. In a codominant model both alleles are fully 
expressed and both influence the phenotype. X-linked variants may be 
dominant or recessive, although if both parents are unaffected, the variant 
cannot be dominant as at least one parent would be affected. A recessive 
variant on the X-chromosome of a healthy dam passed down to a male 
foetus will cause a phenotype owing to males only having a single copy of 
the chromosome. Trio sequencing assumes a monogenic, recessive 
inheritance model, but may also identify variants with additive or X-linked 
inheritance. 
As only a small number of individuals need to be sequenced in trio 
sequencing, the costs associated with whole genome sequencing (WGS) are 
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more manageable than research involving large cohorts. While WES and 
WGS can produce huge lists of variants to annotate and filter, trio 
sequencing can substantially reduce the number of candidates, as those that 
are present in the same genotype in a known unaffected individual can be 
excluded as causative. Additionally, in cases where the parents are 
unaffected and assuming a monogenic, recessive inheritance model, the 
causative variant will be carried in the heterozygous state by the parents and 
the homozygous state by the offspring, or will be a novel variant in the 
offspring. Often this leads to a shorter list of variants that can be quickly 
filtered based on other criteria. The ability to filter variants based on the 
genotypes seen in the sire and dam of an individual offer an opportunity to 
identify candidate variants without the extreme filtering applied in other 
sequencing methods as is often necessary in species with imperfect 
reference genome assemblies and with little data available to assist in 
filtering. Trio sequencing is a common tool in paediatric diagnosis of rare 
diseases and has been used to diagnose a range of diseases (Lee et al., 
2014, Meng et al., 2017a, Smith et al., 2014, Wang et al., 2011a). The 
practice is still relatively rare in animal science, though there are some 
examples using trio SNP genotyping (Lee et al., 2012), WES (Ahonen et al., 
2013) and WGS (Sayyab et al., 2016, Reber et al., 2015). Often mixed sperm 
is used to inseminate females in an agricultural setting, and while it may not 
be possible to sequence a trio with an unknown sire, the sequencing of the 
dam and one or more healthy siblings can be used to assist in filtering of 
candidates to an extent. 
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A barrier to DNA sequencing for mummified foetuses is the quality of DNA 
that can be extracted from them. Mummification occurs in any conditions that 
halt autolysis, which includes the release of digestive enzymes from within 
the organs of the body and bacterial putrification. The process is stopped 
when the tissue water content drops below a critical level and inhibits 
bacterial putrification (Janaway et al., 2009). In the uterus of a healthy 
individual there are no bacteria to decompose the tissue, nor is there oxygen, 
and the foetus is naturally actively dehydrated after death by the dam. Prior 
to the dehydration of the foetus, autolysis from enzymes has already begun 
to damage the DNA, and the subsequent dehydration of the tissue may 
cause fragmentation of the remaining DNA (Zahradka et al., 2006). There are 
very few studies involving DNA extraction from mummified animal foetuses 
with most being carried out on human remains. In a study on mummified 
foetuses in cattle (Ghanem et al., 2006, Ghanem et al., 2005) researchers 
were able to obtain 1.1-3.2 μg/ml and although the authors do not state the 
elution volume whole genome amplification was required before PCR 
amplification of the target regions could be carried out suggesting a low total 
yield from this DNA extraction.. Conversely, in a case where the death of two 
young boys was molecularly diagnosed 40 years post mortem by extracting 
DNA from naturally mummified umbilical cords, researchers were able to 
extract 171.1 ng/μl and 59.1 ng/μl from the cords and diagnosed ornithine 
carbamoyltransferase deficiency via PCR amplification of the OTC gene 
(Takenouchi et al., 2014). Again, the authors do not state elution volume, but 
the kit used recommends 100-200 μl, this likely represents a higher yield 
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from these samples than the Ghanem et al. study. Umbilical cords benefit 
from being virtually sterile and void of digestive enzymes, limiting the 
potential for autolysis. Assuming DNA can be obtained from the degraded 
sample, the damage to the DNA may cause sequencing errors and variable 
or low coverage which can affect downstream variant calling (Parks and 
Lambert, 2015, Chen et al., 2017).  
For this chapter DNA extraction and WGS was carried out on a trio of 
individuals: a mummified foetus, its sire and its dam. The mummified foetus 
was selected from a litter where a quarter of the foetuses were mummified 
during pregnancy, the expected number lost in Mendelian inheritance of a 
lethal recessive variant. Bioinformatic techniques were used to assess levels 
of DNA damage in the mummified foetus and to attempt to identify causative 
variants from the data. This method may be a valuable tool for identifying 
causative variants of specific phenotypes in pigs, just as it has been very 
successfully applied in paediatric diagnosis. 
It should be noted that a larger sample size and selection of individuals from 
a specific pedigree suspected of carrying a variant associated with 
mummification, or investigation of a more well-defined monogenic trait would 
be more likely to be successful in identifying a candidate. However, this work 
serves as a proof of principal that the trio sequencing method can be used to 
greatly reduce a large pool of variants from whole genome sequencing to a 
manageable list of candidates for further filtering even when using a low 
quality reference genome.  
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The majority of the work was carried out by the author of the thesis, DNA 
extraction on the sires, dams and healthy siblings was carried out by Heather 
Finlayson at The Roslin Institute. Sample collection was carried out by the 
author, Heather Finlayson, Claire Stenhouse, and the staff at Dryden farm. 
4.2 Methods 
4.2.1 Sample collection 
Samples were obtained from another project that was primarily concerned 
with foetal growth retardation (Stenhouse, 2017) in which mummified 
foetuses were to be discarded. Eight sows were inseminated using semen 
from two boars, with four sows per boar. Two sows were culled at day 60 of 
pregnancy for each boar, with the remaining four sows culled at day 90 of 
pregnancy. The reproductive tracts of the sows were removed intact, and the 
foetuses were removed from the uterus and whole mummified foetuses or 
samples of suspected resorbed tissue were collected. Additionally, one ear or 
leg from each apparently healthy foetus, blood from the sow and a semen 
sample from each boar was taken for DNA extraction. Foetus samples were 
labelled using the ID of the sow and the position of the foetus in the uterus, 
for example foetus 23976-L7 is from the left horn of the uterus of sow 23976 
and was the seventh foetus in that horn. All samples were transported from 
the farm on dry ice and stored at -80°C prior to DNA extraction.  
4.2.2 DNA extraction, clean up and sequencing 
Unless stated otherwise, all tubes used were DNA LoBind tubes (Eppendorf; 
Hamburg, Germany), centrifuging was done at room temperature (RT) in a 
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Centrifuge 5415D (Eppendorf), or at colder temperatures as specified in a 
Centrifuge 5810R (Eppendorf). 
4.2.2.1 DNA extraction from blood 
DNA was extracted from the blood of the eight sows as follows. 
Stocks of two buffers were used which contained the following: 
Buffer A (Red blood cell lysis buffer): 
 0.32 M sucrose 
 10 mM Tris HCl 
 5 mM MgCl2 
 0.75% Trinton-X-100 
Buffer B (Proteinase K buffer): 
 20 mM Tris HCl 
 4 mM Na2EDTA 
 100 mM NaCl 
8 ml of Buffer A was added to 8 ml of blood and 16 ml of cold Milli-Q 
(MerckMillipore; Massachusetts, USA) water in a 50 ml conical tube. The 
tube was inverted 8 times and incubated on ice for 3 minutes. The tube was 
centrifuged at 1137 x g for 15 minutes at 4°C. The supernatant was 
discarded and the pellet was resuspended in 2 ml Buffer A and 6 ml water by 
vortexing for 30 seconds. 5 ml of Buffer B and 500 μl 10% SDS was added to 
the pellet and it was vortexed for 30 seconds. 50 μl of Proteinase K (20 
mg/ml) was added and the samples were incubated overnight at 55°C in a 
shaking water bath. The samples were allowed to equilibrate to room 
temperature and 4 ml of 5.3 M NaCl was added. They were then gently 
vortexed for 15 seconds. The tubes were centrifuged at 1485 x g for 20 
minutes at 4°C and the supernatant was removed and retained. 13 μl cold 
isopropanol was added and the tubes were gently inverted 6 times. The DNA 
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was gently picked up using a wide bore tip and transferred to a 15 ml tube 
containing 5 ml 70% ethanol which was inverted 3 times. A wide bore tip was 
used again to pick up the DNA and transfer it to a 1.5 ml tube containing 1 ml 
70% ethanol which was inverted 2 times. The samples were spun down at 
10,000 x g for 5 minutes at room temperature and the ethanol was removed. 
The pellets were allowed to dry at room temperature for 15 minutes before 
being resuspended in 300 μl 10 mM Tris-HCl pH 8.0. Samples were left to 
resuspend for several hours before sample cleanup and QC. 
4.2.2.2 DNA extraction from tissue  
DNA was extracted from 117 healthy foetuses as follows. 
Tail buffer was prepared by combining 2.5 ml 1 M Tris HCl pH8.0, 10 ml 0.5 
M di-sodium EDTA, 1 ml 5 M NaCl, 5 ml 10% SDS and 31.5 ml Milli-Q water. 
For each sample tail buffer plus PK was made by combining 600 μl tail buffer 
with 35 μl 20 mg/ml Proteinase K. 
Tissue samples were cut on a chilled sterile petri dish using a scalpel into 
roughly 50mg pieces and then diced into smaller pieces and were 
immediately submerged in 635 μl tail buffer plus PK. The samples were 
incubated in a hybridisation oven at 55°C with rotation overnight. Samples 
were allowed to cool and 170 μl 5 M NaCl was added. The tubes were 
shaken and centrifuged at 16100 x g for 10 minutes. 500 μl of supernatant 
was removed from each tube and added to 1 ml of cold EtOH in a new tube, 
this was mixed by inversion. The samples were incubated at -20°C for 30 
minutes and then centrifuged at 12000 x g at 4°C for 20 minutes. The 
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supernatant was discarded and the pellets were washed with 1 ml 70% EtOH 
and left for 5 minutes at room temperature. The tubes were centrifuged at 
7500 x g for 5 minutes, the EtOH removed, and this wash was repeated. The 
sample was allowed to air dry for around 15 minutes and was resuspended in 
500 μl 10 mM Tris-HCl pH 8.0. 
4.2.2.3 DNA extraction from sperm 
Due to the high DNA compaction by protamines in sperm, standard DNA 
extraction methods cannot be used. A method based on that by Griffin (2013) 
was used as follows. 
100 ml of sperm wash buffer was made by combining 1.5 ml 5 M NaCl, 1 ml 
0.5 M EDTA pH8.0 and 47.5 ml Milli-Q water. 12 ml of extraction buffer was 
made by combining 8.48 ml 6 M guanidine thiocyanate, 240 μl 5 M NaCl, 400 
μl 30% sarkosyl, 1.8 ml 1M DTT, 120 μl Proteinase K and 960 μl nuclease-
free water.  
The frozen sperm pellets containing roughly 109 sperm cells each were 
resuspended in 0.5 ml sperm wash buffer and were then made up to 10 ml 
by adding more wash buffer. For each sample, 5 x 50 ml tubes of 2 ml of 
sample were used and were centrifuged at 750 x g for 10 minutes. The 
supernatant was decanted and the sample was vortexed to resuspend the 
cells in the residual buffer. 10 ml of sperm wash buffer was added and the 
sample was vortexed and centrifuged at 750 x g for 10 minutes. The 
supernatant was decanted and the sample was vortexed to resuspend the 
cells in the residual buffer. For each sample 1 tube was taken forward and 
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the other four sperm pellets were frozen at -80°C for future use. 6 ml of 
extraction buffer was added to each sample and the tubes were gently 
inverted several times to mix. Samples were incubated at 56°C on a shaking 
platform in a hybridisation oven for 2 hours, inverting the tubes 3 times half 
way through the incubation period. The tubes were allowed to equilibrate to 
room temperature. 4.8 ml isopropanol was added and mixed by gentle 
inversion until DNA strands could be seen. A wide bore pipette tip was used 
to transfer the DNA to a 2 ml tube containing 2 ml 0.1 M Na citrate in 10% 
ethanol and was incubated at room temperature for 30 minutes with 
occasional inversions and this was repeated by transferring the pellet to a 
fresh 2 ml tube containing 2 ml 0.1 M Na citrate in 10% ethanol. The pellet 
was transferred to a tube containing 1 ml 70% ethanol and the tube was 
inverted, this was repeated with a fresh tube of 1 ml 70% ethanol. The tube 
was then centrifuged at 5000 x g for 3 minutes at room temperature. The 
ethanol was removed and discarded and the samples were allowed to air dry 
for around 10 minutes. The pellets were resuspended in 800 μl 10 mM Tris-
HCl pH 8.0. Samples were left to resuspend overnight before sample cleanup 
and QC. 
4.2.2.4 DNA extraction from mummified tissue 
A number of methods were attempted to extract DNA from the degraded 
tissue of the day 60 and day 90 mummified foetuses including different 
methods of sampling the tissue, different methods of lysing the tissue and 
different kits for extraction. The following method was the fourth iteration and 
found to be the most effective on the day 60 foetuses, which generally had 
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DNA that was more degraded than the day 90 foetuses. Day 60 foetuses 
were preferable as earlier deaths were deemed more likely to relate to 
causes other than restricted resources. Foetus 23982_R6 was chosen as it 
was a day 60 foetus and a quarter of the litter were mummified, in keeping 
with the expected distribution from a Mendelian inheritance pattern. 
The Qiagen (Hilden, Germany) QIAmp DNA Investigator Kit was used for this 
extraction. The kit is designed for use in forensics and works well on 
degraded samples and small amounts of tissue. The workspace and two 
polystyrene boxes were cleaned thoroughly with trigene disinfectant and 70% 
ethanol. Dry ice was added to the two polystyrene boxes, one fully and one 
half full. To the half-filled box, sterile petri dishes and sterile scalpels were 
placed to cool along with the foetus which had been retrieved from -80°C 
freezer storage. The foetus was weighed on a scale and immediately 
returned to the dry ice, it weighed 6.175 g. The full box of dry ice was 
covered with aluminium foil and used as a work surface to keep the tissue 
cold. A chilled petri dish was placed on top of the foil and the foetus was 
placed in the petri dish. Two chilled sterile scalpels were used, one to hold 
the foetus still and one to cut it in half and scrape tissue from the inside of the 
cut. This method was used to minimise the potential contamination from the 
dam’s blood on the surface of the foetus. It had been impractical to clean the 
foetuses before storing them during sample collection. The target weight for 
the tissue samples was 10 mg per sample, however to reduce the risk of 
thawing due to over handling, larger weights were used and the lysate was 
split accordingly later. Three tissue fragments were placed in three 1.5 ml 
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tubes, these weighed 18 mg, 24 mg and 30 mg. 360 μl of ATL buffer from 
Qiagen QIAmp DNA Investigator Kit was added to the tubes with 18 mg and 
24 mg in, and 540 μl was added to the tube with 30 mg in and they were 
allowed to equilibrate to room temperature before 40 μl Proteinase K was 
added to the tubes containing 18 mg and 24 mg and 60 μl was added to the 
tube containing 30 mg. The tubes were incubated in a hybridisation oven at 
56ºC with rotation overnight. The lysate was split between 7 tubes by moving 
200 μl from the first and second tube into fresh 1.5 ml Eppendorf tubes, and 
2 x 200 μl from the third tube was moved to two new Eppendorf tubes so all 7 
tubes contained 200 μl of lysate. The protocol for QIAmp DNA Investigator 
Kit "Isolation of Total DNA from Tissues" was followed from step 5 as follows. 
200 μl of Buffer AL was added to each tube and mixed by vortexing. 200 μl 
100% ethanol was added to each tube and immediately vortexed to 
homogenise. The tubes were left to stand for 5 minutes. For each sample, 
this mixture was pipetted into a QIAmp MiniElute column in a 2 ml collection 
tube and centrifuged at 6000 x g for 1 minute. The flow-through and 
collection tube were discarded and the collection tube was replaced with a 
new one. 500 μl Buffer AW1 was added to each tube and centrifuged at 6000 
x g for 1 minute. The flow-through and collection tube were discarded and the 
collection tube was replaced with a new one. 700 μl Buffer AW2 was added 
to each tube and centrifuged at 6000 x g for 1 minute. The flow-through and 
collection tube were discarded and the collection tube was replaced with a 
new one. 700 μl of EtOH was added to each tube and centrifuged at 6000 x g 
for 1 minute. The flow-through and collection tube were discarded and the 
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collection tube was replaced with a new one. The tubes were centrifuged at 
20000 x g for 3 minutes and the columns were transferred to 1.5 ml lo-bind 
tubes and incubated at room temperature for 10 minutes. 100 μl ATE buffer 
was pipetted directly onto the spin column membrane and incubated for 5 
minutes at room temperature. The tubes were spun at 10000 x g for 1 
minute. Any visible liquid remaining in the spin column was picked up using a 
P10 pipette and placed directly onto the membrane and the tubes were spun 
again at 10000 x g for 1 minute. 
4.2.2.5 Quantification, quality control and RNase treatments 
The seven tubes of mummified foetus DNA were quantified using the Qubit 
(Life Technologies; California, USA) broad range (BR) kit. 1791 μl of BR 
buffer was combined with 9 μl BR reagent and vortexed thoroughly. 198 μl of 
this mix was added to 7 Qubit tubes for the samples and 190 μl of the mix 
was added to 2 Qubit tubes labelled standard 1 and standard 2. Samples 
were vortexed to homogenise and 2 μl of sample was added to each Qubit 
sample tube and 10 μl of broad range standard was added to the appropriate 
standard tube. The Qubit fluorometer was used to quantify the DNA. The 
quality was assessed using the Agilent (California, USA) Tapestation. A fresh 
Genomic DNA ScreenTape was removed from the fridge along with the 
Genomic DNA sample buffer and the Genomic DNA ladder and these were 
left at room temperature for 30 minutes. In a strip tube, 10 μl of Genomic 
DNA sample buffer was added to all of the tubes. 1 μl Genomic DNA ladder 
was added to the first tube and 1 μl of each sample was added to each 
subsequent tube. This was briefly spun down in a centrifuge before being 
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placed on the IKA (Staufen, Germany) vortexer for 1 minute at 371 x g. The 
tubes were again spun down briefly and were placed in the Tapestation and 
the Tapestation software was run. 
The seven tubes of mummified foetus DNA were pooled into two tubes, one 
containing four samples and one containing three, 1 μl of Riboshredder 
(Epicentre; Wisconsin, USA) was added to each. The tubes were incubated 
at 37°C for 15 minutes. 800 μl of DNA binding buffer from the Zymo 
(California, USA) DNA Clean & Concentrator kit was added to the first tube 
and 600 μl to the second, to get a 2:1 ratio of DNA binding buffer to sample. 
The whole volume from both tubes was transferred to a new Zymo spin 
column in a 2 ml collection tube 800 μl at a time and it was centrifuged for 30 
seconds at 12,000 x g and this was repeated until the full volume had passed 
through the tube. The flow through was discarded and 200 μl DNA Wash 
Buffer was applied to the membrane in the column. The tube was centrifuged 
for 30 seconds at 12,000 x g and the flow through was discarded, this DNA 
wash buffer step was repeated once. 200 μl of DNA elution buffer was 
applied to the membrane and it was incubated for 1 minute at room 
temperature before being transferred to a new 1.5 ml Eppendorf and being 
centrifuged for 30 seconds at 12,000 x g. Quantification with the Qubit BR kit 
was carried out as described above, scaled down to two samples worth of 
working solution. The quantification was done in duplicate and the 
Tapestation analysis was also repeated as described above. 
Further steps were carried out for the sire and dam of the mummified foetus 
23982_R6 only, “CB” and “23982” respectively, the other sires and dams and 
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the healthy siblings were not whole genome sequenced and these steps 
were not necessary. The DNA from CB and 23982 was roughly quantified 
using the Nanodrop (Thermo Fisher; Massachusetts, USA) and was diluted 
with 10 mM Tris-HCl pH 8.0 to 130 μg in 400μl. 1 μl Riboshredder was added 
to each and they were incubated at 37°C for 15 minutes. 2 Phase Lock Gel 
tubes (5PRIME; California, USA) were centrifuged at full speed for 1 minute 
to spin the gel to the bottom of the tubes. In a fume hood, 400 μl 
Phenol:Cholroform:Isoamyl was added to each Phase Lock Gel tube. Each 
sample was transferred into one Phase Lock Gel tube and the tubes were 
mixed by inversion until the contents were white and uniform, then they were 
gently mixed on a rotator for 5 minutes. The tubes were spun at max speed 
for 4 minutes at RT and the aqueous layer above the gel layer was 
transferred to a 2 ml tube. 16 μl of 5 M NaCl was added to each sample the 
samples were mixed with a Genomic DNA pipette tip. 920 μl cold ethanol 
was added to each sample and they were inverted until the DNA was visible. 
The DNA was picked up with a pipette tip and transferred to a new tube 
containing 1 ml 70% EtOH. The tubes were centrifuged at 16000 x g for 5 
minutes at 4°C. The supernatant was removed and discarded and the pellet 
was left to dry at room temperature for 10 minutes. The pellets were 
resuspended in 300 μl 10 mM Tris-HCl pH 8.0. The RNase treated and 
cleaned DNA was quantified using Qubit as described previously, and the 




Despite the mummified foetus sample having very poor quality DNA, it was 
sent to Edinburgh Genomics for sequencing using the TruSeq Nano 
(Illumina; California, USA) library preparation method on the Illumina HiSeqX. 
The resulting sequences were paired end with an expected mean insert size 
of 450 bp. Following initial QC of these data as described below, CB and 
23982 were subsequently sequenced in the same manner. 
4.2.3 Bioinformatic analysis 
Unless stated otherwise, tools were run using default parameters 
4.2.3.1 Quality control and alignment of sequencing data 
FastQC (v. 0.11.5; Andrews, 2010) was used to check the fastq files for 
adapter content and basic sequence quality. The reads were trimmed using 
sickle (v. 1.33; Joshi and Fass, 2011) and FastQC was used again to confirm 
the trimming of low quality base calls. The fastq files were mapped to 
Sscrofa10.2 using BWA mem (v.0.7.15Li, 2013) and converted to sorted bam 
files with Samtools view and sort (v. 1.2; Li et al., 2009a). Additionally, 
Samtools flagstat was used to summarise basic mapping statistics. As the 
23982_R6 was degraded, additional QC steps were taken. BEDtools 
genomecov (v. 2.26.0; Quinlan, 2014) was used to assess genome-wide 
coverage and check for a normal distribution, and coverage on the X and Y 
chromosome relative to the rest of the genome allowed for identification of 
the gender of the foetus.  
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4.2.3.2 Variant calling and filtering 
Picard MarkDuplicates (v. 2.7.1; http://broadinstitute.github.io/picard/) was 
used to mark duplicates in the three bam files. GATK HaplotypeCaller (v. 3.7-
0; McKenna et al., 2010) was used to call variants, this was done using 
parameters --emitRefConfidence GVCF -variant_index_type LINEAR -
variant_index_parameter 128000. Realignment and base recalibration were 
not done as GATK no longer recommends indel realignment with haplotype 
based callers, and it was decided that given the results of chapter 2, there is 
no reliable “truth set” of variants.  Ensembl VEP (v. 89; McLaren et al., 2016) 
was used to annotate the variants. The variants were filtered down to those 
that were heterozygous in CB and 23982 and homozygous in 23982_R6 and 
were also annotated as high impact. Additionally, variants that were de novo 
in 23982_R6 were identified, those which were homozygous reference in CB 
and 23982 and homozygous alternative in 23982_R6. These de novo 
variants were visualised with Integrative Genomics Viewer (IGV; 
Thorvaldsdóttir et al., 2013) however, these are all likely to be false positives. 
This produced a short list of genes containing likely deleterious variants to be 
further investigated through a search of the literature. 
BEDtools intersect (Quinlan, 2014) was used to check how many of the 
prioritised variants occur in low quality or low coverage regions identified in 
chapter 2. These regions were not filtered out in this case, but the annotated 
consequence for these variants are more likely to be unreliable. 
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In addition to the above, regions identified by Derks et al. (2017) as being 
associated with mummification were searched for variants that were 
heterozygous in 23982 and CB and homozygous in 23982_R6, that are 
annotated as having a moderate or high impact on the protein. Additionally, 
variants in the BMPER gene which was identified as a candidate in the study 
by Derks et al. (2017), was searched in the unfiltered, annotated VCF file for 
any variants that may impact the protein at any impact level and with any 
genotype. 
4.2.4 Follow-up genotyping 
Following identification of candidate variants during bioinformatic analysis, 
genotyping of the remaining sire and the seven remaining dams and 117 
healthy foetuses was undertaken for four variants. All DNA samples were 
roughly quantified using the Nanodrop and samples were sent for genotyping 
with LGC (Middlesex, UK) group’s genotyping services. All samples were 
over 100 ng/μl and 10 μl of each was sent along with the reference sequence 





4.3.1 Sample collection 
Tissue samples were collected from 117 apparently healthy foetuses, along 
with blood samples from the eight dams and semen samples from the two 
sires. 17 whole mummified foetuses were collected with 10 from the day 60 
litters and 7 from the day 90 litters. Each sire had a similar number of 
mummified foetuses with 8 from one sire and 9 from the other. The dams had 
between one and four mummified foetuses each, with the majority having 
only 1 mummified foetus recovered. The size of the foetuses varied with day 
60 foetuses ranging from 0.5 cm-2.5 cm and day 90 foetuses ranging from 
2.5 cm-10 cm. Examples of two day 60 and two day 90 mummified foetuses 
are shown in figure 4-1. 
4.3.2 DNA extraction  
Seven separate DNA extractions were carried out for the mummified foetus, 
23982_R6, according to Qubit quantification the concentrations (ng/μl) of 
these were 27.8, 39.6, 43.4, 27.4, 29.8, 45.4, and 39.6 in 100ul each. The gel 
image from the Tapestation for the seven samples are shown in lanes B1-H1 
in figure 4-2 in addition to an example of the electropherogram for one 
sample. Following pooling and RNase treatment, the sample was quantified 
with Qubit in duplicate, the concentrations were poor at 11 ng/μl and 13 ng/μl 
in 200ul total volume. The Tapestation was run on the pooled sample in 




Figure 4-1- Photographs of two day 60 mummified foetuses (left top, left bottom) and 
two day 90 mummified foetuses (right top, right bottom). All are in standard size petri 




Extraction of high molecular weight DNA for the sires, dams and healthy 
siblings was successful, with all samples yielding >100 ng/μl in 100-200ul 
according to Nanodrop. The results of DNA extractions from CB and 23982 




Figure 4-2- Tapestation gel image for seven DNA extractions from mummified foetus 
23982_R6 (top) and an example of one Tapestation electopherogram showing the 




Figure 4-3- Tapestation gel image for pooled DNA extractions from mummified foetus 
23982_R6 in duplicate (top) and an example of one Tapestation electopherogram 
showing the distribution of DNA fragment sizes with a peak at 420bp(bottom). 
200 
 
in table 4-1, these include details of quantity and quality after a clean-up step 
performed because the 260/280 ratio of CB was close to 2, suggesting RNA 
contamination.  
4.3.3 Sequence quality control 
Initial QC with FastQC revealed no adapter content, all samples had similar 
good quality base calls (figure 4-4) and there was no apparent effect of 
degradation on the mummified foetus DNA. All three datasets had reduced 
quality scores towards the end of read 2, which is expected for Illumina data 
and in all cases this was much improved by trimming with sickle. Following 
alignment to Sscrofa10.2, samtools flagstat results (summarised in table 4-2) 




Table 4-1- Table describing DNA quantity and quality of DNA extractions from CB and 








Table 4-2- Summary of key Samtools flagstat results for sequencing data from the trio 
 23982_R6 23982 CB 





















 CB 23982 
Initial DNA 
quantification1 
696 ng/μl in 200ul 582 ng/μl in 300ul 
Initial 260/2801 1.93 1.87 
Initial 260/2301 2.34 2.44 
Quantification post-
cleanup2 
153 ng/μl in 200ul 569 ng/μl in 200ul 









Figure 4-4- FastQC plots for 
read 1 after trimming for 
23982_R6 (previous page, left), 




Genome coverage for 23982_R6 had a normal distribution over the 
autosomes according to BEDtools Genomecov (figure 4-5.A), and coverage 
over the X and Y chromosome was equal and roughly half that of the 
autosomes (figure 4-5.B-C) revealing the foetus to be male and suggesting 
little contamination from the dam’s blood on the outer surface of the foetus 
during DNA extraction.  
4.3.4 Variant calling, annotation and filtering 
Variant calling on the trio identified 16,548,227 variants. In this dataset, there 
are 6,398,821 variants that appear in the homozygous state in CB and/or 
23982. As the sire and dam are alive and capable of reproducing, these 
variants cannot be the sole cause of lethality in the embryo and were filtered 
out. Similarly, variants which are heterozygous or homozygous reference in 
23982_R6, of which there are 8,178,882 and 3,899,814, respectively were 
filtered out. Finally, variants in which one or more individuals had no 
genotype called have been excluded. Further details of the number, 
consequences and filtering of the variants is summarised in figures 4-6 to 4-
8. Filtering for variants that occur de novo in the homozygous state in 
23982_R6 identified 6,026 variants, 6 of which were HIGH impact, however 
these are highly likely to be false positives and may relate to sequencing 







Figure 4-5- (Right) Plots showing 
the average coverage of reads 
for 23982_R6 over the 
autosomes (A), the X 
chromosome (B) and the Y 
chromosome (C) based on 
results from BEDtools 
genomecov. Axes have been 





16,548,227 variants 7  
339,688 homozygous in 
23982_R6, heterozygous 
in sire and dam 
6,104 Overlap genes 
40 HIGH impact 
17 in named genes 
Figure 4-6- Summary of 
filtering results from initial 
dataset to final candidates 
that were followed up on 





Figure 4-7- Pie chart of variant types from annotation of full set of variants found in 
the three samples 
 
Figure 4-8- Pie chart of annotated consequences of variants in full set of variants 
found in the three samples 
Figure 4-9- Pie chart of annotated consequences of variants in genotype filtered set of 
variants from the three samples 
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Following filtering for variants that are heterozygous in CB and 23982 and 
homozygous in 23982_R6, the proportion of variant types was similar, 
however the consequences tended to be of lower impact (figure 4-9), 
revealing a small pool of high impact candidates. 
High impact variants that were heterozygous in CB and 23982 and 




Table 4-3- Table of 40 candidate variants that are high impact, homozygous in the 
mummified foetus (23982_R6) and heterozygous in the sire (CB) and dam (23982). 
Final column refers to regions identified as low quality (LQ) or low coverage (LC) in 
chapter 2. Consequences are abbreviated: F=frameshift, SA=splice acceptor, 















1: 29114892 SNP NHSL1 NHS Like 1 SA  




1: 204304619 Indel CDKN3 Cyclin Dependent 
Kinase Inhibitor 3 
F&SL LC 
1: 293511480 Indel STOM Stomatin F  







Novel gene F 
SA 
LQ 
2: 64446751 SNP ENSSSCG00
000013788 
Novel gene SG LC 
4: 99504244 SNP OR6K6 Olfactory 




5: 88073588 SNP DEPDC4 DEP Domain 
Containing 4 
SD  
6: 125237842 SNP SURF6 Surfeit 6 SG LQ 




7: 14580986 SNP TPMT Thiopurine 
methyltransferase 
SG  




8: 81956756 Indel ENSSSCG00
000028236 





























9: 29559438 SNP ENSSSCG00
000025995 
























10: 15627047 SNP ENSSSCG00
000023390 
Novel gene SL  
10: 47679923 Indel ENSSSCG00
000027759 



















13: 25472029 SNP EXOG Exo/Endonucleas
e G 
SG  
14: 6418550 Indel ENSSSCG00
000023463 
GDNF Family 






Novel Gene SG LQ 
















17: 35256025 Indel NINL Ninein Like F  
17: 57521610 SNP PTGIS Prostaglandin I2 
Synthase 
SL LC 











From this set of 40 variants, the rs332515507 SNP in the EXOG gene was 
prioritised as it had previously been identified as a high quality candidate 
variant (see chapter 3). Three additional variants were also prioritised based 
on their function via a review of the literature, these are the variants in 
SURF6, CYFIP2, and BCL11B. SURF6 is in a region previously identified as 
low quality in chapter 2, while this reduces the confidence in the annotation 
given to it, it has been taken forward due to the relevance of the gene to the 
phenotype. SURF6 is an important gene in implantation and the early embryo 
and knockouts in mice are lethal (Romanova et al., 2006), CYFIP2 knockouts 
are also lethal in mice (Kumar et al., 2013), and BCL11B has roles in the 
development of a number of important systems (Lennon et al., 2017). These 
are discussed further below. 
The six high impact de novo variants that were homozygous in 23982_R6 
were visualised with IGV and were all found to be false-positives. Two of the 
variants were large insertions that began at the edge of assembly gaps (e.g. 
figure 4-10) and likely represent missing sequence from Sscrofa10.2. Other 
variants in this set were in regions with poor mappability due to repeats and 
low-complexity (e.g. figure 4-11). Five were in LQLC regions identified in 






Figure 4-10- Example of a variant called as homozygous in 23982_R6 and 
homozygouys reference in 23982 and CB. The variant is marked by a vertical purple 
line. There is a gap in the genome as represented by the grey bases on the lower 
track. The top track are reads from 23982_R6, the centre track are reads from 23982, 





Figure 4-11- Example of a variant called as homozygous in 23982_R6 and 
homozygous reference in 23982 and CB. The variant is shown as a 7 or 9 base 
deletion. There are mapping low quality reads in all three samples. The variant was 
called by GATK as a 9 base insertion of a T homopolymer. The low complexity 
context of this region can be seen in the lower track where there are CT repeats 
(blue and red) and a run of Ts (red). The top track are reads from 23982_R6, the 
centre track are reads from 23982, and the bottom track are reads from CB. 
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No moderate or high impact variants that were heterozygous in 23982 and 
CB and homozygous in 23982_R6 were identified within the regions 
identified by Derks et al. (2017), with all variants being intergenic, intronic, or 
up- or downstream variants. It is possible one of these has a regulatory role 
rather than a direct effect on the protein, however further investigation of this 
is beyond the scope of this project. Additionally, no high impact variants were 
found in the unfiltered VCF in the BMPER gene, and one moderate impact 
variant was found. This variant was heterozygous in CB and 23982_R6 and 
homozygous for the reference allele in 23982 and so is unlikely to be relevant 
to the phenotype. 
4.3.5 Genotyping  
The candidate variants were genotyped in all of the remaining dams and 
healthy siblings and the remaining sire. The results of the genotyping for the 
siblings successfully genotyped are presented in table 4-4. 
None of the adult animals were homozygous for any of the alt variants. 
For the CYFIP2 indel, only 2 litters were from heterozygous crosses, the litter 
of sows 23982 and 23964, both sired by CB. Of the 13 seemingly healthy 
foetuses from 23982’s litter, only one was homozygous for the deletion, with 
8 homozygous for the reference allele and 4 heterozygous. Conversely, of 
the 13 seemingly healthy foetuses from 23964’s litter only one was 
homozygous for the reference allele, with 7 heterozygous and 5 homozygous 




 Table 4-4- Table of full set of genotyping results for the four main candidate 
variants 













CYFIP2  - 91 27 6 124 84.3 15.7 TCCTC - 
BCL11B rs344332274 37 65 19 121 57.4 42.6 G A 
SURF6 rs707030666 32 63 29 124 51.1 48.8 A T 




There were five litters from heterozygous crosses of the BCL11B variant. The 
average percent homozygous reference for these litters was 30.4%, the 
average percent heterozygous was 38.6% and the average percent 
homozygous alt was 28.3%. 
There were three litters from heterozygous crosses of the SURF6 variant. 
The average percent homozygous reference for these litters was 20.5%, the 
average percent heterozygous was 45%, and the average percent 
homozygous alt was 32.6%. 
There were three heterozygous crosses for the EXOG SNP. The average 
percent homozygous reference for these litters was 26.7%, the average 
percent heterozygous was 36.2% and the average percent homozygous alt 
was 37.1%. 
4.4 Discussion 
Embryonic losses are wasteful as the energy the dam puts into a foetus that 
fails to survive reduces the overall efficiency of the pregnancy. While the 
literature does suggest there may be genetic causes for litter size, stillbirth 
and mummification (e.g. Ghanem et al., 2006, Derks et al., 2017, Schneider 
et al., 2015), these are expected to be multifactorial phenotypes and not 
every stillborn or mummified foetus will have a genetic cause. Protein 
truncating variants are a good starting point when looking for causes of a 
phenotype, as any protein that is cut short has potential to be rendered non-
functional and regulatory variants are much more difficult to annotate. 
However, protein truncating variants are actually common in healthy 
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individuals (Groenen et al., 2012, Lek et al., 2016, MacArthur et al., 2012, 
MacArthur and Tyler-Smith, 2010), and the function of genes must be used to 
further filter these. This filtering is limited by our understanding of the 
functions of genes, and redundancy of gene function in the genome. 
While mummification is a dramatic phenotype, it is purely a consequence of 
the death of the foetus after the bones have started to form and there are 
thus many possible underlying causes. The death of a foetus can be from 
any number of genetic variants or environmental factors, and the timing of 
the death determines whether or not the foetus will mummify. Lethal variants 
may terminate a foetus before the bones form and the loss of the foetus may 
not even be noticed but simply identified as a sow producing a smaller litter 
size. As pigs are already under strong selection for litter size lethal variants 
are already under negative selection, additionally European pig breeds are 
expected to have fewer deleterious variants than most domestic species 
owing to their level of outbreeding (Makino et al., 2018), so it is perhaps not 
surprising that they are difficult to find in a commercial herd.  
The work in chapter 3 employed stringent filtering, but trio sequencing offers 
a method of reducing a huge number of variants to a small number of 
candidates using a different kind of filtering that has less risk of discarding 
true-positive variant calls. A limitation of using trio sequencing without 
stringent filtering is that searching for variants such as de novo variants 
against a poor quality reference genome is likely to produce a list of false-
positives. For phenotypes with a single causative variant against a high 
quality genome it has been demonstrated that trio sequencing can quickly 
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and correctly identify these variants (Meng et al., 2017a). In the case 
described here, focussing on variants that are homozygous in the offspring 
and heterozygous in the sire and dam reduced the number of variants from 
16,548,227 to just 339,688. Not only was the total number of variants 
reduced, but the proportion of those variants that are predicted to be high 
impact was reduced. With as few as 40 high impact variants, these can easily 
be individually investigated for any relationship with the phenotype and 
inspected for reliability, moving the quality control of the variants from the first 
step to the last and avoiding the early loss of true positive variants through 
strict initial filtering. Ideally, all 40 of these variants would have been 
genotyped in the remaining individuals, however, with the number of samples 
involved this is prohibitively expensive. 
Of the 40 variants in the filtered set, 18 were in unnamed genes, with 
Ensembl identifying most of them only as “novel gene”, with the exception of 
ENSSSCG00000025104 (ATP5H), ENSSSCG00000023463 (GFRA2) and 
ENSSSCG00000026023 (PRKAG2). While these genes have been identified 
through homology, they are incomplete, all three have poor percentage 
identity scores with the orthologous of genes in other species, and both 
ENSSSCG00000025104 and ENSSSCG00000023463 are in regions 
identified as LQLC in chapter 2. This renders any variant calls based on 
changes to codons in the exons of these genes unreliable. ATP5H is one of 
many ATP synthase genes, while knockout of some ATP synthase genes 
have been linked with embryonic death in mice (Vrbacký et al., 2016), this 
one specifically has not. This gene sits next to a reference gap and is likely 
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missing part of the gene making the consequence call less reliable, although 
it is a frameshift, so assuming it truly is in an exon of the gene, it may knock it 
out. While the quality of the individual variant is good, visualisation of the 
region on the gEVAL browser (Chow et al., 2016) reveals the surrounding 
region is abnormal (figure 4-12). 
GFRA2 is a neurotrophic factor, and while knockout mice have a number of 
negative phenotypes (Rossi et al., 2003), they are viable. Again, this 
particular variant is supported by the reads, however the fragmented gene 
sits on a short contig between two reference gaps, and gEVAL visualisation 
of this region suggests a misassembled region (figure 4-13). 
PRKAG2 is an enzyme that regulates glucose uptake and glycolysis and this 
is a highly conserved sequence. In humans only missense or in-frame indels 
have been described (Porto et al., 2016), and the ExAC database (Lek et al., 
2016, Exome Aggregation Consortium (ExAC), 2014) estimates a LoF 
intolerance probability of 0.98. In this case CB and 23982 have only 8 reads 
each covering the variant loci, with 23982_R6 having 35 reads. Again, the 
region is next to a reference gap and appears to be of low quality (figure 4-
14), although was not one of the regions identified in chapter 2 and would not 
have been filtered out if these regions had been used as a filter. The variant 
is however just 60 bases away from a region identified as LQLC, which can 
be appreciated in figure 4-14. 
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Figure 4-12- Region surrounding a variant in the fragmented gene ENSSSCG00000025104 as 
visualised in the gEVAL browser. Vertical red line marks approximate location of the indel. The 
top track shows mapped ends of BAC ends from the library used in the assembly of the 
reference genome, bottom track shows mapped fosmid ends. Ends joined in red are in the 
incorrect orientation, in orange are incorrect insert size, in purple are single ends mapping 
multiple times, and in green are ends mapping with the expected orientation and insert size. 
Figure 4-13- Region surrounding a variant in the fragmented gene 
ENSSSCG00000023463 as visualised in the gEVAL browser. Vertical red line marks 
approximate location of the indel. The top track shows mapped ends of BAC ends 
from the library used in the assembly of the reference genome, bottom track shows 
mapped fosmid ends. Ends joined in red are in the incorrect orientation, in orange are 
incorrect insert size, in purple are single ends mapping multiple times, and in green 




Figure 4-14- Region surrounding a variant in the fragmented gene 
ENSSSCG00000026023 as visualised in the gEVAL browser. Vertical red line marks 
approximate location of the indel. The top track shows mapped ends of BAC ends 
from the library used in the assembly of the reference genome, bottom track shows 
mapped fosmid ends. Ends joined in red are in the incorrect orientation, in orange are 
incorrect insert size, in purple are single ends mapping multiple times, and in green 
are ends mapping with the expected orientation and insert size. 
 
Figure 4-15- Region surrounding the gene CEP295 as visualised in the gEVAL 
browser. The top track shows mapped ends of BAC ends from the library used in the 
assembly of the reference genome, bottom track shows mapped fosmid ends. Ends 
joined in red are in the incorrect orientation, in orange are incorrect insert size, and in 
green are ends mapping with the expected orientation and insert size. The blue track 




These fragmented genes demonstrate the importance of a contiguous and 
well annotated reference genome. While the first two genes described are 
unlikely to cause lethality when knocked out, the third is LoF intolerant. With 
regions of the reference genome being of poor quality, this variant and those 
in the completely unidentified genes that may be of interest must be 
overlooked to focus on the more high-confidence variant calls, despite their 
potential relevance to the phenotype. 
CEP295 is another candidate in the list of 40, there are 5 different high 
impact variants called. CEP295 is a highly conserved centrosomal protein 
without which centrioles cannot form (Tsuchiya et al., 2016). It is extremely 
unlikely that there would be true knockout variants of CEP295 persisting in a 
population. This region, like the regions associated with the fragmented 
genes, appears to be poorly assembled with highly fragmented contigs 
(figure 4-15) and several of the variants in the gene are within the LQLC 
regions identified in chapter 2. 
Of the remaining genes in the candidate list, OR6K6 and OR56B4 are 
olfactory receptors and are unlikely to cause a lethal phenotype. NHSL1, 
MTFR2, HMCN2, DEPDC4, SLC44A5, CCDC168 and SLC45A3 have 
insufficient published functional and knockout data available to associate 
them with the phenotype, and CDKN3 (Sun et al., 2016), STOM (Zhu et al., 
1999), NINL (Adissu et al., 2014), PTGIS (Nakayama et al., 2002), ANKRD26 




This reduces the list to the four most likely candidates, two splice donor 
variants in CYFIP2 and BCL11B, respectively, and two stop gains in SURF6 
and EXOG, respectively. For each of these the function is discussed below in 
addition to the estimated probability of loss of function (LoF) intolerance from 
the ExAC database (Exome Aggregation Consortium (ExAC), 2014). This 
number is based on the expected number of LoF variants for the size of the 
gene vs the number of observed variants. A LoF intolerance >0.9 is 
considered to be a gene highly intolerant of LoF variants. 
CYFIP2 is a cytoplasmic protein involved in T-cell adhesion and homozygous 
knockout mice die at birth (Kumar et al., 2013) or shortly thereafter (Han et 
al., 2015) depending on the precise target of the knockout. The predicted 
probability of LoF intolerance in the ExAC database for this gene is 1. While 
this variant is a promising candidate, it is a splice variant, and therefore it is 
difficult to predict the exact effect it would have on the protein. Additionally, 
knockout of this gene is associated with post-natal death whereas the 
mummified foetus in question died sometime between day 30 and day 60 of 
gestation. 
BCL11B is a transcription factor and has roles in the differentiation and 
development of neuronal subtypes, the immune system, integumentary 
system and cardiac system. Knockout of this gene is incompatible with extra-
uterine life (Lennon et al., 2017, Arlotta et al.). Similarly to CYFIP2, knockout 
mice are born alive, but die shortly thereafter. The probability of LoF 
intolerance for this gene in ExAC is 0.93. 
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SURF6 regulates ribosomal biogenesis and is one of the earliest genes to be 
transcribed in the 1-cell embryo, reaching its peak expression in the 8-cell 
morula. In mouse knockouts development halts at the 8-cell stage, 
suggesting an essential role of SURF6 in pre-implantation development 
(Romanova et al., 2006). Just as the previous two variants cause death later 
in development than 23982_R6 died, this one would be more likely to cause 
death much sooner. ExAC predicts the probability of LoF intolerance to be 0, 
however there are no homozygous human knockouts observed in the 
database. This is the only one of the final prioritised variants to occur in the 
LQLC regions identified in chapter 2. 
EXOG is involved in mitochondrial DNA repair, and while no mouse knockout 
has been produced, depletion of the protein has been associated with single 
strand breaks in mitochondrial DNA leading to apoptosis (Tann et al., 2011) 
and cardiomyocyte hypertrophy (Tigchelaar et al., 2016, Tigchelaar et al., 
2014), and knockouts of genes involved in the same mitochondrial DNA 
repair process as EXOG are embryonic lethal (Ludwig et al., 1998, 
Xanthoudakis et al., 1996, Larsen et al., 2003, Puebla-Osorio et al., 2006). 
ExAC predicts the probability of LoF intolerance to be 0, however there are 
no homozygous knockouts observed in the database. 
Aberrant splicing can be caused by variants that disrupt cis-acting elements 
of splice sites such as the 5` or 3` splice site, exon or intron splicing 
enhancers, and exon or intron splicing silencers. During splicing, the exon-
intron boundary is identified in pre-mRNA by conserved sequences. 
Alternative splicing may occur to create different functional proteins by exon 
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skipping, the use of different 5` or 3` sites, mutually exclusive exons and 
intron retention. Mutations in splice site regions may disrupt normal splicing 
and have a deleterious effect on protein function (Jian et al., 2013). 
Disruptions to splice sites are known to have the potential to cause disease 
(e.g. Cartegni et al., 2006) with some work suggesting an estimated 15% of 
genetic diseases in humans can be attributed to them (Krawczak et al., 
1992). Splice donor variants are difficult to interpret in-silico without additional 
data such as mRNA sequencing or experimental assays. Ensembl VEP 
predicts a high impact splice donor/acceptor variant if the first or last two 
bases of an intron are modified, or a low impact splice region variant if there 
is a modification within a few bases of the splice site. While in-silico tools 
have been designed for predicting the location of splice sites and the impact 
of splice variants (e.g. Rogozin and Milanesi, 1997, Pertea et al., 2001, Nalla 
and Rogan, 2005, Divina et al., 2009, Lim and Fairbrother, 2012), these have 
not been rigorously tested and must be followed up with expensive in-vitro 
work.  
All of the variants genotyped were found in the homozygous form in 
seemingly healthy foetuses. However, none of them were found homozygous 
in any of the adults and it is not known if the homozygous individuals would 
have survived until birth. The variant in EXOG was also a candidate in the 
previous chapter and in that case there was an adult found to be 
homozygous, however it was unknown if the variant might make an individual 
less likely to survive. From the results seen here, it seems unlikely that the 
EXOG SNP has an effect on survivability, in litters resulting from 
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heterozygous crosses the homozygous stop-gain was actually slightly more 
common than the homozygous reference and the allele representation 
across the whole dataset was roughly even. Similarly, the alleles of the 
variants in BCL11B and SURF6 were evenly represented and the genotype 
distribution of the offspring of heterozygous crosses was not different than 
expected. The deletion in the splice site of CYFIP2 was underrepresented in 
the population, with an allele frequency of ~16% and only 6 individuals 
homozygous, although it was only present in three of the adults so a low 
allele frequency for the whole set is not unexpected. For the litter the 
mummified foetus originated from there was only one healthy sibling 
homozygous for the deletion making it a promising candidate. However, in 
the only other litter from a heterozygous cross the opposite was true with only 
one individual homozygous for the reference sequence, the inheritance 
pattern of the variant for these two litters is unusual but not impossible. 
The list of 40 candidates includes only those that Ensembl VEP has 
annotated as high impact, while these are the variants most likely to affect 
the function of the protein, there are many examples of missense variants 
causing detrimental phenotypes (Stefl et al., 2013). The list of missense 
variants that were homozygous in the foetus and heterozygous in the sire 
and dam is much longer. One way to reduce this number would be to also 
whole genome sequence one or more siblings of the affected individual. This 
is a method often applied in paediatric diagnosis and allows the elimination of 
variants that match the genotype of the healthy sibling or retain variants that 
occur in multiple affected individuals from the same family. Additionally, 
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sequencing of a cohort of trios produces a large pool of sequence data of 
healthy, reproductively capable adults allowing for further filtering of the 
variants in the affected individuals. This would also allow for homozygous 
variants that occur with high frequency in the affected individuals to be 
prioritised without the variant necessarily having to be causative in all of the 
cases. 
Large structural variants have the potential to cause disease phenotypes 
(Stankiewicz and Lupski, 2010). Finding structural variants in this trio is 
complicated by the poor quality of the reference genome Sscrofa10.2, and by 
the use of short-reads which are difficult to call large structural variants from 
and produce a large number of false-positives and false-negatives (Smith 
and Yun, 2017, Noll et al., 2016). Ideally, structural variants can be called 
from long-read sequencing data (Hampton et al., 2017, Merker et al., 2017) 
aligned to a high-quality reference genome. In this particular case, the highly 
fragmented DNA from the foetus would make this very difficult. It is possible 
that with repeated DNA extractions and the use of technology that selects 
long fragments such as pulse-field gel electrophoresis that it could be done, 
however the foetus is very small and obtaining sufficient DNA for this would 
be unlikely and impractical. Additionally, while contamination appears to be 
minimal in the sample sequenced, selecting for longer fragments may bias 
the sample towards DNA from maternal contamination if it is present. 
Alternative methods of DNA extraction could also be explored, in this case a 
method using spin columns was used, which may further fragment fragile 
DNA. For trio sequencing for other phenotypes with less degraded DNA, 
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long-reads would be ideal for searching for structural variants, however they 
should not be used for SNP and indel discovery due to their high error rates.  
Deleterious variants tend to accumulate with increased inbreeding (Paige, 
2010) and so the likelihood of lethal variants persisting in a population will 
depend on the size of the population and the level of inbreeding. In smaller 
populations deleterious alleles may increase through genetic drift (Paige, 
2010, Star and Spencer, 2013). The population in this study is a large one 
and is under strong selection for reproductive traits such as litter size, as the 
observed maternal phenotype in cases of early embryonic death is reduced 
litter size, many variants that cause this will be being selected against 
already both through genomic selection and traditional selection, however 
purging rare and recessive detrimental variants entirely from a population is 
challenging (Derks et al., 2017). The populations discussed in Derks et al. 
(2017) are separate populations from those in this study, the lethal variants 
present in these populations are likely to differ from those in the current 
population due to differences in the history of the populations and the 
differing occurrences of mutations and inbreeding in those populations. The 
candidates identified in this study are not found in the candidate regions 
identified by Derks et al. (2017). The mummified foetus sequenced here may 
have died from either a genetic variant in another region, a variant with some 
regulatory impact, or an environmental factor. However, if a larger number of 
trios from the same population were sequenced it may be possible to identify 
genetic variants within the population that are associated with mummification. 
Furthermore, whereas the study using the 80K SNP chip was able to identify 
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associated regions, trio WGS has the potential to identify the causative 
variant itself. 
This chapter has used trio sequencing of a mummified foetus, its sire and its 
dam to search for candidate variants that may cause embryonic lethality. The 
method allowed for rapid filtering of a large set of variants and identified a 
number of candidates. While several of these candidates appeared 
promising, further investigation of these revealed that none of them was likely 
to be the sole cause of lethality in the foetus. While 23982_R6 was selected 
from a litter with roughly a quarter of the foetuses deceased, this does not 
necessarily mean there is a genetic component in this case. Importantly, the 
ease by which a dataset of millions of variants can be filtered down to a 
manageable set of candidates makes the methods employed here attractive 
for identifying candidates in other trios both for mummification and for other 
traits of interest. 
The lack of a clear candidate from this work may be in part due to the nature 
of the phenotype, in order to overcome the multifactorial nature of the 
phenotype, further work looking at a cohort of trios would allow for 
identification of variants that are more common in the foetuses, though not 
necessarily present in all of them. This would also include sequencing of a 
larger number of healthy adults with which to assist in filtering, which may 
reduce the candidate pool further and allow for further investigation of 
variants that are not predicted to be high impact but may be missense 
variants, or have some impact on regulation of a gene important for embryo 
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survival. Unfortunately, the cost of this is still likely to be prohibitively 
expensive. 
Many aspects of the trio sequencing method and others that employ strict 
filtering are designed overcome the issue of a poor-quality reference 
genome, however these can only go so far. While trio sequencing is a 
method that avoids the strict filtering required for many other NGS methods, 
the results presented here are still full of false-positives, plagued by 
incomplete annotations and challenging for structural variant calling. Many of 
these issues can only be overcome through aligning NGS data to a higher-







CHAPTER 5: ASSEMBLY OF A 














“The foremost cartographers of the land have prepared this for you; it’s a 
map of the area that you’ll be traversing.” 
[Blackadder opens it up and sees it is blank] 
“They’ll be very grateful if you could just fill it in as you go along.” 




The first methods for sequencing DNA were established in the 1970s with the 
introduction of Sanger sequencing (Sanger et al., 1977, Sanger and Coulson, 
1975) and Maxam & Gilbert sequencing (Maxam and Gilbert, 1977). These 
methods were labour intensive, time consuming, and could sequence only 
short sections of DNA, but nonetheless were a huge breakthrough paving the 
way to our current understanding of genetics and genomics. Since DNA 
sequencing became available, the challenge of sequencing an entire genome 
of a complex organism has been an important goal, but for a long time was a 
huge undertaking. Soon after sequencing methods were established, the 
assembly of DNA using computational methods based on overlapping 
sequence was proposed by Staden (1979).  
Mammals, including humans, mice and pigs, have large, complex genomes 
with high proportions of repetitive content. In the early days of DNA 
sequencing, the sequencing of a genome alone was considered a mammoth 
task, but the added problem of reassembling the sequences only added to 
the challenge. Initial attempts to understand the information in the human 
genome focussed on only the coding sequence, sequencing cDNA clones 
from transcribed sequences. However, it was soon recognised that this 
method could not capture regulatory elements and was insufficient and so 
plans were made to sequence and assemble an entire human genome 
(Dulbecco, 1986, National Research Council, 1988, Chen, 1989). 
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While unique sequences are relatively simple to overlap and combine into 
contiguous sequence (contigs), the major challenge comes from the repeat 
regions. In large, complex genomes such as the pig or human, repetitive 
content can be ~40% of the genome (de Koning et al., 2011). These repeats 
can only be properly assembled if the length of the reads is sufficient to span 
the repeats and reach into unique sequences either side to give them region-
specific context (see figure 1-3). Additionally, repeat sequences and low 
complexity regions often appear in multiple locations throughout the genome, 
making the “anchor” sequence either side of the repeat essential for reducing 
gaps and fragmentation in the final genome assembly. In the early days of 
genome sequencing and assembly, there were no technologies capable of 
producing reads sufficiently long to handle this problem. The solution was to 
break the genome into smaller fragments, sequence and assemble those 
smaller fragments without the complications introduced by similar regions in 
other parts of the genome, and subsequently reassemble these fragments 
into a whole genome (see figure 1-2). This method was first implemented to 
assemble the genome of the nematode and model organism, Caenorhabditis 
elegans (Sulston et al., 1992), and was subsequently employed for the 
human genome (International Human Genome Sequencing, 2001, 
International Human Genome Sequencing Consortium, 2004) and the pig 
genome (Groenen et al., 2012, Schook et al., 2005) based on a physical map 
by Humphray et al. (2007). The method involved fragmenting the genome 
and creating a library of bacterial clones which harbour a fairly large fragment 
of the target genome (see figure 1-1). Clones from these libraries were 
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selected for sequencing based on their position in a physical map of the pig 
genome. The physical map has been constructed based on similarities in 
patterns (fingerprints) of HindIII digest fragments of each Bacterial Artitficial 
Chromosome (BAC) clone (Humphray et al., 2007). BAC clones were 
selected to represent a minimum tiling path, i.e. the smallest number of 
cloned sequences that can be sequenced to cover the entire genome. Each 
of these was then sequenced using a shotgun approach and assembled 
individually, simplifying the assembly problem. A similar strategy has recently 
been employed Zheng et al. (2016) and is now available from 10X Genomics 
in which long fragments (~40-60kb) are isolated in a droplet and fragmented 
and barcoded within the droplet before high throughput Illumina sequencing 
so that they can be associated with their genomic location later. However, 
this is primarily advertised and more commonly used as a method for 
phasing and scaffolding purposes rather than de novo assembly. 
Ideally, the problem could be made easier if the reads were longer to begin 
with. Over the course of the Human Genome Project, the read lengths 
attainable from Sanger sequencing increased from 300-400 bp to around 
700-900bp. Using these longer WGS Sanger sequences, whole-genome 
shotgun sequencing was used to produce genome assemblies for the dog 
(Lindblad-Toh et al., 2005) and the horse (Wade et al., 2009). However, the 
real breakthrough for the long-read approach to genome assembly has come 
with the introduction of long read sequencing technologies from Pacific 
Biosciences single-molecule real-time (SMRT) sequencing and Oxford 
Nanopore Technologies (ONT), both capable of sequencing tens of 
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kiliobases of DNA per read. Using specific methods of DNA extraction and 
library preparation (Quick, 2018), ONT can even deliver so-called “ultra-long” 
reads greater than 2 Mb (Payne et al., 2018). Very long repetitive regions 
such as centromeres are still difficult to span, however a combination 
approach of BACs tiling across a human centromere sequenced with ONT 
have produced a closed human Y centromere (Jain et al., 2018b). 
SMRT sequencing allows for high-throughput sequencing with no 
polymerase chain reaction (PCR) step to introduce GC-bias and, importantly 
PacBio SMRT sequencing can produce a read N50 of around 20kb. These 
long-reads are capable of spanning repetitive regions and incorporating them 
into longer, more unique sequence contexts, allowing them to be placed in 
the correct genomic position during assembly (Chin et al., 2013, Rhoads and 
Au, 2015). A limitation of PacBio sequencing is its high error rate (11-15%; 
Korlach, 2015, Rhoads and Au, 2015, Watson, 2018) which largely consists 
of indels, however these errors are mostly not context specific and tools exist 
to remove these using hybrid methods (Koren et al., 2012, Salmela and 
Rivals, 2014), or with sufficient coverage, by taking the consensus of the 
PacBio reads (Quiver (Chin et al., 2013) and Arrow from PacBio), or by use 
of more base-accurate sequencing technologies such as Illumina using tools 
such as Pilon (Walker et al., 2014). 
Reference genome sequences that are moderately accurate and contain the 
majority of the species’ genes are often sufficient for QTL mapping and 
GWAS. However, as the community increasingly moves into the realm of 
exome and genome sequencing to identify causative variants the accuracy of 
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the reference genome becomes increasingly important. The analyses 
discussed so far in this thesis have one major conclusion in common: the 
published draft pig reference genome is insufficiently accurate (Groenen et 
al., 2012, Warr et al., 2015b). In the preceding chapters and in other studies 
an abundance of false-positives are produced, in studies employing GWAS 
wrongly positioned contigs obscure associations (van Son et al., 2017, Yang 
et al., 2013), and in structural variant analyses the many contig breaks, 
wrongly placed contigs and gaps in the genome will break these up and 
introduce false-positives (Warr et al., 2015b). 
Here I present the assembly of a pig genome using 65X genome coverage of 
PacBio sequence reads from the same individual that was sequenced for the 
assembly of Sscrofa10.2, a Duroc sow named T. J. Tabasco (or Duroc 2-14). 
By using the same individual the data available from previous work can be 
used to quality control, error correct and compare the two assemblies of the 
same genome and visualize the correction of misassemblies from 
Sscrofa10.2. Some low-confidence regions are expected to remain, these will 
mostly relate to regions with low-mappability or extreme GC-contents which 
may be prone to false-positives when aligning short-read sequencing data to 
the assembly.  
5.2 Methods 
The author of this thesis was responsible for the assembly from the initial 
contigs produced by Falcon to submission to NCBI. All analyses after the 
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Falcon assembly reported here were carried out by the author of this thesis 
unless stated otherwise. 
5.2.1 Sample and sequencing 
Extraction of high molecular weight DNA was done by Laurie Rund at the 
University of Illinois. DNA was extracted from Duroc 2-14 cultured fibroblast 
cells passage 16-18 using the Qiagen Blood & Cell Culture DNA Maxi Kit, 
producing 139.15 μg DNA from three extractions. High molecular weight 
DNA was obtained through size selection using the BluePippin (Sage 
Science; MA, USA) device. The high molecular weight DNA was sequenced 
by PacBio using their long read sequencing technology. Libraries for SMRT 
sequencing were prepared and sequenced as described previously 
(Pendleton et al., 2015) using P6-C4 chemistry on the PacBio RSII using a 
total of 213 SMRT cells. 
5.2.2 Assembly 
Unless stated otherwise tools were run with default parameters and standard 
protocols. 
5.2.2.1 Initial contigs 
Contigs were assembled from reads >13 kb using the Falcon (v0.4.0) 
assembly pipeline following the standard protocol by Richard Hall at PacBio. 
Falcon produces “haploid” and “alternative” contigs, the former are the main 
assembled contigs, with the alternative generally being shorter contigs 
representing some of the alternative haplotypes of the contigs present in the 
haploid set. Quiver v. 2.3.0 (Chin et al., 2013) was used to correct the haploid 
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and alternative contigs using the PacBio reads. Only the haploid contigs were 
used in the next stages of the assembly, of which there were 3,206. 
5.2.2.2 Contig quality control and splitting 
Paired-end Illumina reads from the same individual 
(http://www.ebi.ac.uk/ena/data/view/PRJEB9115) were mapped to the 3,206 
haploid contigs and assessed for structural abnormalities using similar 
methods to those described previously (Chapter 2; Warr et al., 2015b). 
Briefly, 1000 bp windows across the contigs were assessed for levels for 
abnormal mapping including high GC-normalized coverage, improper pairing 
and unexpected insert sizes. Additionally BAC end sequences (BES; CHORI-
242 library; Humphray et al., 2007) and fosmids (WTSI_1005 library: 
https://www.ncbi.nlm.nih.gov/clone/library/genomic/234/; ENA 
accession:HE000001 – HE565349; Skinner et al., 2016) from the same 
individual were mapped to the contigs and regions with multiple occurrences 
of incorrect orientation were examined manually in the Integrative Genomics 
Viewer (IGV; v.2.3.88; Robinson et al., 2011). In the cases where there was 
consistent evidence of structural disagreement between the contigs and the 
Illumina reads, BAC ends and fosmids, the contigs were split or trimmed.  
5.2.2.3 Scaffolding 
In order to establish initial scaffolds, the contigs were mapped to Sscrofa10.2 
using Nucmer (v3.23; Kurtz et al., 2004). The positioning of the contigs was 
determined by using the longest ascending subset of mapping locations 
using the show-coords tool from Mummer with the -g flag. Contigs with an 
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identity below 95% were excluded. Contigs that mapped to regions 
substantially larger (>180%) or smaller (<10%) than the contig size were 
excluded. These tolerances were intentionally lenient due to the inflated gap 
sizes (e.g. including 50 kb runs of Ns between scaffolds as required by the 
NCBI submission system in 2011) and highly fragmented nature of certain 
regions of Sscrofa10.2. Adjacent contigs were merged into a single fasta 
entry with Ns representing gaps between them. Gaps were estimated from 
the distance between the mapping locations against Sscrofa10.2, with an 
upper limit of 50 kb. Several of the remaining contigs were placed by 
identifying their longest alignment position, if this alignment was more than 
50% the length of the contig and the aligned region overlapped with a gap 
with an identity >90% they were placed in the gaps leaving 25 bp gaps either 
side. 
5.2.2.4 Gap filling 
PBJelly (PBSuite v.15.8.24; English et al., 2012) was used with the 65X raw 
PacBio reads to fill the gaps in the scaffolds, default parameters were used 
for all stages except the assembly stage where max wiggle (-w) was set to 
100 kb and max trim (-t) was set to 1000 bp. These parameters were 
changed to account for the extremely inaccurate gap sizes and missing 
sequence in Sscrofa10.2 that will have influenced the estimated gap sizes in 
this assembly and to allow overlapping contigs to be closed. Following initial 
gap filling, PBJelly was rerun on the fasta output from the first round, with the 
unused contigs from the Falcon output included to allow extension of the 
scaffolds. These contigs had been excluded initially to reduce secondary 
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mapping between scaffolds and unplaced contigs. PBJelly is able to add 
contigs to the end of scaffolds, but not place whole contigs in gaps, so the 
initial mapping of contigs to scaffolds was examined to find if any of the 
contigs that had been excluded in this stage due to overlap with existing 
contigs might fill the gaps. Contigs were placed on a case-by-case basis if 
there was evidence of overlap with placed sequence on both sides of the 
gap, if the initial contig quality control was relatively good, and if placement 
was well supported by BAC end mapping. Additionally, BACs for which the 
end sequences mapped to adjacent contigs and for which finished quality 
sequence was publically available, were aligned and the gap filled and 
placed following the same restrictions as the unplaced Falcon contigs. On 
completion of these gap-filling procedures 108 gaps remained. Estimation of 
the size of the remaining gaps was based on BAC end mapping, using the 
known median insert size of the CHORI-242 library (see 
https://bacpacresources.org). Any gaps estimated to be <100 bp were sized 
at 100 bp and unspanned gaps were sized at 50 kb. Following gap filling the 
scaffolds were aligned to Sscrofa10.2 to look for any major discrepancies 
between the two assemblies at the point where gaps had been filled. Some 
of the gaps filled appeared very repetitive. The previously described BACs 
and fosmids were aligned to the scaffolds and were found to support the gap 
joins. 
5.2.2.5 Additional sequencing of targeted BACs to fill gaps 
Five BACs from the CHORI-242 library were selected for further sequencing 
(CH242-188M9 (SSC16); CH242-323K10 (SSC18); CH242-284F8 (SSC18); 
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CH242-61K12 (SSC1); CH242-168C15 (SSC12)) based on BAC ends 
mapping either side of gaps. The BAC clones were obtained from BACPAC 
Resources (Children’s Hospital Oakland Research Institute, CA, USA; 
https://bacpacresources.org) and DNA was extracted using the Epicentre 
BACMAX DNA purification kit following manufacturer’s instructions. The BAC 
DNA was sequenced using Oxford Nanopore Technologies’ MinION 
sequencer using a barcoded 2D library following the discontinued protocol 
SQK-LSK208 on an R9 flow cell using MinKNOW v1.0.5. This was done by 
the author of this thesis at the Porecamp 2016 workshop. Sequences were 
assembled using Canu (v.1.5; Koren et al., 2017) with default settings and 
each produced a single contig. The BAC vector sequences were removed 
from the contigs, the contigs were mapped to the assembly initially with 
Nucmer (v3.23; Kurtz et al., 2004) to confirm they mapped to the expected 
locations, with exact positions for placement determined by BWA mem 
(v.0.7.15; Li, 2013).  
5.2.2.6 Polishing 
Owing to the high error rate of PacBio sequencing, additional polishing with 
both the original 65X PacBio data and with Illumina data was carried out to 
reduce the error rate. Error correction was done using Arrow from the 
GenomicConsensus suite 
(https://github.com/PacificBiosciences/GenomicConsensus) using the PacBio 
data. This was followed by Pilon (v1.22; Walker et al., 2014) with fixlist 
restricted to “bases”, but otherwise using default parameters and the paired-
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end Illumina short read data used in chapter 2 that provided 50X genome 
coverage.  
5.2.3 RepeatMasker 
RepeatMasker v.4.0.6 (Smit, 2013-2015) was used to identify repeats in the 
genome using parameter --species pig. 
5.2.4 Quality control of the assembly 
Following assembly, the methods described in chapter 2 were carried out to 
assess the quality of the assembly. Additionally, markers from a radiation 
hybrid (RH) map (Servin et al., 2012) were aligned to the genome to assess 
the agreement between the genome and the expected order of markers. 
SNPs and indels were called by mapping the same Illumina data used 
previously to the assembly using BWA mem (v.0.7.15) and calling variants 
using GATK HaplotypeCaller as described previously to assess the error 
rate. 
5.2.5 Submission to NCBI 
Following polishing, the assembly was submitted to NCBI as Sscrofa11 
(GenBank accession: GCA_000003025.5). As this assembly was based on a 
female pig, a Y chromosome assembly (GenBank accession: 
GCA_900119615.2) was sourced from Skinner et al. (2016) and added to 




5.2.6 External assessments of quality of the assembly 
The assembly was run through the gEVAL pipeline (Chow et al., 2016) by 
William Chow and Kerstin Howe from the Wellcome Sanger Institute. The 
assembly was also analysed using the Cogent pipeline 
(https://github.com/Magdoll/Cogent) by Elizabeth Tseng from PacBio. The 
author of this thesis was not involved in the design or running of these 
pipelines, but the results will be discussed as they reflect the quality of the 
assembly.  
The gEVAL browser will also be used to visualise some notable differences 
between Sscrofa10.2 and Sscrofa11.1. 
5.2.7 Annotation 
Annotation of the genome was carried out by Ensembl and NCBI. The author 
of this thesis was not involved in the annotation process, but the results will 
be discussed as the completeness of the annotations reflect the quality of the 
assembly. 
5.2.8 Detection of remaining errors post-annotation 
Following annotation, some genes were found to be truncated during 
unrelated analyses using this genome assembly as a reference. Additionally, 
other researchers reported indels in some genes of interest. Despite 
polishing, PacBio genome assemblies often have more indels remaining than 
genomes assembled from more accurate technologies (Watson, 2018, Jain 
et al., 2018a, Watson and Warr, 2019). Pilon recommends 100X Illumina 
coverage or greater, in this case only 50X was available and so this 
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assembly may have a greater indel rate than some other assemblies that use 
this method. The main variants observed in these truncated genes appeared 
to be two false indels a short number of bases apart that occur on opposite 
haplotypes. When Illumina data from the reference animal was aligned to 
these regions, GATK either called them as two heterozygous indels a short 
distance apart, or only called one of the two indels. Through visualisation with 
IGV and comparisons with results from Sscrofa10.2 it became clear that 
these were heterozygous SNPs whose reference base was absent from the 
assembly. A problem with PacBio’s Quiver and Arrow tools has been 
reported informally, and recently addressed by PacBio (Drake, 2018) in 
which the tools do not correctly handle heterozygous SNPs in the reference 
individual, interpreting them as two false indels in the same location and 
removing the reference allele base from the reference (figure 5-1). It was 
believed Pilon would be able to resolve these using Illumina data, however it 
appears in certain sequence contexts that this is not the case. To assess the 
extent of this problem, further analyses were undertaken to identify remaining 
indels of this sort in the dataset. 
While GATK did not consistently identify these variants, the Platypus 
haplotype caller (Rimmer et al., 2014) appears to call them reliably. In the 
output VCF from Platypus, different haplotypes are annotated differently in 
the genotype field, with “0/1” representing one haplotype and “1/0” 
representing the other which made these false indels easier to identify. 
Platypus (v0.8.1) was used to call variants in Illumina data aligned to 
Sscrofa11 using BWA mem (v.0.7.15). Custom scripts were used to identify 
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pairs of indels occurring between 1 and 10 bases apart on opposite 
haplotypes and of the two indels the one with the highest quality score was 
selected to be corrected. Through visualisations of 50 of these at random in 
IGV, a cut off value was selected for the Platypus quality score. All of the 
variants inspected with a quality value of >130 appeared reliable and this 
was selected as a cut off value. Some of these deleted SNPs may remain 





Figure 5-1- Figure describing an issue with PacBio-only error correction with Quiver 
and Arrow on unphased genomes. Heterozygous SNPs are interpreted as two false 
indels in the raw data that occur at the same locus. The variant is deleted from the 
consensus sequence and in certain sequence contexts this appears to complicate 
further polishing efforts. 
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5.2.9 Additional corrections to the assembly 
Following identification of false indels introduced during polishing, these were 
corrected using indel-apply (https://github.com/douglasgscofield/PacBio-
utilities Accessed 17/04/2019). Additionally Pilon was run 2 more times as 
described previously to correct any other errors that may have been missed 
the first time. Following this correction the Illumina data was aligned once 
more to assess how many homozygous variants remain. Additionally cDNA 
locations were downloaded from BioMart (Smedley et al., 2015) and the 
number of homozygous variants that overlap these were identified. Identified 
variants were examined to identify any reasons these had not been corrected 
previously. 
5.3 Results 
5.3.1 Initial read statistics 
The read statistics following PacBio sequencing are detailed in table 5-1. 
5.3.2 Initial assembly statistics 
After the raw data had been assembled with Falcon, the assembly statistics 
were as described in table 5-2. 
5.3.3 Contig quality control and contig splitting 
A method adapted from the one described in chapter 2 was used to assess 
the quality of the contigs, this included the mapping of Illumina data, BAC 
ends and fosmids. Regions where there was a high amount of abnormal 
mapping and there was consistent evidence of problematic regions across 
the technologies were visualised in IGV and split where appropriate.  
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Table 5-1- Statistics for raw reads following PacBio sequencing 
Number of reads 12,328,735 
Total length of reads 
(bp)  
175,934,815,397 
Mean read length (bp) 14,270 




Table 5-2- Statistics for initial assembly of Falcon contigs 
Number of haploid contigs 3,206 
Contig N50 (Mb) 14.5 




Table 5-3- Table showing results of RepeatMasker analysis on Sscrofa11.1 








SINEs   1768010 354332615 14.16 
  Alu/B1 0 0 0 
  MIRs 410028 59957948 2.4 
LINEs   955168 521004536 20.82 
  LINE1 644366 441431373 17.64 
  LINE2 264322 69436494 2.78 
  L3/CR1 34866 7480012 0.3 
  RTE 10536 2488991 0.1 
LTR elements   306107 116921282 4.67 
  ERVL 78412 33089318 1.32 
  ERVL-
MaLRs 
129843 43715780 1.75 
  ERV_classI 74712 32656740 1.31 
  ERV_classII 4940 3004330 0.12 
DNA 
elements 
  291574 59974216 2.4 
  hAT-Charlie 168861 32242758 1.29 
  TcMar-
Tigger 
46031 12807393 0.51 




   1053038943 42.09 
Small RNA   1359041 294287877 11.76 
Satellites   3317 5866795 0.23 
Simple 
repeats 
  755370 30567934 1.22 
Low 
complexity 
  123236 5873390 0.23 




This was only the case for 28 of the 3,206 contigs with the majority appearing 
to be good quality or only have abnormal mapping in one technology 
(generally Illumina alignments in repetitive sequence). 
5.3.4 Scaffolding and gap filling 
346 contigs covering 2.3 Gb were included in the initial chromosomal 
scaffolds which contained 410 gaps. Following gap filling 108 gaps remained 
in 125 placed contigs. 
All five BACs sequenced on Nanopore’s MinION assembled into a single 
circular contig with Canu. All of these mapped to the expected positions and 
after removing the BAC vector sequences the insert sequences were placed 
to close the targeted gaps, leaving 103 gaps and 122 placed contigs in the 
final Sscrofa11 assembly and closing acrocentric chromosomes 16 and 18. 
5.3.5 RepeatMasker 
The results of the RepeatMasker analysis are listed in table 5-3. 
5.3.6 Assembly quality control 
The same Illumina dataset used in chapter 2 was aligned to Sscrofa10.2 and 
Sscrofa11.1 using BWA mem (v0.7.15). Table 5-4 shows the mapping 
statistics for the two assemblies according to Samtools (v1.3.1) flagstat. The 
assembly was assessed using the methods described in chapter 2 and the 




Table 5-4- Mapping rates for the same dataset between Sscrofa10.2 and Sscrofa11.1 
 Sscrofa10.2 Sscrofa11.1 





Table 5-5- Results of LQLC analysis described in chapter 2 for Sscrofa10.2 and 
Sscrofa11 




High Coverage 2.6 4.9 
Low Coverage 26.6 7.5 
Low % Properly 
paired 
4.95 3.9 
High % large 
inserts 
1.52 1.72 
High % small 
inserts 
3.99 4.7 
LQ 13.85 11.6 
LQLC 33.07 16.3 
 
Table 5-6- Table showing the homozygous variants called by GATK between Illumina 
data from the reference animal and the reference genome 
 Indel SNP Mixed Total 









Figure 5-2- Figure showing alignment positions of markers against Sscrofa11.1 
compared to the expected position defined by an RH map.   
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Several categories of LQ (LQ includes high coverage, low % properly paired, 
high % with large inserts and high % with small inserts) have increased 
compared to the percentage in Sscrofa10.2, however the total LQ has 
reduced suggesting these categories are more likely to overlap in 
Sscrofa11.1, likely due to the increase in incorporation of repetitive content. 
When the regions which have been flagged as LQLC are compared with 
regions identified by RepeatMasker (v4.0.6; Smit, 2013-2015), only 1.6% of 
the genome is LQLC and not in a repetitive region. 
Figure 5-2 shows an alignment between Sscrofa11.1 and a radiation hybrid 
map (Servin et al., 2012). The two datasets are collinear with only a small 
discrepancy visible on chromosome 3 and an apparent disagreement on 
chromosome 9. The discrepancy on chromosome 3 is currently unexplained 
and likely represents a small misassembly, but the gap on chromosome 9 
represents a gap in the RH map as described by Servin et al. (2012). 
The analysis of SNPs and indels between the Sscrofa11 assembly and the 
reference animal focussed on homozygous variants, as heterozygous 
variants likely represent true variants in the reference animal and contain one 
allele which supports the reference. Homozygous variants are sequences 
where all the Illumina data support a particular base or insertion/deletion, but 
the assembly supports a different base or insertion/deletion state at the 
relevant location. 
Table 5-6 shows a summary of the results from GATK including the raw 
homozygous variant calls and those which do not intersect repeat regions 
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defined by RepeatMasker. Accepting 165,532 as the number of individual 
base errors in the assembly gives an error rate of 0.007%. This error rate 
does not include the additional errors discovered after annotation and 
described below. 
5.3.7 Final assembly statistics 
Ideograms showing the difference in contiguity between Sscrofa10.2 and 
Sscrofa11 are shown in figure 5-3.The assembly statistics of Sscrofa10.2, 
Sscrofa11 and Sscrofa11.1 (Sscrofa11 with added Y chromosome) are 





Figure 5-3- Ideograms for Sscrofa10.2 (top) and Sscrofa11 (bottom) produced using 
NCBI genome decoration page (https://www.ncbi.nlm.nih.gov/genome/tools/gdp 




5.3.8 External assessments of quality 
This section describes work not done by the author of this thesis which 
assesses the quality of the work described above. Responsible parties are 
credited in text. 
5.3.8.1 gEVAL 
The gEVAL pipeline run by William Chow and Kerstin Howe at Wellcome 
Sanger Institute has a measure of contiguity called an assembly badge 
consisting of three numbers, XYZ, where 10X represents the contig N50 in 
kb, 10Y represents the scaffold N50 in kb, and Z is either 1 or 0 for 
assembled to chromosome level or not, respectively. The assembly badge 
for Sscrofa10.2 was 121 and the assembly badge for Sscrofa11.1 is 441, 
matching the assembly badge for mouse (GRCm38) and human 
(GRCh38.p5). Additionally, BUSCO (v2; Simão et al., 2015) was used to 
estimate the completeness of the assembly. The results for this using 4,104 
mammalian BUSCOs with comparisons to other assemblies can be seen in 
table 5-8. 
The gEVAL pipeline also allows for visualisations of alignments of BAC and 
fosmid end sequences and some cDNA sequences to the genome and 
comparisons between genomes. These visualisations will be discussed 
further later to demonstrate corrections between the assemblies. 





Table 5-7- Final assembly statistics for Sscrofa10.2, Sscrofa11 and Sscrofa11.1 N50- 
more than 50% of the assembled sequence is in a contig/scaffold of X bases or 
greater. L50- half of the assembled sequence is in the largest X contigs/scaffolds. 
 Sscrofa10.2 Sscrofa11 Sscrofa11.1 
Total sequence length 2,808,525,991 2,456,768,445 2,501,912,388 
Total assembly gap 
length 
289,373,899 1,869,354 29,864,641 
Gaps between 
scaffolds 
5,323 24 93 
Number of scaffolds 9,906 626 706 
Scaffold N50 576,008 88,231,837 88,231,837 
Scaffold L50 1,303 9 9 
Number of contigs 243,021 705 1,118 
Contig N50 69,503 48,231,277 48,231,277 
Contig L50 8,632 15 15 
Total number of 
chromosomes  
21 19 21 
Number of 
component 
sequences (WGS or 
clone) 
186,661 705 1,308 
Table 5-8- BUSCO results from the gEVAL pipeline for Sscrofa10.2, Sscrofa11.1, the 
mouse reference genome (GRCm38), and the human reference genome (GRCh38.p5). 
 Sscrofa10.2 Sscrofa11.1 GRCm38 GRCh38.p5 








0.7% 0.5% 3.6% 0.8% 
Fragmented 8.2% 3.5% 2.3% 2.5% 





Cogent analysis uses PacBio Iso-seq data to assemble the transcriptome 
and identify gene families, which are then aligned to the genome assembly. If 
these assembled genes do not align to the assembly they are classified as 
missing from the assembly. This work was carried out by Elizabeth Tseng 
from PacBio and results are currently unpublished, but will be published in 
the manuscript for the work described in this chapter. This assessment was 
carried out using high-quality isoform sequences from 7 tissues (diaphragm, 
hypothalamus, liver, skeletal muscle (longissimus dorsi), small intestine, 
spleen and thymus). Cogent partitioned 276,196 high quality isoform 
sequences into 30,628 gene families, of which 18,708 have at least 2 
sequences. Cogent focusses analysis entirely on genes with multiple 
isoforms. Cogent then performed reconstruction on the 18,708 partitions. For 
each partition, Cogent reconstructs transcribed ‘contigs’ that represent the 
ordered concatenation of transcribed exons as supported by the isoform 
sequences. The reconstructed contigs were then mapped back to 
Sscrofa11.1 and contigs that could not be mapped or mapped to more than 
one position were individually examined. The analysis found 5 genes 
missing: CHAMP1, ERLIN1, IL1RN, MB, and PSD4. Of these 5 genes, only 
ERLIN1 was present in Sscrofa10.2. Investigation of these missing genes 
was carried out by the author of this thesis. Two of the missing genes, IL1RN 
and PSD4, were present in the original set of PacBio contigs from Falcon, 
however they were trimmed during quality control. CHAMP1 is known to 
occur in a telomeric region on chromosome 11 and is likely erroneously 
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missing from the assembly. The genes expected to surround ERLIN1 are 
present on chromosome 14, however one of these neighbouring genes, 
CYP2C33, is duplicated and this may represent a misassembly. In the 
location where MB is expected to be located, there is no gap in the assembly, 
but only 14% of MB is present (according to the cDNA alignment in gEVAL). 
This region of the genome on chromosome 5 originated from a single Falcon 
contig and likely represents a misassembly by Falcon. 
5.3.9 Annotation 
Results of the annotation by Ensembl with comparisons to Sscrofa10.2 are 
presented in table 5-9. The assembly and annotation are available in 
Ensembl’s genome browser (http://www.ensembl.org/Sus_scrofa/Info/Index, 
accessed: 06/06/18). 
The results of the annotation by NCBI are presented in table 5-10 with 
comparison to Sscrofa10.2 and the annotated genome is available in NCBI’s 
Genome Data Viewer 
(https://www.ncbi.nlm.nih.gov/genome/gdv/browser/?acc=GCF_000003025.6




Table 5-9- Annotation results from Ensembl for Sscrofa10.2 and Sscrofa11.1 










































Table 5-10- NCBI annotation results for Sscrofa10.2 and Sscrofa11.1 
 
  
Feature Sscrofa10.2 Sscrofa11.1 
Genes 36,396 27,250 
All transcripts 66,378 78,200 
  mRNA 47,251 63,562 
  misc_RNA 1,931 4,438 
  miRNA 425 395 
  tRNA 479 510 
  lncRNA 16,289 9,292 
  rRNA 2 2 




   coding transcripts 
(NM_/XM_ ) 
2,223 2,406 




CDSs 47,251 63,562 
Exons 275,591 283,679 








Introns  232,796 240,989 













5.3.10 Detection and correction of errors post annotation 
An example of a heterozygous SNP that has been deleted during polishing is 
shown in figure 5-4. The figure shows an A/G SNP where the top and bottom 
track are the heterozygous sire and dam of the homozygous (G/G) offspring 
in the middle track. The deleted A allele appears as an insertion which has 
been left aligned due to the adjacent A in the reference, with the G appearing 
as an insertion in the correct position for this SNP. The reference animal is 
heterozygous at this locus. 
Through Platypus variant calling, 471,064 pairs of these false heterozygous 
indels were identified including 3,433 in the coding regions affecting 1,763 
genes. These were corrected using indel-apply from PacBio-utilities 
(https://github.com/douglasgscofield/PacBio-utilities; Accessed 17/04/2019). 
The additional iterations of Pilon reduced the homozygous SNPs and indels 
further as described in table 5-11. 
Of the remaining homozygous indels, 850 of them are in the coding region 
affecting 757 genes. The reason these have not been corrected was 
investigated and it was found that the majority of remaining variants have 
very low coverage in the Illumina data (figure 5-5). Most of these would likely 
be corrected with higher coverage Illumina data, but some are expected to 
remain in repetitive regions. These will be addressed by obtaining higher 






















Table 5-11- Table showing reduction of homozygous variants (likely reference base 













Figure 5-4- An IGV visualisation showing a heterozygous SNP for which the 
reference base has been deleted shown as two adjacent indels (purple). The 
top and bottom track show heterozygous individuals (A/G) and the middle 




Figure 5-5- Histogram showing the number of remaining 
homozygous variants at each coverage level in coding regions. 
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5.3.11 Comparisons with Sscrofa10.2 
As both Sscrofa10.2 and Sscrofa11.1 have been analysed using the gEVAL 
pipeline, it is possible to use this tool to visualise the corrections of loci 
identified as potentially misassembled in previous chapters and other 
researchers’ work. Additionally the correction of fragmented genes and the 
inclusion of missing genes can be visualised to see how these are improved 
in Sscrofa11.1.  
A region discussed in chapter 2.2 on chromosome 6 that was very clearly 
misassembled in Sscrofa10.2 is now corrected in Sscrofa11.1. The 
rearrangement of the misassembled region between the two genome 
assemblies is shown in figure 5-6. Several neighbouring genes have also 
been corrected in this region. Additionally, BAC end alignments now support 
the new arrangement of this region. 
Genes that were misassembled, missing or fragmented beyond usefulness 
can also be seen corrected in the new assembly, two examples are shown in 
figure 5-7. 
Figure 5-8 shows the region in Sscrofa10.2 that was identified as wrongly 
placed on chromosome 15 instead of chromosome 3 during the GWAS in 
chapter 3.3.4. This places the significant variant that was at 15:138464069 in 
Sscrofa10.2 in a region where a number of variants were approaching 
significance for number stillborn on chromosome 3.
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  Figure 5-6- gEVAL visualisation showing a misassembled region in Sscrofa10.2 (top), and its 
corrected region in Sscrofa11.1 (bottom). Green lines between the two tracks show the 
alignment and rearrangement of sequence between the two assemblies. Horizontal bars 
represent isogenic BAC end data aligned to the two assemblies, for which green alignments are 
accurate, orange have incorrect insert sizes, red are wrongly oriented, and purple are 
multimapped ends. Similarly, the CDNA track shows cDNA alignments, with the green genes 
having high coverage and identity. 
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Figure 5-7- gEVAL visualisation showing misassembled regions in Sscrofa10.2 (top track) 
around genes CD163 (A) and IGF2(B), and their corrected regions in Sscrofa11.1 (bottom 
track). Green lines between the two tracks show the alignment and rearrangement of 
sequence between the two assemblies. The CDNA track shows cDNA alignments, with the 
green genes having high coverage and identity. CD163 is likely missing due to the gap in 
























Figure 5-9- gEVAL visualisation showing the misassembly of ESR1 in Sscrofa10.2 (top 
track) and its corrected structure in Sscrofa11.1 (bottom track). Green lines between 
the two tracks show the alignment and rearrangement of sequence between the two 
assemblies. Note that some exons of ESR1 are on the wrong strand in Sscrofa10.2. 
  
Figure 5-8- gEVAL visualisation showing a misplaced contig in Sscrofa10.2 (top track) 
and its corrected position in Sscrofa11.1 (bottom track). Green lines between the two 
tracks show the alignment and rearrangement of sequence between the two 




A region associated with litter size identified by this thesis in chapter 3.3.4 
both supported and opposed by the results of others (Munoz et al., 2007, 
Rothschild et al., 1996, Short et al., 1997, Dall’Olio et al., 2011, Ma et al., 
2012) containing the ESR1 gene, has been rearranged (figure 5-9) which 
may contribute to finding the causative variant of this debated QTL. 
A region containing a variant of interest discussed in chapter 4.4 in which the 
variant was located in fragmented gene ENSSSCG00000025104, thought to 
be a part of ATP5H, is now correctly assembled and the missing portion of 
the gene was likely lost in an adjacent gap (figure 5-10). Additionally, 
neighbouring gene MRPL58 missing in Sscrofa10.2 has also been placed 
correctly. 
Finally, a region on chromosome 4 associated with fatty acid composition 
suspected of being on the wrong chromosome by both van Son et al. (2017) 
and Yang et al. (2013) was indeed misplaced and is now in the region they 
predicted it should be located near SCD on chromosome 14 (figure 5-11) 
neighbouring another QTL for fatty acid composition.  
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Figure 5-10- gEVAL visualisation showing the region ATP5H is missing from in 
Sscrofa10.2 (top track) and its placement in Sscrofa11.1 (bottom track). Green lines 
between the two tracks show the alignment and rearrangement of sequence between 
the two assemblies. 
Figure 5-11 gEVAL visualisation showing a misplaced contig in Sscrofa10.2 (top track) 
and its corrected position in Sscrofa11.1 (bottom track). Green lines between the two 
tracks show the alignment and rearrangement of sequence between the two 








Long read sequencing greatly improves our ability to assemble large 
genomes. With long-read technologies that are capable of sequencing 
individual reads longer than the contig N50 of earlier generations of genome 
assemblies, the challenge of assembling up to chromosome arm level is 
greatly reduced. For Sscrofa11.1, the assembly greatly benefited from a 
wealth of data already produced for the assembly of Sscrofa10.2. Many 
recent genome assemblies lack data such as physical maps to assist with 
assigning contigs to chromosomes. New technologies such as Hi-C, Dovetail, 
and optical mapping (Bionano) can be used to scaffold genomes and assign 
them to chromosomes. In this case, such additional data did not need to be 
produced thanks to the previous efforts to assemble the pig genome which 
were largely held back by the limitations of sequencing technologies of the 
time. 
The new pig genome assembly presented here, Sscrofa11.1, is a substantial 
improvement over Sscrofa10.2. Perhaps the most obvious improvement is in 
the contig N50 of 48.2Mb, which has almost a 700-fold improvement over 
Sscrofa10.2, greatly reducing the potential for duplicated or fragmented gene 
models as demonstrated by the reduction in pseudogenes detected by 
Ensembl between Sscrofa10.2 and Sscrofa11.1. The contig N50 is also 
substantially higher than the goat genome with an N50 of 26.2Mb, which is 
considered the best livestock genome to date (Bickhart et al., 2017). Indeed, 
the contig N50 is comparable to that of the current human reference genome 
sequence (GRCh38.p12), on which considerably more work has been carried 
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out, with a contig N50 of 56.4Mb. When considering only the contigs 
assembled from long reads (Sscrofa11 rather than Sscrofa11.1), there are 
fewer gaps than the corresponding human genome chromosomes. Also of 
note are two closed chromosomes, 16 and 18, these chromosomes are 
acrocentric and are in a single contiguous sequence with no gaps. Contigs 
on chromosomes 4 and 9 appear to span their respective centromeres, 
however the centromeric sequence in the assembly at these loci probably 
represent a collapsed version of these highly repetitive sequences. The 
improved mapping rate of the same dataset between Sscrofa10.2 and 
Sscrofa11.1 may be both due to the increased contiguity and the inclusion of 
sequence missing from the previous assembly. 
External assessments of the quality of Sscrofa11.1, including gEVAL, 
Cogent, and the two annotations suggest the genome is highly complete. 
While the BUSCO alignments provided by the gEVAL pipeline suggest there 
are still up to ~6% missing or fragmented genes, the BUSCO publication 
notes that in large genomes these two categories may be inflated (Simão et 
al., 2015), and these figures are much improved from Sscrofa10.2 and 
comparable to those reported for human and mouse. The Cogent analysis 
from PacBio reported just 5 genes missing, several of which could be traced 
back to the point where they were lost in the assembly. The majority of these 
missing genes originated from repetitive locations and had been 
misassembled by Falcon, or erroneously removed during contig quality 
control. The two annotations differ due to the different datasets and pipelines 
used to produce them, however both suggest fewer pseudogenes and 
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fragmented genes, representation of more isoforms and better representation 
of the coding sequence in general. The non-coding genes are still 
underrepresented in the annotation of this new pig genome when compared 
to human and mouse. However, this omission is likely attributable to the 
conservative nature of the Ensembl annotation system. 
The improvement in the accuracy of the assembly will have a positive impact 
on analyses. For regions previously placed on the wrong chromosomes, the 
corrections in Sscrofa11.1 will simplify association analyses, where regions 
may have previously been searched for candidate genes that were in fact not 
associated with the trait in question (Yang et al., 2013, van Son et al., 2017). 
While a couple of examples have been described here that were identified as 
misassembled during analysis, it is likely that there are other examples that 
were not previously noticed. Additionally certain genes that may be of 
particular interest to the field, such as CD163 and ESR1, are now correctly 
represented in the genome. CD163 is an important gene for Porcine 
Reproductive and Respiratory Syndrome susceptibility (Calvert et al., 2007), 
a disease with a huge economic impact on the pig breeding industry. This 
locus has been used successfully as a target for genome editing to reduce 
susceptibility (Burkard et al., 2017, Burkard et al., 2018). ESR1 has been a 
subject of debate since 1996, with multiple papers either supporting or 
opposing its association with litter size in pigs (Munoz et al., 2007, Rothschild 
et al., 1996, Short et al., 1997, Dall’Olio et al., 2011, Ma et al., 2012). An 
accurate representation of this gene and the surrounding region in the 
reference may allow for a causative variant to be identified. 
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One of the major flaws with long read sequencing technology is the high error 
rate (Watson, 2018). Despite employing multiple polishing techniques, 
Sscrofa11.1 still has more indels than an assembly produced with a more 
accurate sequencing technology would. Some of the remaining indels were 
introduced by the polishing tools Quiver and Arrow: a known issue with bases 
at heterozygous loci being deleted. Pilon likely calls these deletions as two 
indels in much the same way that other variant callers such as GATK and 
Platypus do, and so does not correct them as it only corrects high confidence 
homozygous variants. However, some of the remaining indels have not been 
corrected due to low coverage in the Illumina data used to polish the 
assembly with Pilon. These errors will cause problems for calling SNPs and 
indels, particularly those in the coding region. While variants that are called in 
all individuals in a study are likely to be disregarded, indels in the assembly 
may cause truncation of gene models. If gene models are truncated, variant 
annotation will also be affected and benign variants may be annotated as 
impactful and detrimental variants that occur after a truncation in the gene 
model will be missed. Efforts to improve these issues for a future release 
have been described here and should greatly reduce these problems. 
However, some genes in low coverage regions are currently still affected. 
Despite its flaws, long read sequencing offers an exciting opportunity to 
assemble highly contiguous reference genome assemblies. As prices 
continue to fall, accuracy improves and obtainable read lengths increase, 
even the smallest labs should be able to afford to assemble a high quality 
reference genome for their species of interest. In the future, perhaps whole 
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chromosomes will be sequenced in a single read, negating the need for 
genome assembly. 
5.4.1 Future work 
In order to further improve the pig reference genome assembly, we intend to 
obtain higher coverage Illumina data for the same individual and further 
polish the assembly for a future release. Additionally, plans are in place to 
further improve contiguity. There are only 103 gaps in Sscrofa11, and just 24 
of those are not spanned by a BAC from the CHORI-242 library. By 
sequencing the BACs that span gaps, and BACs that reach into the 
unspanned gaps, we can fill or extend into these using similar methods to 
those in section 5.2.2.5. Additionally, another less contiguous PacBio pig 
genome assembly, USMARCv1.0 (Accession: GCA_002844635.1) has 
recently been released. This can be used to identify potential structural 
misassemblies such as the one Cogent identified at the MB locus. These 
may represent true structural variants, or suggest a misassembly. 
USMARCv1.0 may be used to identify targets that can be examined further 
using other data from T.J.Tabasco such as using the BAC library. Any 
regions suspected of misassembly can then be broken and a gap filler used 
to try to correct them, or can be sequenced across from BACs. 
Following these corrections, the work carried out in chapter 3 and 4 of this 
thesis can be redone and should produce more reliable results. Additionally, 
many of the regions of the genome were excluded from these analyses either 
directly through filtering, or indirectly through inability to accurately annotate 
variants in poorly assembled regions. This means there are relatively 
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unexplored regions of the pig genome that may be associated with some of 
the traits of interest discussed in this thesis. 
In the future, graph genomes are likely to become more widely used. 
Sscrofa11.1 is a highly contiguous assembly which can be used as a 
backbone for a graph genome, overlaying novel haplotypes. However, 
currently the community still does not have the tools and file formats needed 
to implement this. 
5.4.2 Conclusions 
With the increased use of genomic data in livestock breeding, the accuracy of 
available genomic resources becomes increasingly important. In chapter 2 of 
this thesis, the problems associated with the current pig reference genome 
were explored. In subsequent chapters, the difficulties of working with an 
inaccurate reference genome were highlighted. In this chapter a new, more 
accurate reference genome has been produced. While the assembly is not 
perfect due to lingering false indels and a small number of structural errors, it 
is a large improvement on the previous assembly and its contiguity is 



























“There is nothing like looking, if you want to find something. You certainly 
usually find something, if you look, but it is not always quite the something 
you were after.” 
-J.R.R. Tolkien, The Hobbit  
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Analyses to identify genes with an impact on traits of interest are traditionally 
focussed on identifying genomic regions associated with those traits. 
Generally this involves identifying a population or pedigree where quantifiable 
variation can be seen in the trait of interest, generating detailed phenotypic 
data for the individuals in the population, and genotyping the population for a 
large number of genetic polymorphisms. Once these datasets have been 
obtained, they can be tested for associations between the genotypes and the 
trait of interest. This allows for identification of regions of the genome that are 
associated with the trait and markers in the region that can be used to predict 
the trait of an individual. This can be used in a number of applications 
including diagnosis of disease and marker assisted selection in farmed 
animals and plants. These analyses benefit greatly from a draft reference 
genome assembly to assist with identifying haplotypes and regions of 
interest. 
The reducing cost of genome sequencing, however, allows for large cohorts 
of individuals to be sequenced at the exome- or genome-wide level, allowing 
for new approaches to be taken to identify causal variants that affect trait 
variation and better understand how these traits are influenced by the 
variant(s). Through sequencing of large cohorts it has been revealed that 
protein-truncating, or “loss of function”, variants are fairly common, with each 
healthy human harbouring roughly 100 protein-truncating variants with 
around 20 in the homozygous form (MacArthur et al., 2012, MacArthur and 
Tyler-Smith, 2010). However, the majority of these will likely occur in non-
essential or redundant genes. Those protein-truncating variants in essential 
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genes will most likely be seen mostly in the heterozygous form, but when 
carried in the homozygous form may be deleterious and potentially 
embryonic lethal except in cases where there is redundancy in gene function. 
The original aim of this postgraduate research project was to identify putative 
loss of function variants in the pig genome, and to determine whether or not 
these may underlie embryonic loss in the pig. Through the use of multiple 
technologies including exome sequencing, imputation, GWAS, and whole 
genome sequencing, several candidates were identified. However, the 
analyses suffered from being carried out against a low-quality, draft reference 
genome. To improve the future potential of such analyses, the latest in long-
read sequencing technologies was used to assemble a new, highly 
contiguous reference genome. 
This work has identified a number of putative causative variants in genes with 
links to reproductive phenotypes and embryo mortality, including variants that 
have been identified using more than one method such as a variant in EXOG 
found in the 96 exomes in chapter 3 and the mummified foetus trio in chapter 
4, and a variant in SERPINA3 that was selected as a candidate through 
bioinformatic filtering and is in a region associated with number stillborn by 
GWAS in chapter 3. Additionally, candidate genes associated with 
reproductive phenotypes were identified, however, the small sample size 
available for association analyses means that these require further validation. 
For a few of the candidate genes, past studies have identified the same gene 
or loci as candidates for the same phenotype, number stillborn or similar in 
pigs, these may be particularly interesting to follow up on using a targeted 
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approach to identify a causative variant. These include an association 
between number stillborn or live litter size and the oestrogen receptor 1 locus 
(ESR1) in previous studies (Munoz et al., 2007, Rothschild et al., 1996, Short 
et al., 1997, Alfonso, 2005), a region containing GABA receptors associated 
with number stillborn in a previous study (Schneider et al., 2015), a region 
containing ARHGAP24 is close to a previously identified QTL for prenatal 
survival (Hernandez et al., 2014), and a region containing MYOM2 overlaps a 
previously identified QTL for number stillborn (Onteru et al., 2012). 
The candidate variants identified in this work could be further investigated by 
carrying out experimental crosses of individuals carrying the variants and 
genotyping the resulting litters to identify deviations from the expected 
Mendelian inheritance pattern. Alternatively, if heterozygous carriers are 
identified, data may already exist in the form of EBVs that could suggest 
differences between their reproductive success and that of wild-type 
individuals in the same commercial line.   
All of the methods of identifying candidates described here would be more 
successful in larger cohorts. Larger cohorts increase the likelihood of 
observing rare, but non-lethal variants in the homozygous form, increase the 
accuracy of imputation and the power of GWAS, and improve the filtering 
potential when looking for a variant causative of a specific phenotype. The 
costs of whole genome sequencing have decreased greatly in recent years, 
however at current costs it is still not feasible to sequence sufficiently large 
cohorts in this way for most species. Exome sequencing is still a valuable 
tool for identifying variants in the protein-coding region in a cohort, while this 
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comes with the disadvantage of not sequencing the regulatory regions of the 
genome, our ability to understand the impact of variants in these regions is 
still limited and it is likely that even with whole genome sequencing data, 
analyses of this sort would first focus on the coding region. Additionally the 
methods used in this work would likely be more successful through targeting 
individuals from pedigrees that are suspected of carrying traits that are 
demonstrably heritable. 
Researchers using genome sequencing data frequently rely on publicly 
available resources to analyse their data. While the availability of these 
resources has been of benefit to the community, it is important that the 
limitations of these resources is known and accounted for. In this thesis I 
have described the extent of the problems of publicly available reference 
genome Sscrofa10.2, with its many structural errors including sections of 
sequence placed on the wrong chromosome. These problems have a large 
impact other important resources with over half of dbSNP variants for this 
genome being called from low-confidence regions. Additionally, the impact of 
misassemblies in Sscrofa10.2 on analyses can be seen in multiple genomic 
methods including wrongly placed GWAS SNPs obscuring associations in 
chapter 3, and false positives in exome sequencing and whole-genome 
sequencing in chapters 3 and 4. Sscrofa10.2 also suffers from missing 
sequence, including missing genes. While some of these have been 
analysed using targeted approaches, many of these will represent 
unexplored regions of the pig genome and may be relevant to important 
phenotypes. Additionally, missing sequence has consequences for methods 
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such as genome editing, where unique targets must be designed for the 
region to be modified, if sequence missing from the reference genome is 
highly similar to a target sequence this could increase incidence of unwanted 
off-target effects.  
This work has provided the community with a new reference genome with far 
fewer problems than the previous assembly, with very few gaps remaining 
and excellent contiguity there is far less missing sequence. Many genes that 
were known to be missing are now in their expected genomic positions, and 
reads and markers from SNP chips can be more accurately mapped which 
will likely improve the accuracy of imputation and improve ease of 
interpretation of GWAS. While the Sscrofa11.1 assembly is an improvement 
on the previous one, some errors still remain as a consequence of the 
sequencing technology and polishing methods used. Further work will need 
to be done to polish the assembly to increase its reliability for variant calling. 
Additionally, BACs have been identified that span many of the remaining 
gaps and sequencing of these is under way to further increase the contiguity 
of an already highly contiguous assembly. With these final error corrections 
and gap closures the genome will be an extremely valuable resource to 
researchers working on pig genetics and genomics. Following these final 
corrections and reannotation of the genome, the exome and whole genome 
sequencing analyses described here can be repeated and should contain 
fewer false-positive calls and enable the analysis to cover regions of the 
genome that were previously inaccessible. 
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As sequencing technologies continue to improve in accuracy and read length 
it may be possible to further improve the genome assembly by sequencing 
across particularly repetitive regions such as the centromeres, as has 
recently been demonstrated using ONT sequencing to assemble the human 
Y chromosome centromere (Jain et al., 2018b), and produce a completely 
closed linear genome. 
De novo assembly, even with long reads, is a computationally and monetarily 
expensive process. Reference-guided assembly, assuming availability of a 
high-quality reference, is an attractive approach to assembling the genomes 
of different breeds and closely related species with lower cost and fewer 
resources required. Chinese pig breeds are known to have genomes that 
differ from European breeds, and previously a draft genome assembly from 
short reads had been produced to assist with analyses on Chinese pigs 
(Fang et al., 2012). The availability of Sscrofa11.1 may facilitate the 
assembly of a better reference genome for Chinese breeds through 
reference-guided assembly. Researchers working on other species such as 
mice, cattle and dogs have begun to assemble reference genomes for 
multiple breeds, the use of which may more accurately represent certain 
populations, this too is an option for the pig to represent more breeds than 
simply separate European and Chinese assemblies. In the future, graph 
genomes may be more widely used to represent species, incorporating these 
different breeds and in-breed variation, rather than assembling these de 
novo, a high-quality linear reference genome such as the one presented here 
can be used as a backbone. 
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Long-read sequencing has greatly reduced the challenge of genome 
assembly, and as read lengths increase allowing long repetitive regions to be 
spanned by individual reads, closed linear assemblies will be achievable. The 
remaining problems with long reads centre around their high error rate 
compared to short-read sequencing technologies. Polishing currently is still 
best done using short reads, which will likely remove true variation in 
repetitive regions or between subtly different genes, and may fail to polish 
regions with a high number of multimapper or otherwise low-mappability 
regions at all. If polishing can be done solely with long reads this would help 
to reduce this problem as the reads would be anchored by unique sequence 
either side of these regions. If the problem of a high error rate can be 
addressed it will further simplify the assembly process by reducing the need 
for polishing. Currently both PacBio and Nanopore are working on solving 
this problem. PacBio are focussing on improving their PacBio-only polishing 
tool, Arrow, to reduce the error rate in homopolymers and those caused by 
diploid error (Drake, 2018). ONT are working on improving their base calling 
tools to reduce errors at an earlier stage, and additionally have plans to 
improve consensus accuracy through the use of multiple pore types with 
different error profiles (Brown, 2018). Some of the errors in ONT may relate 
to base modifications affecting the shape of the squiggle produced during 
sequencing, and if this is the case the base caller needs only to be trained to 
recognise these. However, similarly to PacBio the error rate in homopolymers 
is still high, it is hoped that through pores with longer constriction points, or 
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multiple constriction points, the base caller will be able to more accurately 
estimate the length of the homopolymer. 
Genome editing in pigs offers exciting opportunities for the improvement of 
pork production. Once variants causative of traits have been identified and an 
accurate reference assembly is available for the design of guide RNA to 
target regions, genome editing can be used to greatly accelerate beneficial 
changes in the genome. Recently, pigs that have had a small edit made to 
the gene CD163 have been shown to be resistant to the Porcine 
Reproductive and Respiratory Syndrome virus, an extremely costly disease 
challenging the global pork production industry. The pigs appear otherwise to 
be normal, healthy pigs (Burkard et al., 2018). CD163 is one of the genes 
missing from Sscrofa10.2. Similarly successful edits have been made in 
other livestock species, such as hornless, or ‘polled’, dairy cattle (Carlson et 
al., 2016). Currently, however, it is unclear whether food products from 
genome edited individuals or their offspring will be allowed to be sold (Jones, 
2015, Voytas and Gao, 2014, Ruan et al., 2017), nor is it clear if the public 
would accept such products (Ishii and Araki, 2016) given the continued 
strong resistance against genetically modified organisms despite scientific 
evidence that these are safe (Blancke et al., 2015, Marques et al., 2014). 
Another application of gene editing in pigs is for medical purposes. This may 
involve replicating variants that are causative of human diseases to make 
medical models, or editing to make pigs safe for use in xenotransplantation of 
cells, tissues or organs into humans. The similarity of pigs and humans make 
this technically possible, however a major barrier in its use is the presence of 
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porcine endogenous retroviruses (PERVs) in the pig genome. These PERVs 
are inactive in the pig and do not harm the host, but may become active and 
pathogenic in a recipient. Genome editing has been proposed as a method to 
inactivate the PERVs, and has been carried out on porcine kidney epithelial 
cells to disrupt 62 PERV genes and reduce transmission to human cells 
>1000-fold (Yang et al., 2015). Following this, genome editing has been used 
to knock out PERVs in pigs, revealing that pigs without PERVs are viable 
(Niu et al., 2017). However, PERVs are not the only barrier to 
xenotransplantation, and further edits may be needed to modulate the 
immune response and reduce risk of rejection (For review, see Hryhorowicz 
et al., 2017) 
Pigs are an economically important species and the improvement of pig 
production efficiency is an important goal towards securing the global supply 
of pork. With an improved reference genome and the reduced cost of DNA 
sequencing, genomics offers powerful methods to understand the underlying 




































“That was it. That was really it.  
She knew that she had told herself that  
that was it only seconds earlier,  
but this was now the final real ultimate it.”  
-Douglas Adams, Dirk Gently's Holistic Detective Agency  
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ABSTRACT The falling cost of DNA sequencing has made the technology affordable to many research groups, 
enabling researchers to link genomic variants to observed phenotypes in a range of species. This review focusses 
on whole exome sequencing and its applications in humans and other species. The exome has traditionally been 
defined to consist of only the protein coding portion of the genome; a region where mutations are likely to affect 
protein structure and function. There are several commercial kits available for exome sequencing in a number 
of species and, owing to the highly conserved nature of exons, many of these can be applied to other closely 
related species. The data set produced from exome sequencing is many times smaller than that of whole 
genome sequencing, making it more easily manageable and the analysis less complex. Exome sequencing for 
disease gene discovery in humans is well established and has been used successfully to identify mutations that 
are causative of complex and rare diseases. Exome sequencing has also been used in a number of domesticated 
and companion species. The successful application of exome sequencing to crops has yielded results that may 
be used in selective breeding to improve production in these species, and there is potential for exome sequenc-






The completion of a reference genome sequence for humans took more 
than 200 scientists over a decade in a project that cost almost $3 billion 
to complete (International Human Genome Sequencing Consortium 
2004). Over the past decade the price of genome sequencing has plum-
meted, much of the work has become automated and methods have 
improved. These advances mean complete genomes can be sequenced 
quickly and affordably. Human genome sequencing is a special case and 
enjoys much lower cost-per-gigabase than other species due to Illumi-
na’s HiSeq X platform (Watson 2014). Sequencing can allow for the 
identification of genetic variants that affect heritable phenotypes in-
cluding important disease-causing mutations and natural variation that 
can be exploited to improve crops and livestock. Despite the significant 
improvement in sequencing technology, sequencing whole genomes to 
a depth sufficient to find variants that affect phenotypic expression is 
expensive when compared with targeted sequencing. This review will 
focus on exome sequencing: a method which targets only a subset of the 
genome, often the protein coding portion, significantly reducing the 
sequencing space and subsequently the cost. Details of the method, 
available platforms, uses in humans and other species and its benefits 
over whole genome sequencing (WGS) will be discussed.
WHAT IS EXOME SEQUENCING?
The exome has been traditionally defined as the sequence encompassing 
all exons of protein coding genes in the genome and covers between 1% 
and 2% of the genome, depending on species. It may also be extended 
to target functional non-protein coding elements (e.g. miRNA, lin-
cRNA etc.) as well as specific candidate loci. There are two main catego-
ries of exome capture technology: solution-based and array-based. 
In solution-based whole exome sequencing (WES), DNA samples 
are fragmented and biotinylated oligonucleotide probes (baits) are used 
to selectively hybridise to target regions in the genome. Magnetic strep-
tavidin beads are used to bind to the biotinylated probes, the non- 
targeted portion of the genome is washed away and the polymerase 
chain reaction (PCR) is used to amplify the sample, enriching the sam-
ple for DNA from the target region. The sample is then sequenced 
before proceeding to bioinformatic analysis. Array-based methods are 
similar except that the probes are bound to a high-density microarray. 
The array-based method was the first to be used in exome capture 
(Albert et al. 2007), but it has largely been supplanted by solution-based 
methods, which require less input DNA and are consequently poten-
tially more efficient; however, studies by Asan et al. (2011) and Bodi et 
al. (2013) found that NimbleGen’s Sequence Capture Array performed 
better than the solution-based alternatives in low GC content regions; 
had high sensitivity and read mapping rates; and single nucleotide poly-
morphism (SNP) detection from these reads was more specific to the 
target region. This suggests that a niche may remain for the older tech-
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nology. Array-based capture has been used successfully and accurately 
to identify rare and common variants and identify candidate genes for 
monogenic diseases in small cohorts (Ng et al. 2009); however, the 
array-based methods are less scalable owing to the limitation of the 
number of probes that can be accommodated on the array and addi-
tional equipment and time required to process the microarrays.
EXOME CAPTURE PLATFORMS
There are several differences between the available platforms, which are 
constantly being updated and improved. The major providers of exome 
capture platforms are NimbleGen, Agilent and Illumina and each have 
different designs and strengths (Summarised in Table 1). The discus-
sion of the characteristics of each platform will focus on the solution-
based human kits; the performance of kits for other species has not been 
subjected to the same level of comparison.
NimbleGen’s SeqCap EZ Exome Library has the highest bait density 
of any of the platforms, utilising short (55-105 bp), overlapping baits to 
cover the target region (Clark et al. 2011). This approach has been found 
to be an efficient method for enrichment with the least amount of 
sequencing needed to cover the target region and sensitively detect vari-
ants (Clark et al. 2011) and also has a high level of specificity showing 
fewer off-target reads than other platforms (Clark et al. 2011; Sulonen et 
al. 2011). Importantly, this bait design has been found to show greater 
genotype sensitivity and more uniformity of coverage in difficult to se-
quence regions, such as areas of high GC content, than the other plat-
forms (Asan et al. 2011; Sulonen et al. 2011; Bodi et al. 2013). 
Agilent’s SureSelect Human All Exon Kit is the only platform to use 
RNA probes, with the other platforms opting for DNA probes. The 
baits used are longer than those used in NimbleGen’s platform (114-
126 bp) and the corresponding target sequences are adjacent to one 
another rather than overlapping (Clark et al. 2011). This design has 
been found to be good at identifying insertions and deletions (indels) as 
longer baits can tolerate larger mismatches (Clark et al. 2011; Bodi et al. 
2013; Chilamakuri et al. 2014); it has been suggested that this may also 
reduce reference allele bias at heterozygous sites compared to other bait 
designs, however in practice the allele bias has been similar to other 
platforms (Asan et al. 2011; Hedges et al. 2011). The platform has been 
found to produce fewer duplicate reads than NimbleGen, but also fewer 
high quality reads (Sulonen et al. 2011). Bodi et al. (2013) found that 
Agilent had a higher alignment rate and fewer PCR duplicates than 
NimbleGen, but also had less uniform coverage.
Illumina’s TruSeq Exome Enrichment Kit uses 95 bp probes that 
leave small gaps in the target region, with paired end reads extending 
outside the bait sequence during sequencing to fill the gap. This design 
has been found to have a high percentage of off-target enrichment 
(Clark et al. 2011) which reduces its target efficiency compared to the 
other platforms. This kit detects more SNVs in the untranslated regions 
(UTRs) than the other platforms (Clark et al. 2011), though compari-
sons of performance with NimbleGen and Agilent’s “+UTR” kits have 
yet to be performed. Following filtering for duplicates, multiple map-
pers, improper pairs and off-target reads, Chilamakuri et al. (2014) 
found that this platform retained fewer reads (54.8%) than NimbleGen 
(66%) or Agilent (71.7%). At high read counts (>50M), this platform 
outperformed Agilent’s SureSelect in downstream identification of in-
dels (Clark et al. 2011). 
Illumina’s Nextera Rapid Capture Exome and Expanded Exome kits 
are similar to the TruSeq kit in their probe design. They differ from the 
other kits in that they use transposomes to fragment the genomic DNA, 
whereas the other platforms use ultrasonication. These kits have not 
been extensively compared to the other platforms with only Chilamakuri 
et al. (2014) having included Nextera in a comparison study. At the time 
of the study there was only one Nextera kit which was the Expanded 
Exome version: the kit with the larger target region of the two. The 
Expanded Exome kit shares a target region with the TruSeq kit which 
includes UTRs and miRNAs. Chilamakuri et al. (2014) found that the 
Nextera kit had increased coverage of high GC content areas due to 
altered bias in the transposome technology used during fragmentation, 
decreasing its overall uniformity; however recent changes to the proto-
col in the new versions may have improved this. They also found that 
out of all platforms tested, the Nextera platform retained the fewest 
■ Table 1 Summary of the differences between the solution-based exome sequencing platforms
 NimbleGen’s SeqCap  Agilent’s Sure Select  Illumina’s TruSeq  Illumina’s Nextera Rapid  
 EZ Exome Library Human All Exon Kit Exome Enrichment Kit Capture Exome Kit
Probe Sizea 55–105 bp 114–126 bp 95 bp 95 bp
Probe Type DNA RNA DNA DNA
Coverage Strategy High-density,  Adjacent probes Gaps between probes Gaps between probes 
 overlapping probes
Fragmentation Method Ultrasonication Ultrasonication Ultrasonication Transposomes
Target region size (Human)b 64Mb 50Mb 62Mb 62Mb
Reads remaining following 66% 71.7% 54.8% 40.1% 
filteringc
Major strengths (i) High sensitivity  (i) Better coverage of indels (i) Good coverage of (i) Good coverage of 
 and specificity (ii) High alignment rate UTRs and miRNAs UTRs and miRNAs 
 (ii) Most uniform coverage  (iii) Fewer duplicate reads 
 in difficult regions than other platforms 
Major weaknesses (i) More duplicate reads (i) Fewer high quality reads  (i) High off-target (i) High off-target 
 than Agilent than NimbleGen enrichment enrichment 
 (ii) Lower alignment rate    (ii) Coverage bias for 
 than Agilent   high GC content areas   
    reducing uniformity
Non-human supported ✔ ✔	 ✘	 ✘
a As described in Clark et al. (2011)-  NimbleGen SeqCap EZ v2.0, Agilent SureSelect Human All Exon 50Mb, Illumina TruSeq Exome Enrichment
b For NimbleGen SeqCap EZ v3.0, Agilent SureSelect V5, and Illumina TruSeq and Illumina Nextera original versions
c Filtering for duplicates, multiple mappers, improper pairs and off-target reads, data from Chilamakuri et al. (2014)
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reads after filtering for duplicates, multiple mappers, improper pairs 
and off-target reads, at 40.1%. 
Chilamakuri et al. (2014) compared the target regions of the human 
kits from three providers (NimbleGen SeqCap EZ v3.0 – 64.1Mb; 
Agilent SureSelect V4 – 51.1Mb; and Illumina TruSeq and Illumina 
Nextera original version and protocol – 62.08 Mb). Despite the fact that 
all of the platforms are targeting the human exome, there is surprisingly 
little overlap between the three designs with just 26.2 Mb covered by all 
three target regions. NimbleGen’s and Agilent’s coverage are more 
similar to one another than either are to Illumina’s; this is likely due to 
the large amount of UTRs covered in Illumina’s target region. Illumina 
has 22.5Mb of targets unique to their platforms and 21.8Mb of these 
are UTRs. NimbleGen and Agilent have 16.1Mb and 7Mb of unique 
targets, respectively. It would be interesting to see how NimbleGen and 
Agilent’s “+UTR” kits compare to Illumina in SNV calling, particularly 
in UTRs.
Currently, in addition to human kits, NimbleGen offer capture kits 
for maize, barley, wheat, soy, mouse and pig exomes and Agilent offer 
capture kits for mouse, cattle and zebrafish exomes. Both providers also 
offer the opportunity to design custom kits for other species. The kits 
for non-human species use similar bait designs and protocols to the 
providers’ human kits. Both manufacturers offer a flexible design pro-
cess allowing for modifications to improve coverage for specific regions 
and purposes. 
USES IN HUMANS
The first successful use of WES to diagnose and inform subsequent 
treatment in a human patient was in the identification of the causal 
variant of a rare form of Inflammatory Bowel Disease (IBD) in an infant 
(Worthey et al. 2011). In this case conventional diagnostics had failed to 
find an explanation for the patient’s severe symptoms and doctors 
needed to understand the underlying cause of the symptoms before 
they could decide how to treat the child. A multidisciplinary team com-
bined clinical phenotyping, exome sequencing, bioinformatics and 
functional studies, eventually finding the causative mutation which 
influenced the future treatment of the child. The analysis of the exome 
data was hampered by the relative lack of software designed for this 
purpose at the time and researchers had to manually inspect over 2000 
variants. Through filtering and manual inspection the candidate pool 
was reduced to 70 genes exhibiting hemi- or homozygous variants. Of 
these only eight variants were novel and predicted to be damaging to 
protein function. Analysis of evolutionary conservation identified two 
variants that were located in highly conserved sequences and one of 
these had a high null genotype frequency. This left a single hemizygous, 
non-synonymous variant in the X-linked inhibitor of apoptosis (XIAP) 
gene. The child was diagnosed with X-linked lymphoproliferative dis-
ease 2, exhibiting a novel IBD-like manifestation caused by loss of toler-
ance to commensal organisms in the digestive system. This diagnosis 
allowed for effective treatment through allogeneic hematopoietic pro-
genitor cell transplant. The unusual manifestation of the condition 
meant that the patient was unlikely to have been diagnosed without the 
exome sequence data.
Following the success of this initial diagnosis, exome sequencing has 
been used extensively to diagnose novel diseases and find novel caus-
ative mutations for known disease phenotypes. Exome sequencing is 
useful in human medicine for diagnosis of particularly difficult to diag-
nose patients, diagnosis of young patients who may not yet exhibit a full 
spectrum of symptoms (Iglesias et al. 2014), prenatal diagnosis (Iglesias 
et al. 2014; Xu et al. 2014) and early diagnosis of debilitating disease 
(Bras and Singleton 2011; Sassi et al. 2014). In addition to reaching a 
diagnosis, finding the causative mutation can allow for alteration of 
treatment, prevention of further invasive testing, accurate prognoses, 
and confirmed diagnoses which are essential for eligibility for benefits 
and access to clinical trials (Grossmann et al. 2011; Rabbani et al. 2012; 
Taneri et al. 2012; Iglesias et al. 2014) and in the future may allow for 
more targeted treatment.
Exome sequencing in human medicine benefits from the availabil-
ity of large databases of known SNPs, known pathogenic variants and 
control genomes; during analysis variants found in these databases 
can generally be excluded when looking for novel variants, signifi-
cantly reducing the variant pool. The Exome Aggregation Consor-
tium (ExAC) has created a user-friendly database containing the 
exome sequences of over 60,000 unrelated individuals, which is 
freely available (Exome Aggregation Consortium (ExAC) 2014). The 
exomes have been analysed using a uniform bioinformatic pipeline 
and are from individuals with adult-onset diseases. This provides re-
searchers with a large set of reference exomes which should be free 
from homozygous variants that cause childhood-onset Mendelian 
diseases. The database provides a wealth of information such as depth 
of coverage, genotype quality, allele frequency and variant conse-
quences. The filtering capabilities and large number of exomes will 
simplify the process of prioritising variants when using exome 
sequencing as a diagnostic tool, particularly in children. 
Where many unrelated, affected individuals are available, an ‘over-
lap’ strategy can be used to simplify analysis and search for common 
variants likely to affect gene function (Johansson et al. 2012). If there is 
a known inheritance pattern this can be used to search for specific gen-
otype zygosity. Sequencing of multiple affected related individuals can 
also increase the power of the analysis (Johnson et al. 2010; Shi et al. 
2011). In rare diseases, case-parent trios can be used to exclude non-
pathogenic variants found in the parents (Smith et al. 2014). However, 
single patient sequencing may be sufficient to identify the causative mu-
tation (Wang et al. 2011; Worthey et al. 2011; Xu et al. 2014). Analysis 
examining how conserved an amino acid sequence is through evolution 
and between genes in a family can help to increase the confidence of a 
mutation having a deleterious effect (Wang et al. 2011; Johansson et al. 
2012; Sassi et al. 2014; Smith et al. 2014; Xu et al. 2014). 
Examples of diseases for which exome sequencing has been used to 
detect a causative variant include Leber Congenital Amaurosis (Wang 
et al. 2011), Alzheimer’s Disease (Sassi et al. 2014), Maturity-Onset 
Diabetes of the Young (Johansson et al. 2012), High Myopia (Shi et al. 
2011), Autosomal Recessive Polycystic Kidney Disease (Xu et al. 2014), 
Amyotrophic Lateral Sclerosis (Johnson et al. 2010), immunodeficiency 
leading to infection with human herpes virus 8 causing Kaposi Sarcoma 
(Byun et al. 2010), Acromelic Frontonasal Dystois (Smith et al. 2014) 
and a number of cancer predisposition mutations (e.g. Yan et al. 2011; 
Greif et al. 2012; Snape et al. 2012; Kiiski et al. 2014; Cai et al. 2015).
The Deciphering Developmental Disorders (DDD) project aims to 
develop a scalable exome sequencing workflow to facilitate the transla-
tion of the method from the research environment to a clinical environ-
ment. So far over 1,000 children with undiagnosed developmental 
disorders and their parents have been sequenced with plans to increase 
this number to 12,000 patients. With diagnostic yields up to 31% in the 
children sequenced so far, this project demonstrates the future potential 
of the method in a clinical setting (Gecz and Corbett 2015; Wright et al. 
2015; The Deciphering Developmental Disorders 2015).
USES IN OTHER SPECIES
Variants discovery for agricultural improvement
Not all protein-altering variants cause disease (MacArthur and Tyler-
Smith 2010). To understand the potential of exome sequencing in areas 
other than disease variant discovery, which is the main focus in human 
research, we can look to studies using the technique to sequence agri-
cultural species. 
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Plant genomes can be extremely complex, repetitive and are often 
polyploid; as a result some of the most economically important crops 
are not well suited for genome re-sequencing studied. For example, 
Bread Wheat (Triticum aestivum) has an allohexaploid (AABBDD) 
genome around 17Gb in size (Brenchley et al. 2012; The International 
Wheat Genome Sequencing Consortium 2014). This is likely too large 
for subsequent WGS studies at the current price of sequencing and data 
storage. Wheat is an extremely important crop for both human and 
livestock consumption and genetic improvement is slow; with the 
human population increasing and additional challenges from environ-
mental changes it is essential to gain a better understanding of the crop 
in order to improve it. An exome capture kit has been designed for 
wheat based on the accumulated transcriptome data (Winfield et al. 
2012). The capture region for this kit is 56.5Mb, which is around the 
lower estimated size of one diploid wheat exome, and owing to similar-
ity between the three genomes may be sufficient to capture most of the 
exome data from the whole allohexaploid genome. This kit has been 
used to identify induced mutations in the genome to aid studies inves-
tigating gene function, a use that was also applied to the rice (Oryza 
sativa) exome in the same study (Henry et al. 2014) and the soybean 
(Glycine max) exome in a separate study (Bolon et al. 2011). WES in 
soybean has also been used to identify unwanted intracultivar genetic 
heterogeneity in the exome that may affect the plant’s phenotype (Haun 
et al. 2011).
The genome of barley (Hordeum vulgare L.) has not been fully 
sequenced. Barley’s genome is smaller than wheat’s at around 5Gb, but 
is still larger than is practical for routine whole genome sequence analy-
sis and contains repetitive elements that complicate the genome’s 
assembly. A gene space assembly has been produced (The International 
Barley Genome Sequencing Consortium 2012) and a barley exome 
capture kit has been developed based on this assembly (Mascher et al. 
2013). The kit has since been used to identify a mutation involved in 
early maturation, a trait relevant to production (Pankin et al. 2014). 
Exome capture in barley has also been used to identify a gene caus-
ative of many-noded dwarfism (mnd) using mapping-by-sequencing 
(Mascher et al. 2014). The mnd phenotype is a shorter plant with more, 
narrower leaves than the wild type. The mutant in this study was created 
using X-ray mutagenesis; a technique which often causes large dele-
tions. An F2 population between mutant and wild type phenotypes was 
created and 18 mutant individuals and 30 wild type individuals were 
exome sequenced. From these sequences SNPs were identified and al-
lele frequencies of these were used to identify an allele over represented 
in the mutant group. Researchers queried the sequencing reads for 
exome targets that were present in the wild type but not the mutant. 
This lead to the identification of a candidate gene (MLOC_64838.2, 
now HvMND), which has a homolog known to play a role in a similar 
phenotype in rice. Screening of other mutants showing this phenotype 
found a variety of null mutations in this gene. The family to which this 
gene belongs is known to have effects on important production traits 
and may include good selection targets to improve production. 
Identification of new genetic markers
Robert et al. (2014) have designed exome capture probes for the pig, 
used these to sequence the exomes of 96 healthy pigs and identified 
potentially deleterious variants. Bioinformatic analysis identified 
236,608 high confidence predicted variants and 28,115 predicted indels 
in the target region. This work revealed notable gaps in the current 
Ensembl S.scrofa genome annotation and identified a large number of 
potential protein truncating variants. As the pigs tested were healthy, it 
is possible that some of these protein truncating variants have pheno-
typic effects on traits other than those relating to the health of the pigs 
or to the production traits currently under selection. This work is an 
important step in identifying phenotype altering variants in the pig: 
a production animal and medical model.
The barley exome kit has been used to differentiate between markers 
of H. vulgare L. and H. bulbosum L.; H. bulbosum L. is a wild species that 
has superior pathogen resistance and tolerance compared to the 
domestic species and the two can be crossed to improve the domesti-
cated crop, however negative linkage drag on production traits has 
hampered its use in elite barley lines. Using exome sequencing to iden-
tify specific markers can allow selective crossing to be used to incorpo-
rate the beneficial variants without incorporating linked variants that 
are detrimental to production (Wendler et al. 2014). Similarly, the 
wheat exome kit has allowed for discovery of previously unidentified 
markers in the genome which can be used in future genetic studies and 
marker assisted selection (Allen et al. 2013).
Black cottonwood (Populus trichocarpa) has had an exome capture 
kit designed (Zhou and Holliday 2012). P. trichocarpa is a model organ-
ism and was the first tree to have its whole genome sequenced (Tuskan 
et al. 2006). The tree is used in lumber production and in cosmetics. The 
tree has experienced a whole genome duplication fairly recently and the 
exome study found that this does not appear to have had an effect on 
SNP detection through exome sequencing (Zhou and Holliday 2012). 
There is potential to use the identified markers to improve production 
in this species.
Health traits
As with exome sequencing in humans, exome sequencing has been used 
in other mammals to discover variants associated with health traits. 
WES has been used in conjunction with a genome wide association 
study to identify a frameshift mutation causing blindness in Phalène 
dogs (Ahonen et al. 2013). In cattle (Bos taurus), WES has been used 
successfully to identify strong candidate variants for haplotypes relating 
to reduced fertility rates in Holsteins which can be used to selectively 
breed against these detrimental haplotypes (McClure et al. 2014). 
Special considerations for non-human species
For many species, the reference genome is not completed to the same 
standard as the human genome; many species have only a draft genome 
or, as discussed for barley, no reference genome. This is an important 
consideration when using WES in non-human species. Poor annota-
tion of genomes mean that in the design of capture probes, causative 
genes may be missed because they are not annotated whereas with 
whole genome sequencing, the data will be there whether the gene is 
annotated or not. Where available, including predicted genes identified 
from RNA-sequencing data may be beneficial to maximize coverage of 
functional elements in poorly annotated genomes. For example, Robert 
et al. (2014) added an additional 14Mb of data to the capture region in 
pigs using EST evidence. Additionally, errors in the reference genome 
will greatly increase the number of false-positive variant calls in these 
species. This increases computational burden and forces more stringent 
filtering which may inadvertently discard causative variants.
WES may be especially useful for model organisms, particularly 
where the sequences of large numbers of individuals are needed. The 
expense of WGS on large cohorts makes it less feasible in animal studies 
than human studies, particularly in species with fairly large genomes 
such as mice (~3.5Gb) and zeberafish (~1.5Gb), both common model 
organisms. Sequencing a smaller portion of the genome, particularly if 
candidate regions are known and can be targeted, would be more cost-
effective, allow deeper coverage and potentially increase the number of 
individuals that can be used in these studies.
The genomes of animals have different levels of linkage disequilib-
rium (LD), which are often high in domestic species and model organ-
isms with limited effective population sizes. The level of LD may also 
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vary by breed, as demonstrated in the domestic dog (Stern et al. 2013). 
When using exome sequencing to identify causal variants, high LD may 
lead to the identification of a benign variant that is in LD with the caus-
ative variant. In this case, the causative variant may have been missed in 
variant calling or lie outside the sequence space; it is therefore impor-
tant to consider the known function of the element the candidate vari-
ant is associated with and the predicted effect of the variant on function. 
Additionally, efforts to sample individuals that are as outbred as possi-
ble may help to reduce this problem. Another consideration with high 
LD is that it may be possible to use this information in imputation, as 
has been done with other technologies such as imputing genotypes 
from SNP arrays (Hickey et al. 2012), from WGS data (Deelen et al. 
2014; Gudbjartsson et al. 2015) and from human exome data (Auer et 
al. 2012). The larger haplotypes associated with high LD increase the 
accuracy and reduce the computational burden associated with imputa-
tion. Imputation may be less accurate than sequencing; however it 
allows for a larger numbers of individuals to be used at lower coverage 
and may help to reduce problems associated with variable coverage in 
exome sequencing.
EXOME CAPTURE TRANSFERABILITY BETWEEN SPECIES
 The Neanderthal exome was successfully sequenced by Burbano et al. 
(2010) using an exome capture kit designed for the human exome. The 
study compared the Neanderthal exome to human exomes and found 88 
fixed substitutions in 83 genes in the human exomes; these substitutions 
did not appear to be a result of positive selection and may be a result 
of accelerated genetic drift from reduced effective population size in 
humans following historical bottlenecks or reduced purifying selection. 
The kit designed for cattle can also be applied to other bovid species; 
Cosart et al. (2011) demonstrated that the kit could be successfully used 
to capture the exomes of, and identify SNPs in, zebu (Bos indicus) and 
American Bison (Bison bison). This transferability of exome capture 
kits, as also demonstrated in studies involving the sequencing of Nean-
derthals and non-human primates using human capture kits (Burbano 
et al. 2010; Vallender 2011), is possible because despite millions of years 
of divergence, functional elements tend to be highly conserved.
WHY NOT USE GENOME SEQUENCING?
With the price of sequencing falling as rapidly as it has done over the 
past decade, questions have been raised concerning WES’s usefulness in 
the era of affordable WGS. However, WGS is still more expensive than 
WES. The costs of WES consist of the cost of the capture plus the cost 
of sequencing, whereas WGS consists only of the sequencing costs. If 
we assume that the cost of capture remains fixed, then as the costs 
of sequencing fall, the cost of WGS will approach the cost of WES. 
However, at present that is not the case; and it would be unwise to 
assume that the cost of sequence capture will not reduce. 
Human genomes are a special case, in that the HiSeq X platform 
offers a cost-per-Gb far less than other platforms, yet is limited (contrac-
tually, rather than technically) to 30X WGS human genomes (Watson 
2014). However, even given that advantage, the $1000 price tag for a 30X 
human genome is (in our estimate) two- to three- times the cost of a 40X 
human exome (depending on scale). It may be advantageous to sequence 
more samples using WES, and gain statistical power, than to sequence 
more of the genome. In other species, the price difference is even higher 
– for example, in pigs (a similar sized genome to human but currently 
without the benefit of access to the HiSeq X platform) we estimate the 
cost of WGS to be 9-10 times the cost of WES (Robert et al. 2014).
While WGS does have benefits over WES, the cost of this technolo-
gy is more than simply the price of sequencing. While sequencing tech-
nology has been improving at a much faster rate than would be pre-
dicted by Moore’s law (a prediction of improvement in computing 
hardware, but often also applied to other technologies), the technology 
for storing and analysing the data has not seen a matching acceleration 
in improvement (Mardis 2010; Sboner et al. 2011). WGS produces 
around one hundred times the data that WES does at the same cover-
age. The infrastructure needed to store, manage and analyse data sig-
nificantly increases the costs of WGS. WGS produces a much larger 
number of variants than WES does, not only because of the size of the 
sequencing space, but because regions outside the exome are less well 
conserved; while this number might include a variant of interest, the 
larger data set significantly increases the computational burden for 
analysis. Additionally variation in non-coding regions is less well 
understood than variation in the coding region (Mu et al. 2011; Mau-
rano et al. 2012; Ward and Kellis 2012), making it more difficult to pre-
dict which variants might be relevant to a trait of interest in WGS data-
sets. The majority of causative variants identified so far in Mendelian 
disease have been found in coding regions (Botstein and Risch 2003), 
although ascertainment bias is likely to play a role in this conclusion. A 
study investigating functional non-coding variants based on WGS data 
from 1092 human genomes showed that functionally deleterious non-
coding mutations were under strong negative selection, in a similar way 
to that of loss-of-function variants in protein-coding regions (Khurana 
et al. 2013). The authors developed a tool to prioritize non-coding vari-
ants in disease studies, which was used to identify non-coding candi-
date drivers in tumour genomes.
With the continuous decrease in sequencing cost, new studies mak-
ing use of WGS to investigate causative variants will lead to the discov-
ery of additional mutations in regulatory elements that contribute to 
the pool of disease-associated variants. In that context, the sampling 
bias currently observed towards coding variants is likely to be reduced 
by WGS investigations of non-coding genomic regions.
However, cost is not the only consideration. WGS covers the whole 
genome at more consistent coverage than WES, can provide more 
accurate detection of structural variants and does not have reference 
sequence bias caused by probe sequences in WES (Majewski et al. 2011; 
Meynert et al. 2014; Belkadi et al. 2015). Recent studies have highlighted 
and suggested roles for promoters (The Fantom Consortium et al. 2014) 
and enhancers (Andersson et al. 2014) in a range of different cell types, 
and these are not traditionally captured by exome sequencing. Impor-
tantly, WES requires prior knowledge of the location and sequence of 
features in order to target them, whereas WGS covers the entire ge-
nome. This means that exome sequencing relies on the accuracy of the 
genome annotation, so phenotype altering variants may be missed in 
poorly or incompletely annotated genomes. It is therefore important to 
take care when designing the capture region or purchasing a commer-
cial kit to ensure any specific regions of interest are included. Exome 
sequencing also invariably fails to successfully capture the entire target 
region (Asan et al. 2011; Bodi et al. 2013; Chilamakuri et al. 2014; Rob-
ert et al. 2014), causing even properly annotated regions to be missed. 
Another consideration is that exome sequencing involves a PCR stage 
which is known to reduce coverage of GC-rich regions (Kozarewa et al. 
2009; Veal et al. 2012). New sequencing technology has allowed for se-
quencing of DNA without the need for DNA amplification, generating 
sequencing from single molecules. This technology can produce accu-
rate, longer reads without the artefacts and biases associated with the 
amplification process in other sequencing methods and the exome cap-
ture stage of WES (Shin et al. 2013). The longer read length in these 
third-generation sequencers is particularly beneficial for detecting 
structural variants and for resolving repetition in assemblies and copy 
number variable regions (Roberts et al. 2013). However, for now the 
price of this long-read sequencing is still prohibitively expensive and is 
not commonly in use for analysis of genetic variation. In the future as 
these sequencers improve and prices come down they may make WGS 
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more attractive to researchers even if their analysis focusses solely on 
the protein-coding region and known functional elements. 
The power of WGS on a large cohort for variant discovery has 
already been demonstrated by Gudbjartsson et al. (2015), who se-
quenced the whole genomes of 2,636 Icelanders to 20X and imputed the 
sequence variants into 101,584 further chip-genotyped and phased 
individuals from the same population. This allowed for discovery of 
6,795 null mutations in 4,924 genes which may play a role in disease. 
They also found evidence of lethal mutations that are not found in the 
homozygous state, which likely impact on fertility in heterozygous cou-
ples. Imputation reduces the amount of sequencing and data storage 
required, though the study found that fewer null mutations were 
detected in the imputed data set suggesting that some mutations were 
missed in these individuals.
WGS will eventually take a leading role in genome interrogation; 
however, it will likely have to wait for data storage and analysis to 
improve before its full potential can be realised. In the meantime, WES 
provides many of the benefits of WGS with lower storage requirements 
and computational burden, at an affordable price. This is particularly 
useful in large scale studies, for example, a recent study sequenced the 
exomes of over 9,000 people (Schick et al. 2015). It is also useful for the 
sharing of information such as in the ExAC database where there are 
over 60,000 exomes stored. WES will likely also remain the method of 
choice in species with exceptionally large genomes, for example in some 
polyploid plant species.
CONCLUSIONS
Exome sequencing is a technology that allows interrogation of the most 
well understood portion of the genome: the protein-coding sequence 
and functional elements. Variants of interest don’t necessarily fall with-
in the exome, but so far most of the known variants responsible for 
Mendelian disease have been found in the coding region and the target 
region can be extended to include other regions of interest. While the 
falling price of sequencing may soon make genome sequencing more 
attractive, the additional costs of data handling and downstream analy-
sis cannot be ignored. The applications of variant discovery, particu-
larly in disease gene identification, cannot afford to wait for data storage 
and processing technology to catch up to sequencing improvements. 
The amount of data produced by WES is far more manageable than 
WGS; particularly for small research groups and groups studying 
organisms with large genomes. WES has established itself as an impor-
tant method in disease gene identification in humans, and increasingly 
in domestic species. The applications of WES in crop research is allow-
ing genomic techniques to be used in species with complex genomes, 
potentially identifying variants important for production that can be 
incorporated into marker-assisted selection. At present, WES is a useful 
and powerful method for variant discovery within coding regions offer-
ing most of the benefits of WGS while allowing for easier analysis and 
storage of the data produced.
However WGS will eventually be the NGS technology of choice with 
regard to the investigation of genomic variations due to the more uni-
form coverage achieved with WGS-versus WES- including coverage 
within the exome (Belkadi et al. 2015) and the more uniform distribu-
tion of sequencing quality parameters (e.g. coverage depth, genotype 
quality) observed with WGS- versus WES-(Meynert et al. 2014; Belkadi 
et al. 2015). Additionally WGS extends the variation search space to the 
whole genome allowing for the additional detection of non-coding vari-
ants (The 1000 Genomes Project Consortium 2012), the functional 
impact of which is becoming easier to interpret with the systematic 
annotation of functional non-coding elements (The ENCODE Project 
Consortium 2012; Ward and Kellis 2012; Andersson et al. 2014; The 
Fantom Consortium et al. 2014).
Ideally -regardless of sequencing costs and storage limitations-, 
integrated approaches combining the advantages of both WES and 
WGS would be beneficial for variant discovery studies with the addition 
of WES-/WGS-exclusive variants with WES providing additional vari-
ants missed in low-coverage dataset (The 1000 Genomes Project Con-
sortium 2012). Additionally, both technologies’ usefulness depend 
on the quality of the reference assembly that the sequenced reads are 
mapped to; poor quality references increase the number of false- 
positive variants identified in the analysis, which inevitably leads to 
more stringent filtering, increasing the potential for discarding a variant 
of interest. In the future, the improvement of reference assemblies, 
bioinformatic tools and sequencing technology will be necessary to 
improve the power of variant discovery techniques. 
The term “exome” may no longer be appropriate for a technique 
which is simply a subset of the more generic technique of sequence 
capture. It is already possible to extend the exome capture region 
beyond protein coding genes to capture non-coding genes, and regu-
latory elements such as promoters and enhancers. In this way, we may 
sequence all of the functional areas of a genome without the cost of 
sequencing everything. Indeed, as clinically important variants are 
discovered, the paradigm may change to sequencing small panels 
of genes that are known to be relevant to disease, as is common in 
cancer genomics.
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